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The synthesis of cavitand-capped porphyrin ligands, with a view towards their potential as 
ligands in homogeneous catalysis, is described.  The ligand apertures, one of which is outlined 
in the figure below, are focal with the aim of synthesising a ligand which can control access to 













The general structure of the target ligand. 
 
Synthesis of the target ligand (where R' = CH2 in the figure presented) was attempted via two 
pathways.  Synthesis commenced by using an in situ protocol, which used successive 
functionalisation of the cavitand structure towards the required aldehyde precursor for porphyrin 
formation.  It was found that subsequent in situ cyclisation and porphyrin formation was 
hindered by steric factors, arising directly from the short -CH2O- bridges used to link the 
cavitand to the porphyrin.  Ligand synthesis was thus unsuccessful. 
 
In a second approach, the porphyrin was synthesised in isolation before being coupled with the 
cavitand in a direct capping protocol, which gave more promising results.  In the case of R = 
C11H23 (in the figure above), preliminary UV-Vis analysis indicated a successful synthesis.  
Subsequent analysis of the reaction product by NMR techniques and mass spectrometry could 
not conclusively confirm the synthesis of the target ligand.  The synthesis could therefore not be 






Computational chemistry was used to investigate synthetic results, and therefore the viability of 
using the -CH2O- bridges to afford limited access to the porphyrin active site.  By using 
molecular mechanics, -CH2O- bridges were found to be too short, giving an aperture of 
insufficient size to enable only the terminus of a linear paraffin to gain access to the inner cavity 
of the ligand.  Further investigation using molecular dynamics indicated that a ligand bearing 
bridges four or five atoms in length would afford an aperture of the desired size to accommodate 
the terminus of a paraffin exclusively. 
 
Consequently, synthesis was redesigned towards the preparation of two new ligands, bearing -
O(CH2)2O- (four atom, R' = O(CH2)2 in the figure above) and -O(CH2)3O- (five atom, R' = 
O(CH2)3 in the figure above) bridges.  Using 2-phenylethyl feet (R = CH2CH2C6H5 in the figure 
presented) and adopting the in situ synthetic protocol, both ligands were successfully 
synthesised.  Characterisation using UV-Vis and NMR spectroscopic techniques, as well as 
mass spectrometry confirmed that both ligands had been obtained pure.  Additionally, the in situ 
cyclisation (in both ligands) was performed via the use of microwave heating, a technique 
hitherto unreported.   
 
A viable synthetic route was thus established for the preparation of two new cavitand-capped 
porphyrin ligands towards their use in size-selective catalysis. 
 
In addition, a number of crystal structures of synthetic intermediates are described, five of 
which are newly reported.  These illustrated notable structural features regarding 
resorcin[4]arene cavitands and their abilities as host molecules.  In particular, the structure of 
the aldehyde precursor to capped porphyrin formation following the (initial) in situ synthetic 
protocol was significant in illustrating the reason as to why in situ cyclisation was unsuccessful 
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“By its very essence, by its ability to create and through the beauty of its objects, chemistry is an 
art as well as a science.  Indeed, it fashions entire new worlds that do not exist before they are 
shaped by the hand of the chemist, just as matter, shaped by the hand of the sculptor, becomes a 
work of art.” 
 









The concept above, put forward by J-M Lehn,[1] that chemistry can be regarded as an art as well 
as a science is particularly apt in describing the discipline of supramolecular chemistry, and the 
development thereof.  The creativity and diversity which so clearly defines the field has seen the 
discipline receive the 1987 Nobel Prize in Chemistry [2] (shared by J-M Lehn, D.J. Cram and C. 
Pedersen), and has led it to be regarded as one of the most dynamic and actively pursued fields 
of chemistry.[3]  Certainly, research involving supramolecular chemistry is having significant 
implications for a vast number of related scientific fields, ranging from chemical technologies 
and material sciences, to biological and medical sciences.  
 
In order to define supramolecular chemistry and to grasp its importance, it is vital to understand 
its place in the science of chemistry, and more importantly, the fundamental concepts on which 
supramolecular chemistry is based.  Synthetic chemistry, or more broadly, molecular chemistry 
is concerned with the breaking and forming of covalent bonds.[4]  Supramolecular chemistry, as 
shown in Figure 1.1,[5] represents the next step in terms of complexity beyond the molecule: the 
aggregation of molecules.  Supramolecular chemistry is therefore concerned with non-covalent 
molecular interactions, or intermolecular forces (as opposed to interatomic forces).[1]  These 
interactions are thus largely centered around ion-ion, ion-dipole, dipole-dipole, hydrogen 
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Figure 1.1: Schematic representation of the relationship between molecular and supramolecular chemistry. 
 
1.2 Biological Systems 
 
Biological systems have played a fundamental role in the development of supramolecular 
chemistry, often serving as both the origin and inspiration of research into supramolecular 
systems.[5]  These systems are considered to be ideal supramolecular arrangements.[6]  This is 
not surprising when taking into account the highly selective, specific and cooperative nature of 
chemistry taking place in biological systems: nature has an abundance of supramolecular 
structures, in the form of the proteins which constitute enzymatic receptor sites, genes, anti-
bodies and ionophores.[6]  These structures serve to selectively interact with species such as 
substrates, inhibitors, co-factors, drugs and antigens; interactions which are largely reliant on 
those abovementioned intermolecular forces.   
 
Therefore, extensive efforts are undertaken to model and/or mimic biological systems with 
simpler, abiotic synthetic analogues, so hoping not only to gain a better understanding of 
biological systems and processes, but also to harness and apply their potential to humanity’s 
needs.  This is particularly true of processes involving enzymatic catalysis of organic chemical 
reactions, and the selective transportation of ions or molecular species, such as oxygen.[6] 
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With the biological basis of this field of chemistry in mind, the fundamental concepts 
surrounding research into today’s supramolecular chemistry can be seen to lie in three 
fundamental principles described by various scientists a century ago: 
 
1. Molecules cannot interact if they cannot, in some way, coordinate.[7] 
2. The coordination of one molecule to another must be selective.[8] 
3. The coordination cannot be selective unless the partners 
involved have a unique affinity for each other, and experience 
a unique interaction.[9] 
 
Thus, molecular reception, selective coordination and recognition are at the core of 
supramolecular chemistry. 
 
It is essential that a key and clear distinction be drawn with regards to interactions within 
biological and biomimetic supramolecular systems: that between host molecule and guest 
molecule.  As will be discussed, the concept of host-guest chemistry embodies the three core 
principles of supramolecular chemistry outlined above, and is vital to the understanding of the 
majority of biomimetic supramolecular chemistry.  
 
1.2.1 Host-Guest Systems 
 
Small molecules are extensively involved in isolation, sequestration and selective reactions 
within biological systems.[1, 10]  These processes are largely facilitated by recognition events at 
a biomolecular level.  One of the major themes within bioorganic and –inorganic chemistry is 
the design of complexes and molecules that are able to mimic the active site responsible for 
these recognition events.[11]  As such, perhaps the most influential force behind the 
development of host-guest systems has been the challenge of understanding and reproducing the 
action of biological processes involving enzymes and nucleic oligomers.[12]  It was enzymes 
which served as inspiration to 1987 Nobel laureate,[13] D.J. Cram, to initially enter into the field 
of supramolecular chemistry and the design and synthesis of simple organic species to imitate 
naturally occurring complexes.[14, 15] 
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Enzymes and nucleic oligomers, such as RNA, are well known to bind various substrates and 
catalyze reactions with remarkable efficiency and selectivity, particularly in the case of 
enzymes.  In an enzymatic system, a reaction initiates and terminates with the respective 
complexation of a substrate and decomplexation of product.  In addition, in many such systems, 
the initiation and/or termination steps are often the rate determining steps of reaction.  A clear 
distinction can be made with regards to the role of the substrate and enzymatic protein, as 
shown schematically in Figure 1.2.  The enzyme (in grey) is accommodating the substrate (in 
blue) in its hydrophobic pocket, so acting as a host.  Consequently the substrate is a guest 









Figure 1.2: Schematic representation of an enzymatic reaction. 
 
The distinction between host and guest molecules thus lies in their respective binding sites as 
well as the type of atoms which characterise the molecules.  Hosts have convergent, usually 
concave, cavities as binding sites and are characterised by atoms that are Lewis base donors 
(such as oxygen, nitrogen) or hydrogen bond donors.  Conversely, guests have divergent, 
usually convex, binding sites and are characterised by Lewis acids (such as metal cations) or 
hydrogen bond acceptors (such as halides).[6, 14, 17]  Together, they form a complex (Figure 
1.2), where the guest is coordinated to the host reversibly, by non-covalent forces (as mentioned 
above).   
 
It is particularly important to note that the respective shapes and sizes of the host and guest are, 
in the case of enzymes especially, complementary to each other.  This facilitates the unique 
interaction shared between the substrate and enzyme, and consequently the selective reaction 
which the substrate experiences.  It is these qualities which synthetic, abiotic host-guest systems 






Within synthetic host-guest systems, a further distinction is made with regards to complex 
stability.[6]  Complexes, where the host is stable in a solid or crystalline state and where 
dissociation occurs in solution, are referred to as inclusion complexes, or clathrates.  In slight 
contrast is a second category of host: those hosts which exhibit significant binding in both the 
solid and/or solution state. It is this second type of host which is the focus of this work.   
 
Biological hosts (such as enzymes and nucleic oligomers) have had millions of years to evolve 
into the effective hosts that are seen.  Synthetic hosts have by contrast only had a little over half 
a century to develop and, therefore, considerable limitations are found within synthetic 
recognition systems, particularly in the form of the absence of significant, strong interactions 
between host and guest molecules.[18]  Thus, compared to their natural counterparts, synthetic 
host molecules are relatively limited.  In addition, very few of these synthetic hosts have 
enforced cavities through which to accommodate guest molecules.[12] 
 
It is generally regarded that the three most common types of host [19] thus far reported by 
researchers in the field of host-guest chemistry are cyclodextrins (CDs), crown ether-based 




Due to the lack of obvious synthetic hosts with cavities sufficiently large enough to 
accommodate guests, much of the pioneering research into host-guest chemistry was undertaken 
using molecules obtained from natural sources.  Cyclodextrins (CDs) represent one of the more 
common of these naturally synthesised molecules.  CDs are regarded as the molecules through 
which the interest in three-dimensional cavitied hosts originated.[20]  Much of the initial 
research into the use of CDs as hosts was undertaken by Cramer [21, 22] who focused research 
towards the inclusion complexes resulting from CDs; this as early as the 1950’s.  CDs are used 
extensively today as host molecules in wide ranging applications, more recently most notably in 
the pharmaceutical industry.  Exhaustive reviews pertaining to applications are available.[23-25] 
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CDs are the product of enzyme-catalyzed digestion of starch, the most common of which are 
α, β and γ CD composed of six, seven or eight glucopyranoside units, respectively, cyclically 





























α: p = 12, q = 6
β: p = 14, q = 7
γ: p = 16, q = 8
n
β: n = 2, d = ~0.78 nm
γ: n = 3, d = ~0.95 nm














Figure 1.3: Structures and characteristics of α, β and γ cyclodextrins. 
 
As depicted in Figure 1.3, the ether oxygen atoms and their associated hydrogen atoms face 
inward, with the hydroxyl groups outward. This results in a bowl-shaped hydrophobic cavity in 
the centre of the macrocycle into which guests can be bound in addition to offering substituent 
groups (the hydroxyl groups) that can easily be functionalised at the primary and secondary 
faces of the macrocycle.[17]  This arrangement and the properties of the macrocycle form 
perhaps a blueprint of properties which ideal host molecules should possess: 
 
1. structural preorganisation and rigidity 
2. an enforced hydrophobic cavity which guests can occupy 
3. substituent groups which can be functionalised 
 
CDs also illustrate the remarkable physico-chemical changes which guest molecules experience 
on inclusion into the cavity of a host molecule.  These changes underline the importance of 
hosts with enforced cavities as a means of studying and mimicking biological processes.  Guests 
can undergo:[25] 
 
1. enhanced solubility 
2. stabilisation (particularly for labile guest molecules) 
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3. decreased volatility and sublimation 
4. physical isolation 
5. managed uptake and release 
 
CDs offer particularly attractive characteristics on which to build effective host molecules, and 
in addition are water soluble.  These qualities make them particularly attractive in biomimetic 
research since biological processes occur in aqueous media.  However, CDs generally need 
extensive functionalisation to ensure a rigid and predictable geometry.  Moreover, as evident in 
Figure 1.3, the cavities of the three most common CDs range from 0.57 nm to 0.95 nm.  Given 
that for an ideal host-guest system, the guest size and shape is complementary to that of the 
host, CD cavity size proves to be too large for the majority of guests, making CDs unattractive 
as hosts for many applications.[27] 
 
1.2.3 Crown Ethers 
 
As the second class of supramolecular host molecules, crown ethers represent a milestone; that 
of the first truly synthetic host molecules.  Among the more appealing and simplest macrocyclic 
structures,[6] their discovery by Pedersen [28] (1987 Nobel Prize laureate) was both fortuitous 
and important, for it showed that host-guest complexes were a synthetic possibility.   
 
Crown ethers are structurally very simple, consisting of a cyclic arrangement of ether oxygen 
atoms linked by organic bridges, usually -CH2-CH2- carbon (ethyl) spacers.
[29]  Their ability to 
act as host molecules is primarily due to the oxygen atoms present in the crown structure; as 







n = 1: [15]-crown-5
n = 2: [18]-crown-6




Figure 1.4: Structure of the three most common crown ethers. 
 
Heteroatoms other than oxygen, in particular nitrogen and sulphur, have also been included as 
part of crown macrocycles.  Extensive reviews covering crown ethers and their derivatives are 
available.[30, 31] 
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The heteroatoms, as excellent Lewis bases, are able to interact with potential guests and allow 
for their coordination into the cavity of the macrocycle.  Guests are usually metal cations 
(including lanthanide species), but anions and neutral guests have also been known to be 
coordinated by crown ethers.[6, 31, 32]  Due to their cyclic nature, these molecules are known to 
have a high degree of selectivity with regards to guest coordination, particularly in cation 
binding.  The cavity for [15]-crown-5 is particularly complementary to the size of a sodium 
cation, that of [18]-crown-6 for potassium cations, and [21]-crown-7 for cesium cations.[6]  
Crown ethers therefore show a degree of size selectivity for cationic guests.  It should be noted, 
however, that the apparent “hole-size relationship” alone does not account for the degree of 
selectivity seen in its entirety: the effective nuclear charge of the cations has a significant 
influence on complex formation and stability.[33]   
 
The cation coordination abilities of crown ethers are illustrated in Figure 1.5 [14] using [18]-























Figure 1.5: The selective potassium coordinating ability of [18]-crown-6. 
 
Crown ethers can undergo a degree of functionalisation at the heteroatoms and at the ethyl 
bridges to allow for the incorporation of rigidity into the crown ether structure. 
Functionalisation includes the incorporation of aromatic residues as bridges, as well as the 
appending of aromatic and crown residues to heteroatoms.[31, 32]  Crown ethers have also been 
elaborated via functionalisation with binaphthyl-based substituents into receptors capable of 
enantiomeric recognition of chiral amine derivatives, amino acids and other biologically 
important molecules.  A review of such crown macrocycles has been published.[34] 
 
In perhaps the first example of three dimensional synthetic hosts, J-M Lehn used Pedersen’s 
crown ether macrocycles as a basis on which to construct cryptands.[1]  By using a bicyclic 
macrocycle, it was anticipated that metal cations in particular could be completely incarcerated 
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within the crown-like three dimensional cavity.  Such an arrangement becomes beneficial in 
terms of cation selectivity and transport.  The structures of the most common members of the 
cryptand family can be seen in Figure 1.6.[6] 
 
n = 1: [2.2.1]cryptand











Figure 1.6: Structure of the two most common cryptands. 
 
For [2.2.2]cryptand, relative to its crown ether analogue [18]-crown-6, it too coordinates 
potassium cations selectively due to the similarity in cavity sizes.  However, its ability to bind to 
potassium cations is four orders of magnitude larger than that of its crown ether analogue.[1]  
This enhanced binding ability of the cryptand is solely due to the three dimensional cavity of the 
macrocycle, which allows for a degree of spherical recognition to occur among metal cations.[6]  
This situation is repeated in the case of [2.2.1]cryptand, where the binding of sodium cations is 
significantly enhanced relative to the crown ether analogue. 
 
1.2.4 Arene-based Systems 
 
As the third class of host molecules, arene-based hosts are arguably the most extensively 
researched type of host.  The versatility and stability of aromatic structures has undoubtedly led 
to their popularity, and there exists a multitude of such host systems all bearing unique 
structures, properties and applications.  Among the more common of these hosts are spherands, 
cyclotriveratrylenes, cryptophanes, cyclophanes and calixarenes. Sample structures of these 
hosts can be seen in Figure 1.7.[33, 35-37] 
 
It is clear from Figure 1.7 that the different hosts have varying structures, and different cavities 
in terms of both shape and depth.  However, it is calixarenes and their related hosts which are of 
interest in this study due to their inherent bowl-shaped cavity (evident above in Figure 1.7) of 
sufficient depth to accommodate guests.  Reviews pertaining to the other arene-based variants 































































Figure 1.7: Sample structures of arene-based host variants. 
 




Calixarene chemistry is arguably among the earliest synthetic chemistry, with research (on the 
then largely uncharacterised compounds) dating back to as early as 1872.  It was not until C.D. 
Gutsche’s work on the construction of suitable enzyme mimics in 1972, however, that 
calixarenes were formally characterised.[6, 38]  Known more appropriately as calix[n]arenes 
where n refers to the number of aromatic residues in the macrocycle,[38, 39] calixarenes are a 
family of cyclic oligomers which are products of the alkaline condensation of p-alkylphenols 
with formaldehyde.[38]  Conditions during synthesis may be varied so that aromatic residues in 
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the macrocycle can number from a minimum of four (for the most common macrocycle, 
calix[4]arene) to as many as sixteen.[6, 39, 40]  It can be seen in Figure 1.8 [39, 41] that 
calix[4]arenes possess a bowl shape much like CDs, thus facilitating their use as effective host 




























Figure 1.8: The general structure of calix[4]arene. 
 
As with CDs, calix[n]arenes can be extensively modified, particularly at the phenolic hydroxyl 
group, and on the aromatic rings, at the extra-annular (R) position para to the hydroxyl 
group.[36, 41, 42] Therefore, the number of calix[n]arene derivatives is vast, allowing the use of 
calix[n]arenes to act as hosts for metal cations, particularly those of the alkali earth metals,[43] 
as well various lanthanides and actinides,[43a, 44] organic cations,[45] anions [46] and neutral 
molecules.[47]  Reviews dealing with the different types of calixarene derivatives and their 
applications are available.[48] 
 
However, what makes calix[n]arenes more versatile than CDs and crown ethers is that, through 
facile modification, control over calix[n]arene conformation can be achieved.  As shown in 
Figure 1.9,[42] calix[4]arene can exist in four different conformers, due to the free rotation 
possible about the methylene spacers between the aromatic residues.  The conformation that 
calix[4]arene takes on can be greatly influenced by functionalisation of the phenolic hydroxyl 







































Figure 1.9: The four stable conformers of calix[4]arene. 
 
In solution, however, a cone conformation with C4v symmetry is preferred, largely due to the 
stabilisation offered by the intramolecular hydrogen bonding that occurs between the hydroxyl 




















Figure 1.10: The hydrogen bonding present in the cone conformer of calix[4]arene. 
 
The high degree of symmetry of the cone conformation makes it a particularly attractive and 
effective host.  Ideally, host binding sites should be spaced somewhat apart from one another so 
as to minimise any repulsive forces which may arise between them, but arranged so as to allow 
for simultaneous interaction with guests.  Such a design allows for more favourable host-guest 
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interaction and a more stable complex.[6, 49]  This highly symmetrical conformation allows for a 
more effective host molecule. 
 
Calix[4]arenes are clearly versatile hosts, able to accommodate a wide variety of guests.  They 
are also versatile in terms of functionalisation and can be customised to provide cavities of 
varying shape (as seen by possible conformers).  However, although enhancing their versatility, 
their ability to change conformation, as seen in Figure 1.9, compromises the cone shape, which 
in turn compromises the favourable C4v symmetry.  Bearing in mind that the hydrogen bonding 
shown above offers some structural rigidity, a potential means of ensuring a more rigid 





Resorcin[4]arenes, like calix[4]arenes, also possess a similar bowl-type shape, so can also be 
used as effective host molecules.  However, synthesis, as established in particular by 
Högberg,[50] and structural properties of resorcin[4]arenes are remarkably different to those of 
calix[4]arenes.   
 
Resorcin[4]arenes are the result of the acid-catalyzed condensation of aldehydes (notably, 
except formaldehyde) and resorcinol.[41]  The use of resorcinol results in a significantly 
different structure to that of calix[4]arene, as seen in Figure 1.11.[6, 39, 51]  It is immediately 
noticeable that resorcin[4]arenes have eight hydroxyl groups at the upper rim of the macrocycle, 
as opposed to four at the bottom of a calix[4]arene macrocycle.  In addition, resorcin[4]arenes 
have two sites at which functionalisation can occur, R1 and R2.  By changing the length and 
nature of the organic substituents at R1, the ‘feet’ of the macrocycle, a degree of control over the 
resorcin[4]arene solubility can be attained.  Functionalisation at the extra-annular position (R2) 
allows a degree of control over the type of guest the cavity may interact with, depending on 













































Figure 1.11: The general structure of resorcin[4]arene. 
 
As in the case of calix[4]arenes, the hydroxyl groups are hydrogen bonded to each other as 
shown in Figure 1.12,[6] which stabilises resorcin[4]arenes such that it preferentially assumes a 
cone-type structure again possessing C4v symmetry.  However, since the hydroxyl groups are on 
the upper rim, the hydrogen bonding results in a wider and shallower cavity for 





























Figure 1.12: The hydrogen bonding present in the cone-type conformation of resorcin[4]arene. 
 
Resorcin[4]arenes have five predominant arrangements in terms of macrocyclic conformers.[51] 
However, in contrast to calix[4]arenes, the interaction of hydroxyl groups and substituents (R1 
and R2) in the structure of resorcin[4]arenes makes the macrocycle more rigid.  Thus, unlike 
calix[4]arenes, resorcin[4]arenes are unable to undergo conformational interchange via free 
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rotation about the alkyl bridges connecting the four aromatic residues to “partial cone” or 
“alternate” structures (see Figure 1.9). What, therefore, results is a host whose basic cone shape 
is maintained by its structural properties, and whose symmetry is largely conserved.   
 
1.3.3 Resorcinarene Cavitands 
 
Resorcinarene cavitands, or more commonly cavitands, as pioneered by Cram et al.[52] 
represent a class of synthetic organic host macrocycles with an enforced cavity which is of a 
size suitable to accommodating guest molecules and ions.[51]  
 
The synthesis of cavitands is accomplished relatively simply using resorcin[4]arenes as a basis 
from which to work.  While resorcin[4]arenes are rigidified by relatively weak hydrogen 
bonding interactions (Figure 1.12), cavitands by contrast are rigidified by covalent interactions; 
that is, by covalently bonding adjacent hydroxyl groups.  What results on completing such 
bridging is a cavitand, a host molecule that has a fixed cone shape with fixed C4v symmetry, by 
virtue of the fact that cavitands have highly limited conformational flexibility.  This therefore 
gives a particularly effective host molecule with perhaps ideal host qualities, in terms of both 
structural preorganisation and rigidity, and an enforced cavity to accommodate guests.  The 









































Figure 1.13: The general structure of a cavitand. 
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It can clearly be seen that by bridging the aromatic residues, they are bound to each other 
covalently on either side by two bonds.  This clearly and completely inhibits any conformative 
lability, such that the cavitand has an enforced cone-shaped cavity.  Methyl bridged cavitands 
(R3 = CH2) are most common, as shown in Figure 1.14, but ethyl and propyl bridges,
[53] as well 




































Figure 1.14: General synthesis of a methyl bridged cavitand. 
 
As with resorcin[4]arenes, the feet of the cavitand at R1 can be synthetically varied in its alkyl 
or aromatic character in order to control cavitand solubility.  Cavitands have been made water 
soluble via the use of hydroxyl, glycolic and phosphate feet.[55, 56]   
 
Extensive modifications can occur at R2 depending on potential guests, be they anionic, cationic 
or neutral in nature.  Modifications range from the attachment of simple alkyl chains and 
heteroatoms,[53] to aromatic and pyridinium substituents [57a] (able to complex p-cresol and p-
toluenesulphonate), various hydroxyl and carboxylic groups [57b] (able to complex metal 
cations in aqueous medium), aromatic amines [57c] (able to complex cyclic adenosine 
monophosphate, as well as adenosine mono-, di-, and triphosphate), and other macrocyclic and 
supramolecular structures such as hexamethylenetetraamine [57d] and crown ethers [57e] (able to 
complex aromatic carboxylates and cations, respectively).  All the reported complexes are 1:1 
for host:guest.   
 
More interesting modifications include the use of dendritic glycols which were used effectively 
to enhance the solubility of both cavitand and aromatic guest in aqueous medium,[56] as well as 
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peptide substituents which were used to complex species such as acetonitrile.[55, 57f]  
Complexes reported again exhibited 1:1 host:guest ratios. 
 
Guest selectivity and cavity shape and depth can be controlled by varying the structure of the 
bridge.  As mentioned, aromatic bridges may be introduced so adding to the number and nature 
of guests which can be accommodated into the cavitand cavity.  Considered the second 
generation of cavitands, ‘deeper’ cavitands, as first synthesised by Cram et al.,[52] make use of 
bridges such as quinoxaline, as shown in Figure 1.15 [14] to produce a cavitand with ‘walls’.  
This results in a cavity shaped like a vase, which is able to accommodate larger guest molecules 























Figure 1.15: The structure of a deepened cavitand as synthesised by Cram et al. 
 
Such cavitands are particularly effective in complexing large guests such as substituted 
benzenes and naphthalenes.[58]  Deeper cavitands have also been elaborated such that very large 
guests such as C60 (fullerene) have been complexed within its cavity.
[59]   
 
Recently, Rebek et al. and Diederich et al. have used Cram’s deeper cavitands as a basis on 
which to construct partially and asymmetrically bridged deeper cavitands which have found 
interesting applications.  Rebek et al.[59, 60] have synthesised cavitands which have two or three 
quinoxaline moieties selectively placed resulting in a range of partially bridged cavitands.  
Rebek et al. have also varied bridging moieties.  Cavitands with bridges bearing 
carboxymethylphosphonate substituents have been synthesised and used to selectively bind 
adamantane derivatives, quinuclidine, ammonium and phosphonium salts, as well as drugs such 
as ibuprofen.[61]   
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Very recently, imidazole bridged deeper cavitands have been used to synthesise cavitands of 
nanoscale proportions; such cavitands were capable of accommodating a series of trimethyl 
ammonium salts, the largest of which was 10 Å in length.[62]  Imidazole bridged, water soluble 
cavitand derivatives bearing carboxylate groups have also been used as effective phase-transfer 
catalysts for a number of hydrophobic substrates.  The cavitands were able to extract the 
hydrophobic substrates from the organic layer in a two-phase system, into the aqueous layer 
where reaction took place, due to their ability to accommodate guests into their hydrophobic 
cavities.[63]  Long alkyl chains have also been appended to the imidazole bridges; such 
cavitands were observed to contain these alkyl chains inside the cavity, to yield a 'self-
containing' host-guest system.  Such cavitands stand to have applications as sensors.[64] 
 
Similar deeper cavitands bearing imidazole moieties derivatised with benzoate groups have also 
been used to create 'revolving doors' on the cavitand through which to regulate binding rates and 
selectivities of alkanes, again in an aqueous medium.[65]  In a slight variation on the imidazole 
based bridges, Rebek et al. have reported a cavitand bearing the amide precursors as bridges, 
with charged ammonium feet capable of mimicking the inner space of proteins.[66] 
 
Salen and hexaamide diamino bridged cavitands have also been used to produce cavitands able 
to catalyze the aminolysis of choline derivatives, as well as act as receptors for phosphocholine 
esters.[67]  Sample structures of these cavitands can be seen in Figure 1.16.  Analogous 
cavitands have also been investigated as Diels-Alder catalysts of maleimides.[68]  For examples 
on more elaborate cavitands, a review of the deeper and extended cavitands as synthesised by 
Rebek et al. is available.[69]  A critical review of related water soluble cavitands is also 
available.[70]  In more recent work, deepened cavitands have been further elaborated with the 
inclusion of chiral moieties into the bridge framework.[71]  Despite showing only modest results 
in terms of enantioselectivity for chiral guests, the study represents the next step in terms of 
application for cavitand host molecules. 
 
Diederich et al. have also synthesised partially bridged cavitands making use of quinoxaline 
walls; such cavitands have been used in the selective recognition of steroids.[72]  In an adaption 
to the above deeper and extended cavitands, Diederich et al. have constructed cavitands with 
























































































Figure 1.16: Sample structures of deeper cavitands, synthesised by Rebek et al. 
 
quinoxaline and tetrathiafulvalene moieties, as walls.[73, 74]  The diazaphthalimide moieties 
were further elaborated such that boron-based substituents were built into the cavitand walls.  
Sample structures can be seen in Figure 1.17. 
 
In further elaboration of the diazaphthalimide moieties, alkynes have very recently been 
attached to the bridges to yield molecular containers able to selectively and reversibly complex 
cyclohexanes.[75]  The hosts were able to switch between two different conformations to yield 








































































Figure 1.17: Sample structures of deeper cavitands, synthesised by Diederich et al. 
 
In a similar study, Diederich et al. used cavitands bearing four quinoxaline-based moieties to 
investigate the controllability and reversibility of guest binding.[76]  It was found that 
conformation had a fundamental influence on these parameters, as well as on the selectivity of 
binding interactions. 
 
Cavitands, much like calix[n]arenes, have moreover been elaborated into [n]cavitands, where n, 
the number of aromatic residues, ranges from five to eight.[77]  Such species stand to expand the 
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applications for cavitands, particularly in light of the fact that [6]cavitands and [7]cavitands 
possess two equally sized cavities as opposed to one for all other cavitands. 
 
In conclusion, therefore, cavitands prove to be remarkably suitable structurally preorganised and 
rigid synthetic host macrocycles with enforced three dimensional cavities.  As illustrated, they 
are exceptionally versatile and easily adapted to complex to a variety of guests.  More 
fundamentally though, they are readily synthesised making them especially accessible and an 
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ENZYME BIOMIMESIS AND METALLOPORPHYRINS 
 
2.1  Introduction 
 
Living organisms successfully maintain numerous internal metabolic processes when in a 
healthy state.[1]  Such processes and their equilibria are largely dependant on the action of a 
range of enzymes which, often in conjunction with cofactors and coenzymes, facilitate the 
biosynthesis and transport of biologically important compounds (such as vitamins), as well as 
the biodegradation of many other compounds (such as steroids, lipids, fatty acids and 
prostaglandins).[2]  In the case of humans, enzymes are also vital in the metabolism of drugs and 
numerous toxins.[3]  The ability of enzymes to play these roles in biological systems stems from 
their capability to catalyze a vast array of reactions, involving a multitude of substrates, in a 
highly efficient and selective manner.  It is therefore of interest to scientists to gain a better 
understanding of enzyme function, and how their potential may be harnessed, through the study 
and use of simpler, synthetic abiotic analogues. 
 
2.2 Biochemical Ligands 
 
In looking at enzymes and their functions from a physico-chemical perspective, it is particularly 
important to note that in many cases the active centre of an enzyme is a metal, which is buried 
within the pocket of the protein constituting the enzyme.[1]  More noteworthy, however, is that 
in the case of such metal centered enzymes, the ligand to which the metal is complexed is 
commonly macrocyclic in nature, and able to chelate to the metal via a number of Lewis bases 
(such as oxygen and nitrogen atoms).[4]  Indeed, such macrocyclic arrangements are not limited 
exclusively to metal-centered enzymes, but are found to be key in a number of biological 
processes such as electron and energy transfer,[4-6] redox processes,[6] and the transport and 
storage of molecular oxygen.[4, 6, 7] 
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Bearing in mind that the metal complexes involved in such enzymes are often substitutionally 
labile, the preference for macrocyclic ligands lies in two important effects:[4, 8]  
 
1. The chelate effect: 
Since the ligand complexes to the metal through more than one (multidentate) 
interaction, the resulting complex experiences enhanced stability (both 
thermodynamically and kinetically), particularly in solution. 
 
2. The macrocyclic effect: 
Closely related to the chelate effect, the macrocyclic effect further enhances 
stability of the ligand-metal complex via the preorganisation of the chelating 
Lewis bases; binding energy is thus not exhausted on rearrangement of ligand 
binding sites. 
 
Ligand-metal interactions and metal-centered enzymes in biochemistry, and in host-guest 
interactions as discussed in Chapter 1, are therefore synonymous with each other.   
 
Biochemistry’s preference for macrocyclic ligands is clearly illustrated in the complexes which 
constitute arguably among the most important biological processes: energy transfer and oxygen 
transport and storage.  As the prime example of energy transfer,[5] photosynthesis is vital in the 
propagation of life on earth; as such, the chlorophylls as macrocyclic ligands are fundamental to 
biochemistry.  Equally as important to life is hemoglobin and myoglobin, both of which are 
instrumental in the function of the mammalian respiratory systems, serving to complex and 
transport oxygen.[9]  The structure of the active sites of these macrocyclic ligands can be seen in 
Figure 2.1.[4] 
 
Based on the Fe(II) protoporphyrin XI, heme not only finds use in hemoglobin and oxygen 
uptake and transport, but also serves as the prosthetic ligand which constitutes the class of 
heme-based enzymes, the monooxygenases.[10]  Such enzymes are readily used in the 
biosynthesis and biodegradation of lipids and steroids, and are also involved in the metabolism 
of drugs and toxins.[11]  They facilitate an extensive array of important oxidation reactions, such 






























Figure 2.1: The structures of macrocyclic ligands important in biochemistry. 
 
oxygen to amine nitrogen atoms and thioether sulphur atoms.[3, 11, 12]  It is these heme based 
enzymes which are of interest in this study. 
 
2.2.1 Tetrapyrrole Ligands 
 
In looking at the structures in Figure 2.1, it is evident that the basic skeleton on which the 
macrocycles are based is very similar.  These ligands form part of the broader class of 
tetrapyrrole ligands.  It is this basic skeleton in particular which has seen these macrocycles 
used in a wide variety of conditions, where relatively strong and size-selective binding of main 
group and transition metals is necessary.[4] 
 
Their significance can be attributed to their structural features which facilitate their excellent 
complexation abilities:[2, 4] 
 
1. Tetrapyrroles are planar or near planar in structure, enhancing stability. 
2. Bearing four nitrogen atoms, they are able to chelate to a metal cation, and are 
able to carry both a single and double negative charge, so allowing labile 
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cations to coordinate. Dissociation can only occur on the simultaneous 
severing of the four cation-nitrogen interactions. 
3. Since the four nitrogen atoms are in a fixed position and the macrocycle rigid, 
the coordination of metal cations has a degree of size selectivity. 
4. The coordination sites are in the plane of the macrocycle, allowing 
coordination of species from above and below the cation. 
5. There is extensive conjugation that obeys Hückel’s rule for aromaticity; so not 
only allowing tetrapyrroles good stability, but also extensive redox chemistry 
(the framework itself may be readily reduced). 
 
The general structure of a tetrapyrrole ligand illustrating these structural properties can be seen 


















Figure 2.2: The general structure of tetrapyrrole-based ligands. 
 
2.3 Heme-based enzymes 
 
Heme-based enzymes represent a class of oxygenases which have outstanding oxidative 
catalytic abilities.[12]  Extensive research has been undertaken on metalloporphyrins in order to 
mimic their catalytic abilities and harness their potential.  However, in order to understand 
research into synthetic heme mimics, it becomes important to grasp the nature of biological 
heme enzymes in terms of their structure and function.   
 
As mentioned, heme-based enzymes use as a structural basis a Fe(II) protoporphyrin XI ligand, 
which serves as the enzyme’s active site.  This moiety is situated within a protein pocket which 
governs substrate access to the site.  Accessibility is regulated by the protein based on the shape 
and size of substrates; thus the protein pocket plays an important role in the selectivity of the 
enzyme.[1,12]  In addition the iron metal centre is not only coordinated to the four nitrogen 
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Lewis bases of the protoporphyrin, but also has coordinated to it a proximal, fifth thiolate ligand 
from a cysteine residue (R’ in Figure 2.2).[11]   
 
This leaves a remaining sixth coordination site (R in Figure 2.2) where initially water, then 
dioxygen (which serves as the oxidant), is coordinated reversibly.  It is from this coordination 
that the enzyme catalyzes the transfer of a single oxygen atom to substrates, which are present 
in close proximity.  This catalysis thus occurs exclusively from one “face” of the ligand.  The 
generally accepted mechanism of substrate oxidation can be seen below in Figure 2.3.[13]  The 
structure of R can vary widely, ranging from simple aliphatic and aromatic structures to more 
complex, heteroatom-containing substrates, and is always found in close  proximity to the active 
site of the enzyme.[6]  In addition, while Figure 2.3 shows the hydroxylation of a substrate, the 


















































































Figure 2.3: General (schematic) mechanism for substrate oxidation by heme-based enzymes. 
 
 32
The peroxide shunt reaction noted above is limited to synthetic models only, where the use of 
peroxide oxidants circumvents the reaction following the pathway shown when oxygen is used 
as oxidant.  In-depth discussion of mechanistic aspects of heme-catalysed oxidation can be 
found in a recent review article, and the references cited therein.[14]  
 
It is thought that the nature of oxidative chemistry (hydroxylation, epoxidation, etc., known as 
chemoselectivity) performed on the substrate as catalyzed by heme-based enzymes is dependant 
on the activity of the iron centre and the proximal cysteine ligand attached to it. Substrate 
selectivity, in contrast, is dependant on the nature and shape of the protein which constitutes the 
hydrophobic pocket in which the active protoporphyrin is found.[3]  It is these two areas in 
particular which have been focal in much of the research into synthetic metalloporphyrin heme 
mimics. 
 
2.4 Synthetic Heme Analogues: Sterically Hindered Porphyrins 
 
Porphyrins and metalloporphyrins have become particularly useful synthetic macrocycles 
through which to study heme-based enzymes.[12]  They are the product of the condensation of 
pyrrole with an aldehyde (usually benzaldehyde), and were first synthesised in low yield by 
Rothemund 70 years ago.[15]  Since then, synthetic conditions have been largely revised by 
Adler et al.,[16] and more recently by Lindsey et al.[17] to give better yields  
 
Their popularity as ligands in the study of heme analogues stems from their structural properties 
as evident in Figure 2.4 below,[4] which shows an abbreviated repeat unit structure for 
simplicity.  It is immediately evident that synthetic porphyrin ligands have a basic skeleton 
identical to that of the heme protoporphyrin XI ligand; this is particularly useful given the 
excellent characteristics of tetrapyrrole macrocycles discussed above.  Synthetic porphyrins can 
be readily functionalised at the meso and β-pyrrole positions (shown in Figure 2.4) thus 
allowing a degree of control over the steric environment in which the catalytically active site of 
the porphyrin may be established.[12]  The substituents at the meso position (R, in Figure 2.4) 
















































Figure 2.4: General structure of a porphyrin ligand. 
 
In terms of modeling heme enzymes using porphyrins, it has been established [9b] that the 
following requirements must be satisfied in order to produce an effective model system: 
 
1. The formation of a five-coordinate heme precursor having a proximal base 
(cysteine, pyridine, imidazole, etc), must be possible; 
2. Structural properties of the porphyrin ligand must be such that irreversible 
oxidation is prevented. 
 
With regards to the first requirement, by using a porphyrin ligand this condition is readily met, 
as can be seen by the presence of R' in Figure 2.4.  It is the second requirement which has 
proven to be more difficult to meet.   
 
Synthetic metalloporphyrins, particularly Fe(II) centered species in combination with a 
proximal base are extremely sensitive to air and light.[11]  In the presence of molecular oxygen, 
the metalloporphyrins tend to undergo rapid and irreversible auto-oxidation to form the μ-oxo 



















































Figure 2.5: Reaction pathway towards μ-oxo dimer formation. 
 
In order to avoid this, it is necessary to sterically hinder either the axial ligand (the proximal 
base), or one or both faces of the porphyrin moiety.  In creating such steric hindrance, not only 
is the μ-oxo dimer reaction pathway blocked, but oxidation of the porphyrin ligand is also 
prevented.[11]  This greatly improves the stability and activity of the synthetic heme analogue.   
 
In one of the earliest examples of successful catalytic oxidation of an organic substrate by a 
synthetic metalloporphyrin, Groves et al.[19] reported the use of a simple iron centered 
tetraphenylporphyrin, TPP (where R is C6H5, and R' is Cl in Figure 2.4) to catalyze oxygen 
transfer to cyclohexane and cyclohexene, via the shunt reaction pathway (Figure 2.3) with a 
peroxide oxidant.  Yields were low to moderate, while the catalysts proved to be unstable, and 
readily lost activity.  While results clearly showed that metalloporphyrins can function as 
oxidative catalysts, Groves’ work also serves as an illustration of the necessity to sterically 
hinder porphyrin-based catalysts: examining the TPP catalyst employed, it can be seen that 
there is a lack of significant steric hindrance, which has a marked effect on both the catalytic 
activity and stability. 
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It was through the subsequent research by Collman et al. that the most significant contributions 
to the use of sterically hindered porphyrins as a means of catalyzing oxidative reactions were 
made.[12]  This was achieved via the use of functionalisation to construct steric hindrance at one 
face of the porphyrin moiety, in what came to be known as ‘picnic-basket’ or ‘basket handle’ 
porphyrins.[20-22]  The use of a proximal base (as mentioned above) meant that oxidation was 
limited only to the sterically hindered face of the porphyrin moiety. 
 
This initiated a succession of sterically hindered porphyrin variations, including ‘capped’,[23] 
‘strapped’,[24] ‘bridged’,[25] ‘co-facial’ [26] and ‘twin coronet’ [27] metalloporphyrin species, of 
which the former was largely pioneered by the research of Baldwin et al.  Sample structures of 
these species can be seen in Figure 2.6, where the bridges used in the strapped, bridged and twin 
coronet species represent alkyl and aryl chains of varying length and character.[9b]  The 
proximal base in each structure has been omitted for purposes of clarity. 
 
The above variations have been used effectively in a variety of oxidative reactions.  With 
regards to the simpler TPP derivatives, the most common application has been the epoxidation 
of alkenes, based on a manganese centered porphyrin moiety.[28]  Yields and catalyst activity 
with regards to substrate oxidation, and product selectivity, have improved vastly from Groves’ 
initial work.   
 
Collman’s picnic-basket active site analogues have been shown to be shape-selective with 
regards to olefin epoxidation.[22, 29]  Strapped metalloporphyrins have been used in mimicking 
cytochrome monooxygenases,[30a, b] as well as in enantioselective oxidative catalysis of olefins.  
In the case of the latter catalysts, remarkable enantiomeric excesses and, more recently, catalytic 
turnover numbers have been detailed.[30c, d]   
 
Co-facial metalloporphyrins have largely been used as surface-adsorbed species,[31a, b] and 
have been reported to catalyze multi-electron reductions and oxidations of various 
molecules.[31c]  More recently, these porphyrins have been used as photo-oxidation catalysts in 
the oxidation of sulphides and olefins, with high turnover numbers.[31d]  Twin-coronet 
analogues have been shown to be selective with regards to oxidation products; again mostly in 


















































































































Figure 2.6: General structures of common sterically hindered metalloporphyrins.  The proximal base in 




Capped metalloporphyrins have found limited use, having been employed in studies into 
cytochrome monooxygenases,[33a] as well as having been shown to be effective epoxidation 
catalysts.[33b, c]   
 
These single face hindered species have moreover been elaborated into particularly effective 
regio- and enantioselective catalysts, as well as efficient asymmetric catalysts.  By building 
chiral moieties into the straps and bridges of the above catalysts, remarkable selectivities with 
respect to enantiomeric distribution and regioselective oxidation have been achieved, most 
notably in epoxidation reactions of alkenes.  Thus steric bulk has not only become a means by 
which to improve heme analogue stability and activity, but it has also become a way in which to 
control where and how a substrate may undergo oxidation.  Reviews pertaining to chiral and 
asymmetric catalysis by metalloporphyrin species are available.[12, 13, 34] 
 
In light of the necessity to sterically hinder metalloporphyrins, the use of supramolecular 
structures to form superstructured metalloporphyrins has become progressively more common.  
It should be remembered that biological enzymatic active centers are largely found within the 
confines of a protein pocket.[1]  Therefore, by using supramolecular structures and macrocyclic 
assemblies (many of which contain hydrophobic cavities capable of accommodating molecules 
as guests as outlined in Chapter 1), not only will such superstructured metalloporphyrin-based 
analogues have enhanced stability and activity, but the function of the protein pocket in the 
biological enzymes may also be mimicked.  Bearing in mind that substrate selectivity (and 
thereby oxidative selectivity) is dependant on the shape of the protein in biological enzymes, it 
is conceivable that by sterically hindering synthetic porphyrin moieties in such a manner, a 
degree of control over substrate and oxidative selectivity may be achieved.  
 
2.5 Supramolecular Porphyrins 
 
In an effort to improve on the single face, sterically hindered porphyrins and their catalytic 
properties as outlined above, supramolecular porphyrins have become increasingly popular.  
The ability of supramolecular structures to act as host molecules by providing hydrophobic 
cavities into which guest molecules may be accommodated is undoubtedly one of their most 
decisive features which has seen their common use as a means of sterically hindering 
metalloporphyrins.  The enhanced stability and solubility imparted on guests that are complexed 
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within supramolecular cavities can become particularly useful when it comes to binding a range 
of substrates, especially in the case of biomimetic applications, where the binding and 
orientation of substrates is important.   
 
Thus, given these qualities of supramolecular macrocycles, there have been a range of reported 
supramolecular porphyrins; that is, porphyrins appended with macrocyclic species, as well as 
porphyrins bearing macrocyclic ‘caps’ much like Baldwin’s ‘capped’ porphyrins noted above.  
Porphyrins appended and/or capped with crown ether macrocycles,[35] cyclophane derivatives 
[36] as well as resorcinarene moieties [37] have been described.  More common, however, are 




CD’s are arguably the most popular means by which to construct artificial enzymes and other 
biomimetic processes and materials; hence their widespread use to construct supramolecular 
porphyrins.[38]  This is largely attributed to their availability and importantly, their ease of 
functionalisation.  Certainly, porphyrin-CD supramolecular catalysts constitute some of the 
most effective enzyme mimics and biomimetic catalysts to date.[38, 39] 
 
Coenzyme B12 mimics based on β-CD-appended porphyrins have been shown to be successful 
in mimicking steps in enzymatic rearrangements accomplished by biological coenzyme B12.
[40, 
41]  In such studies, it was most notably the ability of the β-CD to accommodate the substrate as 
a guest which facilitated the biomimetic reaction by the supramolecular porphyrin. 
 
Metalloporphyrin species carrying two or four β-CD rings appended as substituents to TPP 
phenyl moieties, as shown in Figure 2.7, have been synthesised by Breslow et al.[42]  Using a 
Mn(III) centre, such catalysts not only performed effectively, but exhibited a degree of 
selectivity in the oxidation of olefin substrates.  It was again the abilities of the CD as a host 
which facilitated catalytic activity, by suspending the substrate across the metalloporphyrin’s 
metal centre.  Utilizing the same CD-porphyrin species, Breslow et al. were also able to mimic 
the heme-based Cytochrome P450 enzymes via hydroxylating a dihydrostilbene substrate, with 



































Figure 2.7: Structures of the CD-appended porphyrin ligands of Breslow et al. 
 
Moreover, with a protected androstanediol steroid substrate, and the same catalyst, it was shown 
that hydroxylation could be achieved with complete regio- and stereoselectivity at carbon-6,[43a, 
44, 45] a result based explicitly on the ability of the CD macrocycles to bind both ends of the 
substrate into their cavities.   
 
CD’s have also been used to form capped porphyrin catalysts.  The bis-capped species of 
Ogoshi et al. [46] seen in Figure 2.8 below was synthesised such that a β-CD cap was held at 
each face of the metalloporphyrin moiety.  The CD rings were able to bind cyclohexene and 
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catalyze oxidation far more effectively than the equivalent metalloporphyrin without any 






























Calixarenes have also become popular macrocycles from which to construct supramolecular 
porphyrins through which to study molecular recognition and biomimetic oxidative processes. 
[47]  Due to their inherent versatility as host molecules, the reported number of calixarene-
porphyrin derivatives is vast; reviews and literature on these species are available.[48, 49]  
However, it is the family of calixarene-capped porphyrins (most notably the calix[4]arene 
derivatives) which are of particular interest, especially since calixarenes can mediate the binding 
of small molecules within their cavities, as in the case of CD’s.[47]  This ability has important 
effects on the capability of porphyrins to recognise and coordinate molecules, as illustrated in 
the work noted above with CD-porphyrin species. 
 
The first reported example of a calix[4]arene-capped porphryin was by Shinkai et al. [47] who 
used chiral amide-based spacers to link the calix[4]arene to a Zn(II) metalloporphyrin.  It was 
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shown that the resulting supramolecular porphyrin was able to bind a range of hard-soft ditopic 
metal compounds, some with remarkably strong interactions.  The structure of the ligand can be 













































Figure 2.9: Structure of the calix[4]arene capped porphyrin of Shinkai et al. 
 
As in the case of CD-porphyrin species, calix[4]arenes have also been used to hinder both faces 
of a porphyrin moiety to form a bis-capped ligand, as reported by Reinhoudt et al.[50]  Again 
using amide spacers, as evident in Figure 2.10, it was shown that the Zn(II) metalloporphyrin 
was able to complex a range of pyridine derivatives, piperidine and most notably, N-
methylimidazole, regarded as analogous to the binding interaction of molecular O2.
[51]  
Importantly, the binding observed was up to 1000 times stronger than for the unhindered Zn 
TPP analogue; an effect attributed to the abilities of calix[4]arenes as host molecules. 
 
Porphyrins have also been capped by larger calix[5]- and calix[6]arenes.  Fukazawa et al. [52] 
have successfully synthesised a calix[5]arene-capped porphyrin with amide spacers (Figure 
2.10), and used the Zn(II) metalloporphyrin to complex a range of pyridine derivatives.  Again 
it was illustrated that, in general, guests were bound with a stronger interaction in the case of the 
calixarene-capped species than in the case of the unhindered TPP analogue.  However, 
significantly, it was found using UV-Vis techniques, that the bulkier guests were excluded from 
binding in the calixarene cavity since they could not pass through the apertures between the 
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porphyrin and calixarene moieties.  Such guests were instead bound on the unhindered face in a 






























































Figure 2.10: Structures of the calix[4]arene capped porphyrins of Reinhoudt et al. and Fukazawa et al. 
 
Calix[6]arene-capped porphyrins have also been reported, and are the only example of a 
catalytically active calixarene-capped superstructured porphyrin.  In a variation to the bis-
capped calix[4]arene-porphyrin described by Reinhoudt et al., Zhao et al. [53] attached two 
porphyrin moieties to a calix[6]arene and investigated the ligand’s ability as an epoxidation 
catalyst.  Results showed that, in comparison to the simple TPP analogue, the calix[6]arene-





Few examples of cavitand-porphyrin ligands are found in the literature as a means to sterically 
hinder porphyrins.  As in the case of calixarene-porphyrins, there have been many reported 
examples of cavitand appended porphyrins and derivatives, which have been used to complex 
various guests.[54]  However, of interest in this study is the cavitand-capped species of 
porphyrin, of which there are only two known examples in the literature.   
 
In the first example of a cavitand-capped porphyrin, Reinhoudt et al. [51] synthesised a range of 
these species with either two or four amide-based spacers, of varying length, linking the 
cavitand to the porphyrin as shown in Figure 2.11.  Using the Zn(II) metalloporphyrin, and 
pyridine and imidazole derivatives as guests, among them N-methylimidazole, enhanced 
binding interactions of molecules were observed as a result of the cavitand’s rigidity and 
abilities as a host molecule.   
 
Importantly it was also observed that spacer length had a marked effect on the binding ability of 
the capped porphyrin.  The longer, more flexible spacers, although allowing the bigger guests to 
be accommodated by the cavitand, resulted in a less defined environment through which to 
complex guests.  Binding interaction between guest and capped porphyrin was thus found to be 
diminished.   
 
In contrast, the shorter, rigid spacers had a more profound effect on binding interactions; the 
cavitand-porphyrin encapsulating guests via a stronger interaction due to a better defined and 
rigid binding environment.  Additionally, it was also observed that the use of four spacers 
further enhanced binding ability, showing up to a 700-fold improvement with respect to various 
guests.  Spacer distance was also shown to have a clear effect on the symmetry of the ligands. 
 
More recently, Naruta et al. [55] used a cavitand-capped porphyrin to encapsulate small 
hydrocarbons.  A degree of flexibility in the system was introduced by having two adjacent 
spacers linking the cavitand to the porphyrin, as evident in Figure 2.12.  Notably the spacers 
were simple ether bridges, resulting in a cavitand-capped porphyrin with the smallest cavity 











































































































2.6 Aims and Objectives of Study 
 
Given the ability of sterically hindered porphyrins to perform catalysis, and the enhanced and 
selective encapsulation of guests by supramolecularly hindered porphyrins, the interest in this 
study lies in the synthesis of cavitand-capped metalloporphyrins towards a homogeneous 
(solution phase) catalyst.  In light of the importance of spacer length on binding ability and 
selectivity of capped porphyrins, as illustrated by Fukazawa (in the case of calixarenes) and 
Reinhoudt (in the case of cavitands), it is envisaged that spacer properties may be used to induce 
a degree of regioselectivity into the oxidative catalysis reaction.    
 
The ligands synthesised by Reinhoudt et al. show that the use of four spacers linking the 
cavitand to the porphyrin results in four apertures between the cavitand and porphyrin.  It was 
also observed that for those guests that proved to be too bulky to fit through the apertures, they 
were prevented access to the cavity within the ligand.  Therefore, by varying these aperture 
sizes, a degree of size-selectivity with regards to guest complexation may be achieved.  Thus, 
should the apertures be made sufficiently small, such that only the terminus of a linear 
hydrocarbon can gain access to the cavity, the exclusive oxygen transfer from the 
metalloporphyrin to this terminus can occur; thereby regioselectively oxidizing hydrocarbons at 
the terminal positions.  Oxidation from outside of the cavity (from the metalloporphyrin’s sixth 
coordination site) would be prevented by the use of a cysteine residue, in keeping with 
biological heme enzymes.  
 
In terms of the other structural properties of the envisaged ligand, simple ether spacers would be 
used to link the cavitand and the porphyrin moieties as shown in Figure 2.13 (the 
abovementioned aperture outlined in red; the sixth ligand on metal centre M has been omitted).  
Spacer length (R'), and therefore aperture size, would be investigated via computational 
methods in order to see if the chosen aperture size matches that of the terminal end of a linear 
hydrocarbon.  The solubility of the cavitand may be controlled by varying the length and 
hydrophobicity of the cavitand ‘feet’ (R, in Figure 2.13) as discussed in Chapter 1, depending 




































Figure 2.13: Structure of proposed cavitand-capped porphyrin catalyst. 
 
In summary, therefore, the primary aims of this work are as follows: 
 
1. To establish a procedure for the synthesis of the cavitand-capped porphyrin ligand with 
the appropriate bridges, varying cavitand ‘feet’ to vary ligand solubility. 
2. Identify what bridge length affords a successful synthesis in addition to the desired size 
selectivity. 
3. Via computational methods, investigate if cavitand-porphyrin bridges are suitable in 
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SYNTHESIS OF CAVITAND-CAPPED PORPHYRIN TARGET LIGAND 
 
The length of bridge to couple the cavitand to the porphyrin, as shown in Chapter 2, was based 
on an initial Corey-Pauling-Koltun (CPK) modeling of the target ligand.  It was observed that 
the use of -CH2O- ether bridges to link the cavitand and porphyrin moieties resulted in apertures 
of a sufficient size to accommodate the terminus of an alkane substrate.  Therefore, it was vital 
that the synthetic design of the ligand take into account these requirements.  In terms of 
porphyrin formation and synthesis of the target ligand, a review of the literature reveals that 
supramolecularly-capped porphyrins were synthesised via two different approaches: an in situ 
approach, and a direct capping approach.  Since the proposed ligand is novel, both approaches 
were attempted to see if either afforded the desired ligand. 
 
3.1 In situ Approach 
 
The synthetic methods by which cavitands and their derivatives are obtained have been well 
established, particularly by Cram et al.,[1-5] over the last fifteen years.  The in situ approach 
seeks to make use of these methods to successively functionalise the cavitand to facilitate the 
cyclisation reaction that forms a porphyrin moiety above the cavitand structure.  It should be 
remembered that synthetic porphyrins are generally synthesised by the condensation of pyrrole 
with an aromatic aldehyde.  The success of an in situ approach in the formation of a cavitand-
capped porphyrin therefore requires that the aromatic aldehyde be incorporated into the 
framework of a functionalised cavitand structure.  Thereafter, the aromatic aldehydes are 
reacted with pyrrole towards the in situ formation of the porphyrin. 
 
This approach of porphyrin formation was first reported in the case of calix[n]arene- and 
cyclophane-capped porphyrins, and was used to make a range of supramolecules with a variety 
of applications.[6]  It was also used by Reinhoudt et al. in the synthesis of the first cavitand-
capped porphyrin molecules as discussed in Chapter 2.[7]  The functionalisation of their 








































Scheme 3.1: Functionalisation of cavitands by Reinhoudt et al. towards aldehyde incorporation. 
 
The final porphyrin formation step from the tetraaldehyde precursor was accomplished in low 
yields (<10 %) and was seen to be strongly dependant on the synthetic conditions applied as 
well as bridge length.  The low yields achieved may be rationalised by the large entropic effect 
of arranging the eight interactions required, between the four aldehyde residues and four pyrrole 
units, for porphyrin formation.  In the synthetic protocol, two sets of conditions were employed: 
the Adler conditions,[8] and the Lindsey conditions.[9]  Importantly, Reinhoudt et al. observed 
that for the different bridge lengths, in situ formation proceeded by only one set of conditions, 
never both.  Thus, for n = 1, ligand synthesis was successful only by the Adler conditions, 
whereas for n = 5, synthesis proceeded only by the Lindsey conditions.  
 
Scheme 3.2 is a proposed retrosynthetic pathway towards the synthesis of the ligand of interest 
in this study.  As is evident, this pathway uses procedures largely established and which provide 
good reported yields.  The subsequent, complete synthetic scheme towards the target ligand is 
shown in Scheme 3.3.   
 
Formation of resorcin[4]arene 3 is the result of the acid-catalyzed condensation of 2-
methylresorcinol, 1, and acetaldehyde, 2.  The synthesis of cavitand 4 can proceed by two 
possible pathways.  Firstly, cavitands are prepared by heating a solution of the resorcin[4]arene 
starting material and the alkylating reagent (bromochloromethane in this case) in the presence of 
potassium carbonate at atmospheric pressure.[1b]  The reaction proceeds over a number of days, 




































Scheme 3.2: Retrosynthetic pathway of the in situ porphyrin formation for the proposed ligand in this 
study. 
 
Since bromochloromethane is volatile and boils at 68 °C, reaction temperature is limited to a 
range between 60 and 70 °C.  This in turn affects yields of cavitand, which by using such a 
reaction protocol are typically in the order of 40 – 60 %.  More recently, Kaifer et al.[4] reported 
a procedure which solved the problem of bromochloromethane volatility, via the use of a sealed 
tube as a reaction vessel, heated to 88 °C.  The reagents were heated in the presence of cesium 
carbonate, which is used instead of potassium carbonate due to the templating ability of the 
cesium cation, which aids in the formation of macrocyclic assemblies such as cavitands.[10]  
Under these conditions, yields are in excess of 80 %.  However, the pressures involved and the 
size of the reaction vessel used limits the protocol by Kaifer et al. to a scale of 1 g of starting 
material per reaction.   
 
The bromination of the extra-annular methyl position of methyl cavitand 4 to give 5 is 
accomplished by free radical bromination using N-bromosuccinimide, under conditions set out 
by Sorrell et al.[2]  Reported yields for such brominations are in the order of 70 %.  In a 
Williamson-type ether synthesis, this bromomethyl cavitand precursor can be reacted with 
salicylaldehyde in the presence of NaH to give the novel tetrasalicylaldehyde cavitand 6 which 

































































Scheme 3.3: The synthetic pathway towards the target ligand.  The in situ step can be seen in the conversion of 6 to 7. 
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With regards to the synthetic conditions to form porphyrin 7, both the Adler and Lindsey 
conditions need to be used in order to determine which set of conditions favour porphyrin 
formation.  Adler conditions are the more severe of the two sets of conditions, requiring the 
dried tetrasalicylaldehyde starting material and freshly distilled pyrrole to be added (in high 
dilution) simultaneously to refluxing propionic acid at 100 °C.  Variations on these conditions, 
including the use of Zn(OAc)2·2H2O as a templating agent,
[11] as well as the use of microwave 
irradiation as a source of energy,[12] have been reported as a means by which to improve yields.   
 
The Lindsey conditions are more rigorous, requiring freshly distilled, dry chloroform (as a 
reaction solvent) and pyrrole under an inert atmosphere.  The reaction makes use of a Lewis 
acid catalyst (BF3) and an auxiliary oxidizing agent (2,3-dichloro-5,6-dicyano-p-benzoquinone, 
DDQ) to form the porphyrin, which generally forms in higher yields in comparison to the Adler 
conditions.  However, in addition to the requirement of dry glassware and reagents, reagent 
concentrations are particularly influential in determining porphyrin formation and yields.  
Optimum conditions require the concentrations of starting material and pyrrole to be 0.01 M. 
 
3.1.1 Results: In situ Protocol 
 
Resorcin[4]arene 3 was synthesised in good yields according to procedures set out and results in 
the literature.[1c]  Subsequent synthesis of cavitand 4 was completed according to the method by 
Kaifer et al. in yields approaching 90 %.  Characterisation of both 3 and 4 was completed using 
proton (1H) and carbon (13C) NMR, spectra of which can be seen in Appendix 1 (Spectrum 1.1 
and 1.4, respectively for the 1H NMR, and Spectrum 1.2 and 1.5 for the 13C NMR).  Proton 
signals can be assigned with reference to Figure 3.1, showing the expanded structures of 3 and 
4. 
 
Figure 3.1 clearly illustrates the symmetrical nature of resorcin[4]arene-based molecules, which 
results in relatively uncomplicated 1H NMR spectra.  With regards to 3, the most prominent 
protons are those belonging to the eight hydroxyl groups (H1), which in d6-DMSO appear as a 
singlet downfield at 8.68 ppm, due to the deshielding nature of the oxygen atoms to which these 
protons are attached.  This signal integrates to eight protons.  The aromatic protons (H3) also 
appear as a singlet in the aromatic region at 7.40 ppm, integrating to four protons.  The protons 
associated with the feet appear in the alkyl region at 1.69 ppm, integrating to twelve protons, 












































Figure 3.1: Expanded structures of 3 and 4, showing distinctive protons. 
 
The H2 protons, which are able to couple to the methyl protons of the feet, give a distinct quartet 
downfield at 4.44 ppm, integrating to four protons.  Finally, the benzylic protons, associated 
with the methyl groups at the extra-annular position of the aromatic rings, appear at 1.94 ppm as 
a singlet integrating to twelve protons.  These are of particular interest since any 
functionalisation at this position will result in a change in this signal.   
 
Alkylation of 3 to give 4 resulted in the appearance of two distinct signals characteristic of 
cavitands.  The methylene protons are orientated such that one is facing into the cavity of the 
cavitand (H4) and the other facing outwards (H5).  This results in these two sets of protons being 
anisotropic, and therefore able to couple with each other.  This yields two doublets in the 1H 
NMR spectrum in CDCl3, one at 4.26 ppm (for H4), and another at 5.91 ppm (for H5).  Both 
signals integrate to four protons.  The signals for H2 and H3 remain unchanged, appearing at 
4.97 ppm and 7.10 ppm, respectively, while also maintaining their multiplicity.  The same 
applies to the methyl feet and the extra-annular methyl groups, which appear at 1.73 ppm and 
2.00 ppm, respectively.    
 
The bromination of 4 to give 5 proceeded according to literature in yields between 60 and 70 %.  
The synthesis of the novel tetrasalicaldehyde cavitand 6 initially required that salicylaldehyde 
and NaH be added to DMF under nitrogen, to form the corresponding phenolate salt, before the 
addition of the bromomethyl cavitand precursor as a powder to the resulting solution.  
Thereafter, the solution was heated to approximately 40 °C.  It was found by TLC that reaction 
proceeded to give the tri- and tetrasalicylaldehyde products.  However, on workup of the 
reaction solution by pouring it into water followed by extraction of the organic material using 
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chloroform, it was found that significant amounts of product was lost as an emulsion.  This 
could not be avoided even by using a brine solution. 
 
It was decided to change the reaction solvent from DMF to THF.  On employing THF, TLC 
showed four distinct products formed corresponding to the mono-, di-, tri- and tetra 
salicylaldehyde products with the tetra-substituted product being the dominant product.  The 
desired product was isolated and purified, and vacuum dried.  Crystals of 5 and 6 were obtained, 
both of which recrystallised from 1:1 ethyl acetate:hexane.  The X-ray structures of 5 and 6 
have hitherto not been reported, and as such samples were analysed by single X-ray 
crystallography, and their structures solved.  The single crystal data will be discussed in more 
detail in Chapter 6. 
 
With reference to Figure 3.2, the various signals present in the 1H NMR spectra of 5 and 6 
(Spectrum 1.7 and 1.10, respectively in Appendix 1) can be assigned.  It is notable again that 5 
and 6 retain the high degree of symmetry seen in the case of 3 and 4, which yields simplified 1H 
NMR spectra.  Bromination of the extra-annular aromatic methyl groups in the case of 5 results 
in a significant downfield shift in the signal of the associated protons.  The signal for these 
methyl protons previously appeared as a singlet at 2.00 ppm in CDCl3, which after bromination 
appears at 4.43 ppm, due to the deshielding nature of the bromine atoms which have displaced 
four of the twelve benzylic protons.  Since the remaining protons (H6, Figure 3.2) are isotropic, 
the signal remains a singlet, integrating to eight protons.  The remaining signals, as discussed 
above (H2, H3, H4 and H5, Figure 3.1), essentially remain unchanged in terms of both chemical 
shift and multiplicity. 
 
Conversion of 5 to 6 yields a number of aromatic signals in the 1H NMR spectrum, as well as a 
distinct singlet for aldehyde protons, as shown in Figure 3.2 (H7 - H10, and HAld respectively).  
The aromatic region shows new signals at 7.04, 7.14, 7.53 and 7.73 ppm (all integrating to four 
protons), corresponding to the four different protons present on the aromatic salicylaldehyde 
residues.  The multiplicity of the signals, two doublets (at 7.14 ppm and 7.73 ppm) and two 
triplets (at 7.04 ppm and 7.53 ppm) supports the presence of an ortho-substituted aromatic ring.  
The doublets arise from the coupling of H7 with H8, and H10 with H9, while the triplets arise 
from the coupling of H8 and H9 with the neighbouring protons on either side of both these 
protons.  Most prominent in the spectrum is the presence of the signal for the aldehyde proton, 
HAld, which appears at 10.18 ppm integrating to four protons.  The downfield position of this 
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signal is characteristic of the deshielded nature of aldehyde protons due to the presence of the 






















































































Figure 3.2: Expanded structures of 5 and 6, showing distinctive protons. 
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The signal due to the methylene H6 protons again appears downfield, at 4.96 ppm, due to the 
deshielding nature of the neighbouring oxygen atoms.  This signal, along with the signals 
relating to the feet (including H2, Figure 3.1) and those relating to cavitand (H3, H4 and H5, 
Figure 3.1) remain unchanged in terms of multiplicity and integration.  However, all these 
protons have experienced very small changes in terms of chemical shift. 
 
3.1.2 In situ Cyclisation and Crystallographic Analysis 
 
With the -CH2O- bridges and the required aromatic aldehyde successfully incorporated into the 
cavitand structure for in situ porphyrin formation, a number of approaches were taken towards 
obtaining the target ligand.  With regards to the conditions set out by Adler, several attempts 
were undertaken varying the synthetic conditions.  Initial protocols made use of the classical 
Adler conditions, where the starting materials were added simultaneously to refluxing propionic 
acid.  Tracking of the reaction by TLC using a benzene mobile phase indicated that no product 
formed.  Thereafter, the protocol was changed to include the use of Zn(OAc)2·2H2O as a 
templating agent; however, again no product was detected by TLC.  As a final modification, the 
classical Adler conditions were attempted with the use of microwave irradiation as an energy 
source.  In addition, this method made use of high concentrations of reagents, as opposed to 
high dilution.  Nonetheless, again, no product was detected by TLC. 
 
Synthetic conditions were therefore changed in favour of the more stringent Lindsey conditions.  
However, analysis of the material by 1H and 13C NMR did not confirm the presence of the target 
ligand.  The 1H NMR spectrum (Spectrum 1.13) did not show the presence of the required 
aromatic signals from either the cavitand or the porphyrin, while the signals from the inner and 
outer cavitand protons were also absent.  The 13C and attached proton test (APT) spectra 
(Spectrum 1.14 and 1.15, respectively) showed more conclusively that the desired ligand had 
not been formed. Subsequent UV-Visible spectroscopy (Spectrum 1.16) in CHCl3 showed the 
distinct absence of a strong Soret band, associated with porphyrins, at ~ 420 nm.  It was 
concluded that both the Adler and Lindsey conditions proved inadequate in affording the target 
ligand. 
 
Initial modeling of the target ligand using CPK models indicated that the use of short -CH2O- 
bridges used to bridge the cavitand to the porphyrin, in conjunction with the rigidity of the 
resorcinarene itself, may introduce inherent inflexibility preventing the in situ cyclisation 
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required to form the porphyrin according to Scheme 3.3.  However, single crystal X-ray 
crystallographic analysis (see Chapter 6) of cavitand 6 provides structural information offering 
an explanation as to why in situ preparation of the target ligand was not a possibility.  Figure 3.3 











Figure 3.3: Molecular structure of 6 from side on (left), and from above (right). 
 
It is evident that the aldehyde residues above the molecular cavity of 6 are accommodated in a 
non-symmetric fashion.  This indicates that perhaps it is not the flexibility of the -CH2O- 
bridges that is most influential in the in situ formation of porphyrin, but rather spatial issues 
above the cavitand, coming about as a direct result of the short -CH2O- bridges.  The relative 
positioning of the salicylaldehyde residues seems to indicate a significant degree of steric 
crowding above the cavitand.  This steric hinderance creates insufficient space to accommodate 
the salicylaldehyde residues in a symmetric manner.  It should be remembered that in situ 
cyclisation requires the interaction of these four salicylaldehyde residues with an additional four 
pyrrole units in order to complete cyclisation.  Potentially, therefore, while a number of the 
salicylaldehyde residues may indeed react with a corresponding pyrrole unit, the 
accommodation of the remaining pyrrole units may be difficult, leading to incomplete 
cyclisation and resulting in polymer formation.   
 
Considering the bridges of supramolecularly-capped porphyrins synthesised by the in situ 
approach, as reported in the literature,[6, 7] bridge length varies widely.  In terms of cavitand-
capped porphyrins, the shortest reported bridge consists of five atoms (Scheme 3.1), which 
allows for enough space for the salicylaldehyde residues to orientate in order to complete 
porphyrin formation.  Shorter bridges consisting of three atoms have been reported in the case 
of calix[4]arene-capped porphyrins,[6c] however, it should be remembered that unlike cavitands, 
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calix[n]arenes themselves have a degree of flexibility which aids in the in situ porphyrin 
formation process. 
To summarise, the in situ synthetic protocol did not afford the target ligand as required, 
primarily due to the short nature of the two-atom -CH2O- bridges required to bridge the cavitand 
to the porphyrin.  This is evident by the X-ray structure of the tetraaldehyde precursor 6, as 
discussed above.  Therefore, in order to synthesise the desired ligand, an alternative approach of 
direct capping of the porphyrin was investigated. 
 
3.2 Direct Capping Approach 
 
As with in situ formation, the direct capping approach of forming supramolecularly-capped 
porphyrins was first reported in the case of calix[n]arenes [13] and thereafter recently in the case 
of resorcin[4]arenes.[14]  This approach essentially involves porphyrin, synthesised in isolation, 
being directly coupled with a suitable cavitand by a Williamson-type ether synthesis, 
reminiscent of the reaction required to form the tetrasalicylaldehyde 6 above, and therefore 
represents a somewhat different approach to that of the in situ protocol above. 
 
In terms of cavitand-capped porphyrins, this approach has been recently used by Naruta et al. 
[15] to synthesise a host with the smallest reported cavity, able to reversibly encapsulate small 
hydrocarbons.  Importantly with respect to the bridges used, Naruta et al. made use of the same 
-CH2O- bridges used in this study to couple the cavitand to the porphyrin, as shown in Scheme 
3.4.  As is evident, the ligand reported by Naruta et al. made use of a cavitand-capped porphyrin 
where the cavitand was attached to the porphyrin by two ether bridges.  This allowed retention 
of some flexibility in the system, and enabled the reversible encapsulation of guests.  The 
proposed retrosynthetic pathway pertaining to the synthetic target in this study can hence be 

































































































































In terms of porphyrin synthesis, the two conditions (Adler conditions, and Lindsey conditions) 
available for porphyrin formation have been discussed.  Scheme 3.6 illustrates and compares 
these two conditions.  With regards to porphyrin 12, both conditions give best yields when the 
synthesis is performed via the tetramethoxyphenylporphyrin 11 pathway.  It has been shown 
that use of the 2-hydroxybenzaldehyde starting material results in an especially low yield of 
product, regardless of what set of reaction conditions are used.[8, 16]  For this study, however, 
the chosen set of synthetic conditions was in favour of the Lindsey conditions, since it provided 
fewer synthetic steps towards the desired porphyrin in higher yields, as evident in Scheme 3.6.  
Adler conditions give increased yields when synthesis is performed using zinc around which to 
template the porphyrin formation to give metalloporphyrin 10.[17]   In addition to representing 
an extra synthetic step towards the desired porphryin 12, demetallation of porphyrin 10 is not 
quantitative.  As such, overall yield towards porphyrin 12 using the Adler conditions is in the 
order of 10 – 20 %, in contrast to the Lindsey conditions, which yields 35 % of porphyrin 12 in 
fewer synthetic steps. 
 
Porphyrin synthesis therefore commenced with the use of o-anisaldehyde as the starting 
material.  This gives rise to a product which is a mixture of four possible atropisomers, with the 
methoxy substituents (or hydroxy substituents, after subsequent removal of methoxy groups, 
Scheme 3.6) on the phenyl rings facing in different directions in various combinations, namely 
αααα, αααβ, αβαβ, and ααββ, where α refers to ‘down’ and β to ‘up’.  In order to facilitate 
the coupling of cavitand to porphyrin by four ether bridges, it is preferable to isolate the αααα 
isomer.  The required chromatography has been reported [17] and requires careful and 
meticulous control of chromatographic conditions.  In addition, the literature also shows that the 
desired αααα isomer forms in least abundance along with the ααββ isomer, with the αααβ 
isomer forming in preference.  The complete synthesis of the target ligand via the direct capping 

































































































































3.2.1 Results: Porphyrin Synthesis 
 
The synthesis of the required porphyrins 11 and 12 was completed successfully in yields 
comparable to those reported in literature.  Analysis using 1H NMR as well as UV-Vis 
spectroscopy was carried out in order to confirm porphyrin formation.  In order to discuss the 
1H NMR spectra of 11 and 12, reference will be made to Figure 3.4, the complete structure of 



























11: R = CH3

















Figure 3.4: Expanded structures of 11 and 12, showing distinctive protons. 
 
Figure 3.4, as with Figures 3.1 and 3.2, again illustrates the symmetry of the molecules being 
dealt with.  The equivalence of the protons present as evident in Figure 3.4 again leads to 
simplified 1H NMR spectra.  The most notable feature of the porphyrin free ligand is the 
presence of the protons associated with the nitrogen atoms.  The signals due to these protons 
appear at chemical shifts of between -2 ppm to -3 ppm, largely due to the electronic 
delocalisation of the porphyrin ring and the well-documented ring current associated with it.[18]  
In the case of 11 and 12, in addition to the signals from the amine protons, characteristic signals 
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appear as a result of the R groups on the meso-aromatic rings, as well as from the eight β-
pyrrole protons (Hβ).   
 
Looking at Spectrum 1.17, the 1H NMR spectrum of 11, the amine protons could not be seen 
below 0 ppm and are hence not shown on the spectrum.  The methoxy groups (R = CH3, Figure 
3.4) give rise to signals in the methoxy region, at a chemical shift of 3.55 ppm to 3.60 ppm.  
This signal integrates to twelve protons as expected, but appears not as a singlet but as a 
multiplet, due to the presence of the four different isomers of 11, as discussed.  The meso-
aromatic protons H3' to H6' yield signals in the aromatic region, from 7.28 ppm to 8.03 ppm.  
Protons H3' and H5' give rise to a multiplet signal ranging from 7.28 ppm to 7.36 ppm.  The 
multiplicity is due to coupling of these protons with protons on either side: H3' couples with H4' 
while H5' couples with H4' and with H6'.  The signal integrates to eight protons.  The signal from 
H4' yields a triplet integrating to four protons at 7.76 ppm; multiplicity as a result of coupling 
with protons H3' and H5'.  Finally, proton H6' results in a set of doublets at 7.93, 7.99 and 8.03 
ppm, with the set integrating to a total of four protons.  The signals are a result of the 
superposition of six doublet of doublets, which appear due to the coupling of these protons with 
the neighbouring H5' protons.  Interestingly, the intensity for these signals appears in a ratio of 
1:1:2:2:1:1, which arises as a result of the presence of the four isomers.  This ratio corresponds 
to the product distribution of the isomers, which is in the ratio of 1:4:2:1 for 
αααα:αααβ:ααββ:αβαβ.[17]  Lastly, the signal for the β-pyrrole protons appears as two 
singlets at 8.69 ppm and 8.80 ppm having relative intensities of 3:1, collectively integrating to 
eight protons.  
 
Cleaving of the methoxy groups in 11 to the corresponding tetrahydroxyporphyrin 12 leads to a 
notable change in the 1H NMR spectrum of 12 (Spectrum 1.22, Appendix 1) from that of 11, in 
the region of 3 ppm to 5 ppm.  The disappearance of the methoxy groups results in the 
disappearance of the corresponding signals at 3.55-3.60 ppm, and the appearance of a signal at 
4.93 ppm integrating to four protons.  This indicates the presence of the hydroxyl group and 
confirming the removal of the methoxy groups.  The signal has also become broad compared to 
that of the methoxy signals, which is indicative and characteristic of hydroxyl protons.  With 
regards to the signals related to the meso-aromatic protons, signal position and multiplicity has 
remained largely unchanged, with some simplification of some of the signals occurring.  The 
signals for protons H3' and H5' again appear as a multiplet in the region of 7.32 ppm to 7.38 
ppm, integrating to eight protons.  The signal from H4' remains as a triplet integrating to four 
protons, as it did for porphyrin 11.  However, the signal for H6' no longer appears as a set of 
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doublets, but instead has simplified down to a broad multiplet at 7.95 ppm integrating to four 
protons.  In addition, the signals for the β-pyrrole protons have also simplified from two 
singlets, down to one singlet at 8.91 ppm integrating to eight protons. 
 
While porphyrin synthesis was a success, the isolation of the αααα isomer proved to be 
problematic.  Replication of the column chromatographic conditions cited in literature could not 
be achieved.  However, on examination of the procedure of Naruta et al. it was found that in the 
case of the reported cavitand-capped porphyrin, the synthesis was completed via the use of a 
mixture of porphyrin isomers, since isomerisation was observed to occur at room temperature.  
Once reaction was complete, separation of the different products was possible by careful 
column chromatography.   
 
Since the αααα isomer could not be exclusively obtained in this study, the mixture of porphyrin 
isomers was used to couple cavitand to porphyrin under the same conditions as those used by 
Naruta et al.   
 
3.2.2 Results: Direct Capping of Porphyrin 
 
The procedure by Naruta et al.[15] to cap the porphyrin makes use of the starting materials 
shown in Scheme 3.4, accompanied by long reaction times (four days) at temperatures of 120 °C 
in a sealed stainless steel reaction tube.  It was decided to repeat the procedure, using a lower 
temperature (100 °C) under reflux for a longer period of time (five days) using 5 and 12, as 
evident in Scheme 3.7.   
 
After five days it was found by TLC that, in addition to polymeric material, only one additional 
compound was observed.  A possible explanation of this observation lies in the reaction 
conditions that were used: the high temperature used over the period of five days is sufficient to 
facilitate the isomerisation of the porphyrin phenyl rings, about the meso bonds.  This would 
allow the meso-OH substituents to be orientated accordingly to facilitate the coupling of the 
cavitand to the porphyrin.  Indeed, the energy required for this interconversion between the 
atropisomers of porphyrin 12 has been reported, and is in the order of 100.42 kJ.mol-1 (24 
kcal.mol-1).[19]  It should be remembered that molecules have sufficient kinetic and thermal 
energy to allow processes ranging from 62.8 to 83.7 kJ.mol-1 (15 to 20 kcal.mol-1) at room 
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temperature.[20] Therefore, the reaction conditions are more than sufficient to facilitate 
isomerisation.  
 
Since the target ligand is a non-polar compound, analogous to tetraphenylporphyrin in terms of 
polarity, the compound with the highest Rf value was identified as potentially being the target 
ligand.  The chromatographic protocol followed by Naruta et al. (a benzene mobile phase on a 
silica gel column) was used to isolate this material.  It was, however, found that separation using 
benzene was greatly affected by the amount of polymeric material present in the crude product.  
In this regard, a preliminary column using a mobile phase of chloroform was very effective in 
removing the majority of the unwanted material from the crude product, and improving 
separation on the subsequent benzene eluted column. 
 
The potential product was successfully isolated according to the above protocol.  However, on 
removing of the eluant to obtain a violet solid, it was found that the product became insoluble in 
most organic solvents, including chloroform as well as DMF and DMSO.  As a result, 1H and 
13C NMR spectroscopy could not be completed on the material.  However, while solubility 
rendered the characterisation of the synthesised material difficult, it had further implications for 
synthesis of a catalyst based on this ligand.  In order to place a metal within the porphyrin 
macrocycle, the ligand needed to be soluble in DMF, the solvent most commonly used for 
metallation of porphyrins.[15-17]  The insolubility of the material meant that, even if the ligand 
was indeed successfully synthesised, metallation would prove to be impossible.  Such 
insolubility issues related to methyl feet have been encountered before, in the case of the first 
closed molecular container, a carcerand, as reported by Cram et al.[1b]  Since the target ligand is 
analogous to such molecules, as discussed in Chapter 4 to follow, cavitands with enhanced 
solubility in organic solvents need to be considered in order to improve solubility of the target 
ligand. 
 
3.2.3 Synthesis of Cavitands Having Improved Solubility 
 
As discussed in Chapter 1, cavitand solubility can be controlled by varying the hydrophobicity 
or hydrophilicity of the cavitand feet.  In the interests of improving solubility of the target 
porphyrin therefore, longer cavitand feet were required.  As such, the synthesis towards 
obtaining bromomethyl cavitands similar in structure to 5 was undertaken, according to Scheme 
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16: R = C5H11
17: R = CH2CH2C6H5
18: R = C11H23
19: R = C5H11
20: R = CH2CH2C6H5
21: R = C11H23
22: R = C5H11
23: R = CH2CH2C6H5
24: R = C11H23
13: R = C5H11
14: R = CH2CH2C6H5
15: R = C11H23






















Scheme 3.8: Proposed synthetic protocol towards bromomethyl cavitands bearing longer feet. 
 
The synthesis of resorcin[4]arenes 16 - 18 from 1 and aldehydes 13 - 15 was accomplished 
according to the protocol as set out in section 3.1 above.  Resorcin[4]arenes 16 [1c] and 18 [21] 
have already been reported in the literature; however 17 is a novel resorcin[4]arene, synthesised 
according to the protocol as for 16.  These resorcin[4]arenes were again characterised using 1H 
NMR; spectra for 16, 17 and 18 appear in Appendix 1 as Spectrum 1.27, 1.30 and 1.33, 
respectively.  Since the 1H NMR spectrum of 3 has been fully discussed above, the 1H NMR 
data for 16 - 18 is tabulated in Table 3.1 below.  Reference is made to Figure 3.1 above, 
regarding the labeling of the different protons.  As a novel compound, crystals of 17 were 
grown from methanol; samples were sent for crystallography and the X-ray structure solved.  






Table 3.1: 1H NMR data for compounds 16 - 18. 
Chemical shift/ppm (multiplicity‡, integration/protons) 
Proton 16* 17* 18† 
H1 8.67 (s, 8) 8.73 (s, 8) 7.98 (s, 8) 
H2 4.18 (t, 4) 4.26 (t, J = 7.0 Hz, 4) 4.34 (t, 4) 
H3 7.25 (s, 4) 7.39 (s, 4) 7.43 (s, 4) 
Feet 
0.86 (t, 12) 
1.33 (m, 24) 
2.20 (m, 8) 
2.49 (m, 28)≠ 
7.13 (m, 20) 
0.91 (t, 12) 
1.32 (m, 72) 
2.29 (m, 8) 
‡ s refers to a singlet, t to a triplet, and m to a multiplet. 
* Spectrum recorded in d6-DMSO; 17 is a novel compound.  
† Spectrum recorded in d6-acetone. 
≠ Includes residual solvent signals from DMSO in integration. 
 
With regards to the synthesis of the corresponding cavitands from the resorcin[4]arene starting 
materials, cavitand 19 could not be synthesised from 16 using the method as set out by Kaifer et 
al., and the original protocol as set out by Bryant et al.[1d] was attempted.  This procedure was 
successful in yielding the desired cavitand.  In contrast, cavitands 20 and 21 were successfully 
synthesised from corresponding resorcin[4]arenes 17 and 18 via the method of Kaifer et al.  
These cavitands were again characterised using 1H NMR, the data for which appears in Table 
3.2.  Full spectra again appear in Appendix 1, Spectrum 1.36, 1.39 and 1.42 applicable to 19, 20 
and 21, respectively.  Reference is made to Figure 3.2 regarding the labeling of the protons 
present in 19 - 21.  In addition, crystals of the novel cavitand 20 were grown from liquid 
diffusion of methanol, into a solution of 20 in 1:1 ethyl acetate:hexane.  Samples were sent for 
single crystal X-ray crystallography, and the structure was solved.  A more detailed discussion 





Table 3.2: 1H NMR data for compounds 19 - 21 in CDCl3. 
Chemical shift/ppm (multiplicity‡, integration/protons) 
Proton 19 20* 21 
H2 4.73 (t, 4) 4.83 (t, J = 8.0 Hz, 4) 4.73 (t, 4) 
H3 6.95 (s, 4) 7.00 (s, 4) 6.95 (s, 4) 
H4 4.25 (d, 4) 4.26 (d, J = 7.0 Hz, 4) 4.25 (d, 4) 
H5 5.85 (d, 4) 5.88 (d, J = 7.0 Hz, 4) 5.85 (d, 4) 
Aromatic methyl 1.95 (s, 12) 2.00 (s, 12) 1.93 (s, 12) 
Feet 
2.15 (m, 8) 
1.33 (m, 24) 
0.89 (m, 12) 
2.44 (m, 8) 
2.62 (m, 8) 
7.11 (m, 20) 
2.16 (m, 8) 
1.24 (m, 72) 
0.86 (t, 12) 
‡ d refers to doublet. 
*20 is a novel compound.  
 
Bromination of the benzylic methyl groups of cavitands 19 - 21 proved to give mixed results.  
The bromination of 20 to synthesise 23 using the method set out by Sorrel et al.[2] did not afford 
the desired brominated cavitand; instead, 1H NMR analysis indicated the presence of a mixture 
of partially brominated compounds, accompanied by loss of signal resolution and broadening of 
signals.  Reaction conditions were changed in favour of the conditions of Gardner et al.[21] 
where chlorobenzene instead of CCl4 is used as reaction solvent in order to facilitate higher 
reflux temperatures.  However, 1H NMR analysis of reaction product again gave the same 
results as above.  In order to ascertain whether or not loss of symmetry was resulting in the 
broadened and unresolved 1H NMR signals, variable temperature 1H NMR was performed on 
products from both bromination protocols.  Spectra were recorded at -20 °C, 0 °C, room 
temperature, and 50 °C, however, no improvement in signal quality was observed.  Subsequent 
synthesis involving the CH2CH2C6H5-footed cavitand was thus abandoned.   
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In contrast, the bromination of 19 and 21 to give 22 and 24, respectively, proceeded as per 
conditions set out in the literature.[2, 21]  The resulting bromomethyl cavitands were again 
characterised by 1H NMR, results of which are tabulated in Table 3.3.  Complete spectra appear 
in Appendix 1, Spectrum 1.45 and 1.48 pertaining to 22 and 24, respectively.  Again, reference 
is made to Figure 3.2 regarding the manner in which protons present in 22 and 24 are labeled.  
Additionally, crystals of 22 were grown by slow liquid diffusion of methanol into a solution of 
22 in 1:1 ethyl acetate:hexane.  Samples were again sent for single X-ray crystallography, and 
its X-ray structure solved.  A more detailed discussion of crystal data follows in Chapter 6. 
 
Table 3.3: 1H NMR data for compound 22 and 24 in CDCl3. 
Chemical shift/ppm (multiplicity, integration/protons) 
Proton 22 24 
H2 4.76 (t, 4) 4.72 (t, 4) 
H3 7.11 (s, 4) 7.14 (s, 4) 
H4 4.55 (d, 4) 4.53 (d, 4) 
H5 6.02 (d, 4) 6.05 (d, 4) 
H6 4.40 (s, 8) 4.38 (s, 8) 
Feet 
0.89 (t, 12) 
1.33 (m, 24) 
2.19 (m, 8) 
0.85 (t, 12) 
1.31 (m, 72) 







3.2.4 Results: Capping of Porphyrin Using Cavitands With Improved Solubility 
 
With the successful synthesis of 22 and 24, the reaction to couple cavitand to porphyrin was 
repeated using the same reaction protocol as in the case of 5 and 12, and as shown in Scheme 
3.9.  In both cases, the crude material was isolated and purified as per the protocol which was 












22: R = C5H11
24: R = C11H23
25: R = C5H11






































Scheme 3.9: Synthetic protocol towards target ligand bearing longer feet. 
 
The use of 22 as ligand precursor in reaction towards 25 gave very low yields of material once 
isolation was complete.  Preliminary analysis using UV-Vis spectroscopy in CHCl3 showed the 
distinct absence of a strong Soret band, associated with porphyrins, at ~ 420 nm.  In addition, 1H 
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NMR analysis indicated a lack of aromatic signals, with signals belonging to the β-pyrrole 
absent in the spectrum.  It was consequently concluded that the reaction was unsuccessful in 
affording 25. 
 
Reaction involving 24 as ligand precursor proved to be different in terms of yield and result.  
Upon isolation, the yield of material was found to be 22 %.  Preliminary analysis using UV-Vis 
spectroscopy indicated the presence of the Soret band, at 418 nm (Spectrum 1.58).  In addition, 
Spectrum 1.58 exhibits additional signals associated with porphyrins at wavelengths between 
480 and 700 nm (seen more clearly in Spectrum 1.59), which are also seen in the UV-Vis 
spectrum of porphyrin 12.  The spectrum also shows two signals between 200 and 350 nm 
(Spectrum 1.60), which are a result of the presence of the cavitand structure as seen in the UV-
Vis spectrum of 24 (Spectrum 1.51).  The UV-Vis spectrum thus appears as a combination of 
the spectra of 12 and 24, indicating the formation of cavitand-capped porphyrin 26.  This is 
shown more clearly in Spectra 1.61 and 1.62, comparisons of the UV-Vis spectra of the 
respective starting materials (in blue) with 26 (in red) over corresponding wavelengths.  A 
summary of the UV-Vis signals present in 26, compared with those of the two starting 
materials, 12 and 24, appears in Table 3.4. 
 
The analysis of 26 using NMR techniques (at 400 MHz) was anticipated to give the same results 
as per the UV-Vis analysis, with both the 1H and 13C NMR spectra expected to appear as 
combinations of the respective spectra for the two starting materials.  Regarding the 1H NMR 
spectrum (Spectrum 1.52) of 26, the presence of the aromatic β-pyrrole protons as well as the 
protons belonging to the meso tetraphenyl rings, is suggested by the range of signals from 7.75 
ppm to 9.03 ppm.  Protons belonging to the feet of 26 give signals at 0.88, 1.26 and 2.18 ppm, 
which are consistent with the chemical shifts and multiplicity of the corresponding signals of 
the bromomethyl cavitand starting material (Table 3.3).  The two signals associated with the 
methylene bridges of the cavitand structure (at approximately 4.5 and 6.0 ppm), along with the 
signal arising from the uncoupled methylene protons of the -CH2O- cavitand-porphyrin bridges 
(at approximately 4.4 ppm) lack resolution but appear to be present.  In order to improve the 
quality and resolution of these signals, low temperature 1H NMR experiments were attempted.  
However, as shown in Spectrum 1.53, the 1H NMR spectrum of 26 at -40 °C, no significant 





Table 3.4: Comparison of UV-Visible data between starting materials 12 and 24, and 26 in CHCl3. 
λmax of UV-Vis signal/nm 













‡ sh refers to the presence of a shoulder. 
 
Given the poor resolution and the number of additional signals in the 1H NMR spectra, 13C 
NMR spectroscopy stood as a valuable tool in the characterisation of 26.  However, signals, 
particularly in the aromatic regions of the 13C NMR spectrum of 26 (Spectrum 1.54), proved to 
be very broad and weak.  Subsequent two dimensional NMR experiments, such as HSQC 
therefore proved to be difficult, and correlations, especially in the aromatic region, were absent.   
NOESY experiments were also attempted.  The initial CPK modeling of the ligand showed that 
protons from the cavitand -OCH2O- ether bridges were in close proximity to the β-pyrrole 
protons of the porphyrin.  Such proton-proton interactions through space were identified as a 
possible means of confirming complete capping.  Thus, NOESY was anticipated to give a 
correlation between the cavitand protons (at approximately 4.5 and 6.0 ppm) with the β-pyrrole 
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protons (at between 8.0 and 9.0 ppm).  NOESY spectra of 26 were recorded at both room 
temperature, and at -20 °C (Spectrum 1.55 and 1.56, respectively) at 600 MHz.  However, in 
both cases, only correlations between the cavitand protons were seen, and none between the β-
pyrrole protons and the cavitand protons. 
 
Therefore, NMR techniques offered no absolute proof of the successful synthesis of 26, and that 
the capping protocol afforded the desired ligand.  Therefore, as a means to conclusively show a 
successful synthesis, mass spectrometry was employed.  Both fast atom bombardment (FAB) 
and electrospray ionization (ESI) mass spectrometry (MS) were attempted.  The FAB mass 
spectrum of 26 (Spectrum 1.63) was unable to show a parent M/z signal at 1880 as expected; 
indeed, no signal higher than approximately 700 M/z in value was observed.   
 
As an alternative method, ESI-MS techniques were employed.  ESI is commonly used for 
macromolecules since it prevents the tendency of the molecule to fragment on ionization.[22]  
As such, this technique stood to give more promising results.  However, while larger fragments 
were observed at high M/z values (Spectrum 1.64), the parent signal was again absent. 
Therefore, both MS techniques failed to confirm that 26 had been successfully synthesised. 
 
3.2.5 Crystallographic Analysis of Precursors to Direct Capping 
 
Crystallography again proved useful in offering an explanation as to why the direct capping 
protocol failed to give the desired capped porphyrin.  As mentioned in section 3.1.1, crystals of 
bromomethyl cavitand 5 were obtained and the X-ray structure (hitherto unknown) solved.  As a 
representative precursor of the cavitands used in the direct capping procedure, the structural 
characteristics obtained from the X-ray analysis provided invaluable information regarding 
synthesis. 
 
Figure 3.5 shows the molecular structure of cavitand 5.  Although one bromine atom appears to 
be disordered, the symmetry typical of such functionalised cavitands is evident.  The bromine 
atoms are orientated such that two (opposite) bromines face into the cavity, and two out.  The 
methylene carbons which have inward-facing bromine atoms are 9.83 Å apart, while the same 
distance for those carbons having outward-facing bromine atoms is found to be 9.36 Å.  













Figure 3.5: Molecular structure of 5 from side on (left), and from above (right). 
 
In contrast, the distance between two opposing hydroxyl oxygen atoms of porphyrin 12 is (by 
crystallographic analysis) approximately 10.1 Å.[23]  The porphyrin therefore appears to be too 
large to fit comfortably with the cavitand and complete capping.  Since the methylene carbons 
are unable to move significantly due to the rigidity of the cavitand scaffold, and given the rigid, 
planar character of the porphyrin macrocycle, the nucleophilic porphyrin oxygen atoms remain 
too far apart to completely interact with the cavitand carbon atoms to cap the resorcinarene. 
 
Observations in hemicarcerand chemistry additionally support the notion that the porphyrin was 
unable to suitably fit over the resorcinarene to complete capping.  Hemicarcerands[24] are the 
result of an analogous synthetic procedure.  However, it has been noted that shell closure of a 
container molecule such as a hemicarcerand, or indeed, a capped porphyrin, does not proceed 
when the enclosure process occurs around empty space.  It is conceivable that container 
molecules require solvent within the confines of the host molecules in order to solvate and 
stabilise the transition state through which the guest molecules pass during synthesis.[25]  
Should the cavitand have solvent molecules within the confines of the molecular cavity 
stabilising the required transition state, it is possible that the porphyrin may experience 
difficulty in reacting across the open bonds at all four points to complete capping.  
 
In summary, while UV-Vis suggested that the synthesis of 26 was successful, it could not be 
conclusively proved by NMR and MS methods.  Therefore, the direct capping approach, in 
essence, failed to afford the target ligand.  As seen in the in situ approach, crystallography 
played an important role in illustrating that the chosen bridge length was in fact too short to 
allow a successful synthesis.  The porphyrin appears to be too large to comfortably fit over the 
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cavitand during synthesis to complete capping.  This is a direct result of the short -CH2Br- 
functional groups required to ultimately yield the desired -CH2O- capped porphyrin bridges. 
 
3.3 In situ Approach Revisited 
 
In order to verify the results seen in the in situ approach which made use of the methyl footed 
cavitand derivatives, the same protocol was applied to cavitands bearing longer feet.  Therefore, 
using 22 as a precursor, in situ formation of target ligand 25 bearing C5H11 feet was attempted 


























Scheme 3.10: In situ synthetic pathway towards 25. 
 
Although identical synthetic conditions were applied to the synthesis of 27 as in the synthesis of 
6, tracking the reaction by TLC showed only tri- and tetrasubstituted products.  This is in 
contrast to the synthesis of 6, which showed the formation of mono-, di-, tri- and 
tetrasubstituted products.  In addition, the yield of 27 was vastly improved; 80 % in the case of 
27 as opposed to 28 % in the case of 6.  Since the precursor to tetrasalicylaldehyde formation in 
each case differs only in feet length (CH3, in the case of precursor 5, versus C5H11, in the case of 
precursor 22) it is conceivable that this increased yield is due to improved solubility of 22 
relative to 5.   
 
Characterisation of 27 was completed, again using 1H NMR at 400 MHz. Since the 1H NMR 
spectrum of 6 has been discussed in detail already, the results for 27 (Spectrum 1.65) are 
tabulated in Table 3.4, with reference to Figures 3.1 and 3.2 regarding the labeling of the 
various protons.   
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Table 3.4: 1H NMR data for compound 27 in CDCl3. 
Chemical shift/ppm (multiplicity, coupling constant, integration/protons) 
Proton 27 
H2 4.83 (t, J = 8.1 Hz, 4) 
H3 7.27 (s, 4) 
H4 4.54 (d, J = 7.1 Hz, 4) 
H5 5.77 (d, J = 7.0 Hz, 4) 
H6 4.95 (s, 8) 
H7 7.03 (t, J = 7.5 Hz, 4) 
H8 7.14 (d, J = 8.4 Hz, 4) 
H9 7.53 (t, J = 8.9 Hz, 4) 
H10 7.75 (d, J = 7.5 Hz, 4) 




0.91 (t, J = 7.1 Hz, 12) 
1.36 (m, 24) 
2.26 (m, 8) 
 
The use of a 400 MHz instrument to record the spectrum of 27 yielded particularly noteworthy 
information in terms of the salicylaldehyde aromatic signals.  As seen in Spectrum 1.66, the 
COSY spectrum for 27, and more clearly in Spectrum 1.67, the triplet at 7.53 ppm and the 
doublet at 7.75 ppm exhibit secondary coupling, and appear as a triplet of doublets, and a 
doublet of doublets, respectively.  The coupling constants for the secondary coupling are in the 
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order of 1 - 2 Hz, which is indicative of long range coupling present between salicylaldehyde 
protons. 
 
The cyclisation reaction protocol towards 25 made use of the Lindsey conditions, as described 
in section 3.1.2.  Again, however, no porphyrinic material was detected.  It can therefore be 
concluded that solubility and the length of the feet used in capped porphyrin formation has no 





The synthesis of the target ligand was attempted via the two approaches reported in the 
literature.  The in situ protocol as reported by Reinhoudt et al.[7] in the synthesis of the first 
cavitand-capped porphyrin, was unable to afford the ligand.  The use of longer feet had no effect 
on the success of the synthesis, thereby showing that improved solubility did not significantly 
influence synthesis.  Indeed, from the crystallographic evidence obtained during the course of 
synthesis, it is suggested that in fact the -CH2O- bridge length was most influential in 
determining the success of the in situ protocol.   
 
The direct capping approach as used by Naruta et al.[15] gave more promising results.  The use 
of methyl feet in synthesis led to insoluble material as a final product.  As such, longer feet were 
used to improve synthesis.  However, the synthesis of the target ligand using C11H23 feet could 
not be conclusively confirmed by a number of NMR techniques, or by MS techniques.  Instead, 
UV-Vis analysis suggested only qualitatively that the synthesis of 25 yielded a cavitand-capped 
porphyrin.  Therefore, the direct capping protocol cannot be deemed successful.  
Crystallographic analysis was again used to illustrate that the inability to form 25 via the direct 
approach was, once more, a result of the short bridge length used in synthesis. 
 
Thus, both the in situ protocol and the direct capping protocol failed to produce the target 
ligand.  Bearing in mind the ligands synthesised by Reinhoudt et al. and Naruta et al., however, 
noteworthy conclusions can be drawn with regards to the synthetic results.   
 
The ligand reported by Naruta et al., bearing short -CH2O-bridges identical to those in this 
study, was a ligand without complete capping.  That is, only two bridges linked the cavitand to 
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the porphyrin, as opposed to four.  In contrast, the shortest bridge seen for a completely capped 
cavitand-capped porphyrin is five atoms in length, as reported by Reinhoudt et al.  In addition, 
this ligand was synthesised using the in situ protocol, and was shown to be highly dependant on 
bridge length. 
 
In this study, however, the following was observed:  
 
1. The success of the in situ synthetic procedure is dependant on bridge length, 
as observed by Reinhoudt et al. 
2. The use of bridges as short as -CH2O- proves to be too short to successfully 
complete cyclisation following the in situ protocol. 
3. The use of bridges as short as -CH2O- appears to be too short even when 
employing a direct capping approach. 
 
Therefore, in conclusion, the synthetic results of this study suggest that there appears to be a 
minimum requirement for bridge length in order to synthesise a completely capped cavitand-
capped porphyrin.  This also seems to apply to both synthetic protocols, not just the in situ 
approach as observed in this study, as well as by Reinhoudt et al.  Moreover, the failure to 
completely cap the porphyrin in this study using an identical bridge length and (direct capping) 
synthetic procedure, as reported by Naruta et al., may be an additional indication that direct 
capping using very short bridges is not a possibility.  Thus, it is necessary to use bridges (at 
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COMPUTATIONAL CHEMISTRY AND MOLECULAR MODELLING 
 
The inability to synthesise the desired target ligand, and the suggestion of the existence of a 
minimum requirement of bridge length in order to successfully couple the cavitand to the 
porphyrin, prompted a computational investigation of cavitand-capped porphyrin ligands.  This 
was in order to gain insight into the ability of the proposed ligand to selectively accommodate 
the terminus of a paraffin, in addition to identifying a bridge length which would afford a 
successful synthesis.  Before describing the computational study, a short overview of 
computational chemistry, pertinent to this study, will be presented.  Additional detail on the 




Computational chemistry is a branch of chemistry which makes use of mathematical tools and 
principles, and the laws of physics (both those of classical and quantum physics) to simulate and 
analyze chemical properties and processes.  The majority of mathematical theory and algorithms 
required for computational chemistry have been available for many years.  However, the great 
advances made over the past twenty years in computer hardware and software have resulted in 
the discipline becoming more accessible and significant as a chemical tool.[1b, e] 
 
The discipline allows chemists a more comprehensive understanding of chemical reactions and 
processes, ranging from prediction of stability of chemical reactions and explanation of reaction 
mechanisms, to estimation of energy differences between different chemical states.[2]  It also 
aids in the design of experiments, interpretation of experimental results, as well as the design of 
new compounds and materials with desirable properties.[1e]  The information gained by 
computational chemistry is thus indispensable and invaluable in research, especially where 
laboratory-based experiments can be financially restrictive and time consuming. 
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The basis by which computational chemistry simulates chemical structures and reactions 
numerically is firmly grounded in the fundamental laws of physics.[3]  There are accordingly 
two major categories within computational chemistry, electronic structure theory and molecular 
mechanics. 
 
4.2 Electronic Structure Theory 
 
Electronic structure theory is a category of computational chemistry which uses the laws of 
quantum physics as its governing basis, in conjunction with the values of a number of physical 
constants.  These include the speed of light, the mass and charge of both electrons and atomic 
nuclei, and Planck’s constant.[3]  Electronic structure theory consists largely of three methods: 
ab initio, density functional theory, and semi-empirical methods. 
 
4.2.1 Ab initio Methods 
 
Ab initio methods are based explicitly on theoretical principles governing quantum physics (as 
listed above) and therefore do not include any experimental data as input into the algorithm.  
The method is therefore the most expensive in terms of time and computer resources. 
 
Ab initio computations find solutions to the empirically derived Schrödinger equation (Eq. 4.1) 
via the use of a series of mathematical approximations, so providing high quality quantitative 
predictions for a wide range of atomic and molecular systems.[3]  The equation is as follows: 
 
     (4.1) Ψ=Ψ EH
)















































Here, M represents nuclear masses, a electrons, and A nuclei.  RAB represents the distance 
between nuclei, rab that between electrons, and rAa that between nuclei and electrons.  The first 
two terms describe the kinetic energy of nuclei and electrons, with the remaining three terms 
describing Coulombic interactions between particles.[4] 
 88
 
The Schrödinger equation is a combination equation derived from the differential equations 
defining the profile of a simple harmonic oscillator, and dé Broglie’s premise that matter 
(particles) have wave-like properties.[5, 6]  On manipulating the equation, a description of 
molecules (in terms of nuclei-electron interactions) and molecular geometry (in terms of energy 
minima or maxima in nuclei arrangement) can be obtained.[7] 
 
However, as an equation describing many electrons, the Schrödinger equation cannot be solved 
exactly when systems involving three or more interacting particles are considered.  Thus, in 
order to solve for such systems, a number of approximations need to be introduced.[8]  It should 




The Born-Oppenheimer approximation assumes that all nuclei within a system are stationary, 
and only electrons move.[7]  Atomic nuclei have a mass which is a number of orders of 
magnitude larger than that of electrons.  Thus, nuclei move slowly relative to electrons, while 
electrons essentially move instantaneously in relation to nuclear movements.[9]  The energy of a 
molecule in its ground state can thus be exclusively treated as a function of nuclear coordinates, 
since the movement of nuclei are independent of the movement of electrons.  Since these are 
essentially fixed according to the Born-Oppenheimer approximation, electron wavefunctions 
can be considered to be dependant only on the position of the nuclei, and not the momenta of 
nuclei.[1e, 9] 
 
Such an approximation greatly simplifies the Schrödinger equation to give the electronic 
Schrödinger equation.  The equation is free of the term describing nuclear kinetic energy, while 
the term describing the inter-nucleic Coulombic interactions is a constant.  The Hamiltonian 
operator consequently simplifies to: 
 



























to give the electronic Schrödinger equation in the form: 
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     (4.4) elecH Ψ
)
The total energy of the system under consideration in the computation therefore becomes: 
elecelecelec E Ψ=
 



























Even though the Born-Oppenheimer approximation simplifies the Schrödinger equation to give 
the electronic Schrödinger equation, the latter still proves to be intractable.  As another 
approximation in an attempt to simplify matters further, the Hartree-Fock approximation 
assumes that electrons move independently of each other.[8, 9]  What thus results is substitution 
of the many electron wavefunction, Ψ, with a total wavefunction. The total wavefunction is 
represented by a single determinant (a Slater determinant, Eq. 4.6) which results from the 
product of many one-electron wavefunctions, termed spin orbitals.[8]  This determinant is as 
follows: 
 
    (4.6) 
 
 
χi represents individual spin orbitals, themselves the product of a spatial function (or molecular 
orbital), ψi, and a spin function, α or β.  The fact that there are only two types of spin functions 
stems from the fact that only a maximum of two electrons may occupy any molecular orbital at 
any one time, provided they possess opposite spin.  Hartree-Fock level of theory represents the 
minimum level of theory required for ab initio computations.  However, the Hartree-Fock 
approximation is particularly drastic and results in a curtailed description of the manner in 
which the motion of one electron affects that of all the other electrons.  As such, Hartree-Fock 
(HF) models are in many cases ineffective in modeling transition states, and bond breaking and 
formation.[8]  The description of interactions and correlations between electrons may be 








Through the application of the Hartree-Fock approximation, a set of differential equations 
(known as the Hartree-Fock equations) result.  While these have numerical solutions, it is useful 
to introduce a further approximation that allows the Hartree-Fock equations to become algebraic 
in nature.[8]  The LCAO approximation uses molecular orbitals expressed as linear 
combinations of a finite set (basis set) of prescribed functions, known as basis functions, φ.  
Since basis functions are usually centered at nuclear positions, they are referred to as atomic 
orbitals.  The equation used to describe the approximation (Eq. 4.7)  
 






is termed the linear combination of atomic orbitals, or LCAO approximation.  Here, c represent 
the molecular orbital coefficients (often incorrectly referred to as molecular orbitals).  It is 
important to note that Hartree-Fock theory makes use of the variation principle to solve for the 
set of molecular orbital coefficients.  This solution is such that the set of coefficients, where the 
resultant wavefunction energy is at a minimum, is found.  This principle is also involved for the 
determination of saddle points (the lowest maxima on any energy profile) in transition state 
modeling.  
 
Roothaan-Hall Equations [7] 
 
If both the Hartree-Fock and LCAO approximations are simultaneously applied to the electronic 
Schrödinger equation, the Roothaan-Hall equations result,[7, 8] expressed as: 
 
    (4.8) ( ) 0=−∑ vi
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where εi are orbital energies, F the Fock matrix and S the overlap matrix (extent to which the 
basis functions correlate with one another).  The Fock matrix is analogous to the Hamiltonian 
operator in the Schrödinger equation [8] and can be represented in atomic units as:[4] 
 



















The first term represents the kinetic and potential energy of individual electrons, and the second 
term represents the interactions between electrons.  P is the density matrix, the energy of a 
single electron in the field of the bare nuclei; Pλσ is expressed as: 
 
     (4.10) ∑=
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Solutions to Roothaan-Hall equations for a considered system, are referred to as ab initio (or 
Hartree-Fock) models, and provide good accounts of equilibria in terms of geometries and 
conformations.[8]   
 
4.2.2 Electron Correlation (EC) Methods  
 
As mentioned, HF models are in many cases ineffective in modeling transition states, and bond 
breaking and formation; a phenomenon that stems directly from the HF approximation.  As 
such, EC methods represent a means of obtaining more accurate modeling via an improved 
description of electronic interactions.[8]  EC methods largely consist of two different models: 
Møller-Plesset and DFT models.  It should be noted, however, that these methods involve 




A common means by which to represent electron correlation is in the use of perturbation 
theory;[10] specifically second-order Møller-Plesset (MP2) models.  Considered superior to DFT 
in describing electron correlation, MP2 models make use of more accommodating descriptions 
of electronic motion.  This involves using a combination of HF models, where HF models are 
used to describe systems in ground states, as well as in excited states.[8, 10]  What results 
through application of MP2 theory is a specific calculation of the effect of electron correlation.  
This affords exceptional descriptions of equilibrium geometry and conformations, as well as the 




Density Functional Theory  
 
Density functional theory (DFT) methods are similar to ab initio methods in terms of 
requirements on computer resources, but are not as costly in terms of time.[12]  DFT is based on 
the theories as set out by Kohn and Hohenberg [13] and is based on the premise that any 
molecule in a ground energy state can be described in terms of total electron density.  Therefore, 
each molecule has a unique functional determining its geometry and ground state energy.[8]  
DFT approximates the effect of electron correlation in its calculation of total electron density of 
a system.  In contrast, HF models do not calculate electron density but instead consider an 
average electron density in the algorithm by considering the average interaction of electrons 
with both nuclei and all other electrons.[7]  HF models thus overestimate system energy, relative 
to DFT models which give more accurate modeling via the calculation of total electron density 
through the modeling of electron correlation.  DFT in general gives more reliable results, 
particularly in the modeling of equilibrium geometries and conformations, and transition 
states.[8]  However, results are largely dependant on the choice of basis set and density 
functional.[4]  In addition, in the case of the density functional, there appears to be no means of 
systematically improving algorithms such that experimental results are approached 
asymptotically, as they are in ab initio methods.  DFT is also unable to describe van der Waals 
interactions.[8b] 
 
4.2.3 Semi-empirical Methods  
 
Semi-empirical methods follow directly from Hartree-Fock models.  The fundamental 
difference to Hartree-Fock models again lies in the manner in which electrons are treated.  
Semi-empirical methods consider only valence electrons, since these valence orbital electrons 
are involved in bonding.[2, 3, 8]  In addition, semi-empirical methods may also take into account 
parameters obtained from experimental data, or high level ab initio calculations.  These factors 
greatly simplify calculations and reduce demand on computer resources. 
 
Apart from the valence orbital electron approximation, a second significant approximation is 
implemented in restricting basis sets to a minimal representation.  Thus, main group elements 
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comprise a single s-type function, and a set of p-type functions; for example, 2s, 2px, 2py and 
2pz.  Transition metals have an additional set of d-type functions.
[12] 
 
Fundamental to semi-empirical methods is maintaining that atomic orbitals belonging to 
different atomic centers do not overlap significantly.  Such an approximation, known as the 
Neglect of Diatomic Differential Overlap (NDDO) approximation, further simplifies the 
Roothaan-Hall equations.  It is, however, important to include some overlap in even the simplest 
semi-empirical models.[12]  
 
Semi-empirical methods are able to produce a range of experimental data, such as heats of 
formation, dipole moments and ionisation potentials.  Accuracy can vary widely, and results are 
greatly influenced by the parameters used in the calculation.[2]  Thus, for any given system 
considered by semi-empirical methods, it is important to choose an appropriate method if 
reasonable results are to be obtained.  This is particularly important for systems which involve 
transitions states and bond breaking and formation; indeed, semi-empirical methods are not 
suitable for such modeling.[8, 10b, 12] 
 
4.3 Molecular Mechanics  
 
While electronic structure theory provides important information about chemical properties and 
processes, many systems prove to be too large (for current resources and software) for 
consideration and modeling via quantum mechanical methods.  Electronic structure theory, as 
its name suggests, deals largely with electrons; however, even if electronic characteristics are 
simplified (semi-empirical methods), there still remains a large number of particles for 
consideration. 
 
Molecular mechanics (or force field methods) allow for the consideration of larger systems, as 
electronic motions are ignored, and only the positions of nuclei are considered.[3]  Molecular 
mechanics (MM) assumes that electrons are stationary, in contrast to electronic structure theory, 
which assumes that nuclei are stationary (Born-Oppenheimer approximation).   
 
MM is characterised by the use of force fields, analogous to basis sets for electronic structure 
theory.  Force fields are a set of equations describing variations in the potential energy of a 
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molecule, as a function of the position of its component atoms.  These are used to obtain good 
estimates of molecular energy and geometry, taking into account all the forces between atoms 
calculated via a mechanical approach.  The energy of any system is thus calculated based on 
classical physics, again in contrast to electronic structure theory which makes use of quantum 
physics. 
 
The energy in a system considered by MM is described as the sum of contributions arising from 
distortions from idealised bond distances, bond angles and torsion angles.  These contributions 
are taken into account in conjunction with contributions due to “non-bonded” interactions (van 
der Waals and Coulombic interactions).[8, 10b]  Given the inclusion of the contribution from 
non-bonded interactions, the van der Waals radii of the atoms under consideration thus play a 










































Coulombic, van der Waal’s Forces  
 
Figure 4.1: Schematic representations of energy contributions in a molecular mechanics system. 
 
 95
The first three terms in Eq. 4.11 are the energies arising from all bonds, bond angles and torsion 
angles.  In contrast to electronic structure theory, bond information serves as an input into MM 
calculations, whereas in the former, such information is as a result of calculation.[8]  The 
remaining term in Eq. 4.11 serves to describe energies over all non-bonded atom pairs. 
 
Bond lengths, bond angles and torsion angles can be changed using potential energy functions 
during optimisation processes.  Such dynamic methods can in fact yield particularly accurate 
results for large systems in terms of molecular energies and geometries.  Importantly, these 
results can be achieved in a fraction of the time and cost of ab initio methods.[12]  However, 
MM is prone to significant error if a force field not specific to the system under consideration is 
used.  In addition, because MM ignores electronic motions and assumes electrons to be 
stationary, MM calculations cannot be used to investigate bond breaking or formation, such as 
in transition states.   
 
4.4 Molecular Dynamics 
 
In many applications of both electronic structure theory, and MM, it is important to first obtain 
the arrangement of atoms in a system which represents the global energy minimum.  This is 
particularly important where the molecule under consideration has a number of conformers, 
resulting in the possibility that multiple minima may exist.[14]  The starting geometry of the 
system under consideration is particularly important in obtaining the global minimum.  Should 
the starting geometry be far from the geometry of the global minimum, it becomes necessary to 
perturb the system by providing atoms with enough energy to overcome vibrational, rotational 
and conformational energy barriers.   
 
The classical means of providing energy to atoms is via molecular dynamics (MD) simulations.  
MD simulations follow the time dependant movements of each atom in a molecule, on 
application and solution of Newton's equations of motion to molecules.[1e, 6, 15]  During MD 
simulations, kinetic energy is provided to the system under consideration (via a mathematical 
algorithm) such that any vibrational, rotational and conformational energy barrier can be 
overcome.  Importantly, the time scale used must be sufficiently long to allow the system to 
attain equilibrium.  At the equilibrium temperature, all conformations should be observed over 
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time; should this not be the case, the temperature at which MD was performed should be 
increased and the system allowed to reach a new equilibrium.[1e, 6] 
 
The amount of time spent at a particular conformation during a MD calculation is directly 
proportional to the stability of the conformation.  Therefore, the system will spend more time 
assuming the global minimum conformation than any other conformation.  For very flexible 
systems, the identification of the global minimum is often completed with the aid of statistical 
analysis.[9, 12]   
 
MD calculations make use of a mathematical scale of temperature, such that simulations can be 
completed at a range of theoretical temperatures so as to control the amount of energy provided 
to atoms in order to overcome the respective energy barriers.[15]  It is, however, particularly 
important to note that the mathematical temperature scale may not be reflective of real 
temperature and as such the simulation system should ideally be calibrated to gauge simulation 
temperature relative to real temperature.[16]  An effective means of demonstrating this is 
through the use of cyclohexane:[16] it is well known that cyclohexane can interconvert between 
its energetically favourable chair conformations, and its less favourable boat conformations, at 
room temperature.  Therefore, by performing MD on cyclohexane at various temperatures, and 
observing at which temperature the molecule is able to interconvert between conformers, an 
estimation of room temperature can be made with respect to the simulation system.   
 




The target ligand, with the ether bridges can be regarded as being analogous to the 
hemicarcerands which were studied by Cram et al.  As mentioned previously, hemicarcerands 
are a class of host molecules which are the result of the coupling of two cavitands joined at the 
extra-annular position by up to four short bridges of varying alkyl or aryl character, as evident 
in Figure 4.2,[17a] showing the more common bridges.  This results in a host which has four 
apertures representing access points into the host cavity, much like the proposed ligand in this 






























R = C5H11, CH2CH2C6H5



























Figure 4.2: General structure of a hemicarcerand showing more common bridges used to create apertures. 
 
Hemicarcerands are able to accommodate guests within the molecular cavity in a size selective 
manner; therefore, hemicarcerands serve as the basis for the concept of size selectivity in this 
study.  Reviews pertaining to hemicarcerand chemistry, their host-guest capacity and their 
applications are available.[17]  Both computational [18-20] and experimental [20, 21] 
investigations of hemicarcerands and their complexes (hemicarceplexes) indicate that aperture 
size can be appreciably increased such that guests can be accommodated through the apertures 
of a hemicarcerand and into its cavity by heating the host sufficiently.  This physical process is 
usually performed in the presence of excess guest.  The process can be reversed upon reheating 
the complex to the same degree that was needed to initially incarcerate the guest.   
 
The inherent size selectivity exhibited by hemicarcerands stems from the ability of the bridges 
of the host to expand and contract upon heating and cooling, thereby widening and narrowing 
the apertures that afford access to the molecular cavity.  Therefore, by using bridges of a 
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particular length, a specific aperture size can be attained at increased temperatures.  Should this 
aperture size correspond to that of the guest molecule, the guest is able to be complexed within 
the confines of the hemicarcerand.[18e, 21]  Guests which have shapes that complement the 
aperture also aid in ease of hemicarceplex formation.[19]  
 
This study seeks to use the same principles as seen in hemicarcerand chemistry; that is, to create 
a ligand which possesses bridges linking cavitand to porphyrin such that, upon heating, an 
aperture size is afforded which matches that of the terminus of a paraffin.  Such an aperture size 
would effectively govern access to the active site of the porphyrin, such that oxidation only of 
the paraffin terminus occurs, as discussed in more detail in section 2.6 of Chapter 2. 
 
According to the studies by Cram et al., among the most versatile hemicarcerands prepared was 
that bearing four tetramethylene bridges,[22] as seen in Figure 4.2 above.  Guests incarcerated 
included p-xylene, nitrobenzene, DMA and p- and o-hydroquinone.  Interestingly, Cram and 
coworkers observed that for hemicarcerands bearing such alkane-based bridges, the use of 
penta- or hexamethylene bridges did not necessarily afford better selectivity towards larger 
guests compared with the tetramethylene bridged hemicarcerand.[18d]  Thus, the computational 
investigation of the proposed ligands, which follows, will make use of a range of bridge lengths.  
 
4.5.2 Preliminary Investigation: CPK Study 
 
Before any computational modeling was undertaken on the target ligand, a preliminary 
modeling study was done using Corey-Pauling-Koltun (CPK) models.  With reference to Figure 
4.3, the basic structure of the target ligand, a series of variations were built where bridge length 
n varied, ranging from one to four.  For simplicity, R, the feet of the model, were kept as methyl 
groups. 
 
It was found that the CPK models of the molecules were rigid and did not have significant 
flexibility; an observation which was expected given the inherent rigidity of both the porphyrin 
and cavitand moieties.  It was further observed that by using either one or three methylene 
spacers (n = 1 or 3), the cavitand cap fitted comfortably over the top of the porphyrin moiety, 
while the use of two or four methylene spacers (n = 2 or 4) resulted in significant strain in the 

































Figure 4.3: Target ligand structures used as basis for CPK modeling. 
 
4.6 Choice of Computational Method 
 
A review of the literature reveals that computationally, hemicarcerands and hemicarceplexes 
have been studied via both MM [18] as well as semi-empirical methods.[19]  In a MM study by 
Sheu and Houk,[18f] a number of observations were made regarding hemicarcerands, 
hemicarceplexes and their properties.  The minimised structure of the host obtained by MM was 
found to be highly dependant on the orientation of the atoms found at the extra-annular position 
of the cavitand scaffold.  In addition, the -OCH2O- bridges of the cavitand structures were found 
to interconvert between a chair and boat formation during MD studies, which allowed passage 
of guest molecules in and out of the host cavity, even though in some cases the guest was larger 
than the minimised aperture size.   
 
The semi-empirical study by Liddell et al. [19] differed slightly in that focus was placed on the 
thermodynamic and kinetic properties of hemicarcerands and hemicarceplexes, in an effort to 
investigate whether hemicarceplex formation could be predicted using computational tools.  It 
was found that the semi-empirical (AM1) investigation was precise in replicating data with 
respect to experimental results of complexation-decomplexation of guests, as well as the crystal 
data of hemicarceplexes.  The study also represented the first investigation of the electronic 
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structure of hemicarcerands and hemicarceplexes.  While the study showed good precision 
regarding complexation behaviour, it exhibited difficulty in predicting orientations of guests 
within the host molecule, relative to crystal data of corresponding hemicarceplexes. 
 
In terms of computational investigation of cavitand-capped porphyrins, there has been only one 
study by Naruta et al. into the complexation of the reported ligand with various small 
hydrocarbons.[23]  The computations were performed at an ab initio level, and were able to 
accurately reproduce experimental binding constants.  However, given the rigidity, and 
importantly, the larger number of atoms present in the target ligand as well as resources 
available in this study, MM becomes an attractive and efficient means of investigating the target 
ligand computationally.   
 
There is in addition no need to compute transition states, making MM more attractive.  Indeed, 
MM has been shown to be particularly suited to investigating a variety of host-guest systems 
involving calixarenes and related hosts as discussed in Chapter 1.  The conformational aspects 
of calixarene chemistry have been extensively studied computationally with wide use of MM 
methods.  Typical force fields used included the CHARMM and MM3 force fields.[24]  Similar 
studies have been performed investigating resorcin[4]arene conformation using MM3 and 
AMBER force fields.[25]  Cavitands and hemicarcerands (molecules consisting of two cavitands 
bridged at the extra-annular position) have also been investigated through the use of MM 
calculations, implementing the CVFF, AMBER* and MM3* force fields.[18f, 26]   
 
Porphyrins and metalloporphyrins have also been the subject of computational investigation 
using MM.  Investigations into the effect of porphyrin flexibility, orientation of phenyl groups 
in the case of tetraphenylporphyrins, axial ligation, and size of metal cation (in the case of 
metalloporphyrins) have all been undertaken using MM2 force fields.[27]  Heme model 
compounds and the influence of steric hinderance on the competitive binding of carbon 
monoxide and oxygen has also been investigated using AMBER and MM2 force fields.[28]  In 
addition, methods have also made use of hybrid quantum mechanical-molecular mechanical 
techniques.[29]  For systems involving supramolecularly-capped porphyrins, a very limited 
number of computational studies have been reported in the literature; however, in these systems 
and investigations, MM has also found application.[30]  Exhaustive reviews on the various force 
fields, and comparative studies of these force fields, are available.[6, 31]   
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In order to decide on a method of calculation and a force field, the structure of a simple cavitand 
bearing methyl feet, and a proton at the extra-annular position was minimised and examined 
using MM.  Since the crystal structure of this cavitand has been reported,[32] the interatomic 
distances between atoms are known.  Therefore, the precision of the computational investigation 
and the applicability of the chosen force field can be gauged.  The distances considered in the 
comparison are presented in Figure 4.4.   
 
In terms of the choice of force field, previous investigation, as noted above, indicates that MM2 
and MM3 are particularly effective in simulation of molecules such as cavitands and 
porphyrins.  Indeed, it has been shown in the literature that in terms of predicting various 
parameters in organic molecules, MM2 and MM3 (and force fields based on these) performed 
best in a number of investigations.[6, 33]  Therefore, the MM3* force field was the chosen force 
field in this study.  Based on the original MM3 force field, the MM3* force field differs only 





















Figure 4.4: Structure and criteria used for comparison between computation and crystal structure. 
 
As such, the computational minimisation of the simple cavitand made use of the following 
parameters: 
 
Software: Maestro 7.0.113. 
Force field: MACROMODEL's MM3* force field. 
Minimisation method: Polak-Ribiere Conjugate Gradient (PRCG) method. 
Maximum iterations: 1000 
Convergence threshold: (energy) less than 0.01 kJ.mol-Å-1 
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Minimisation commenced by a conformational search, using Monte Carlo (MC) low-mode 
sampling.  The search made use of 1000 steps, taking 50 of the lowest energy structures.  The 
global minimum identified after a complete search was then submitted for a further 1000 steps 
to ensure the global minimum was obtained.  The minimisation process was also accompanied 
by MD in order to obtain respectable starting geometries in addition to aiding in identifying the 
global minimum of the cavitand structure.  MD simulation was performed as vacuum 
simulations, where fifty low energy structures were sampled during the course of simulation.  
Thereafter, each structure was minimised, such that the structure having the lowest potential 
energy was used for a subsequent round of minimisation.  The MD parameters were as follows: 
 
Force field: MACROMODEL's MM3* force field. 
Method of dynamics: Stochastic. 
Time step: 1.5 fs. 
Equilibrium time: 5.0 ps. 
Simulation time: 100.0 ps. 
Temperature: 800 K 
 
As is evident from the results of the minimisation procedure in Table 4.1 after application of the 
above method, the percentage deviation of the computationally obtained measurements from 
those obtained experimentally from the crystal structure indicates a close agreement.   
 
Table 4.1: Comparison of selected (MM3*) calculated interatomic distances‡, with X-ray data reported in 







a 0.904 0.929 2.8 
b 0.796 0.814 2.2 
c 0.526 0.522 0.8 
d 0.419 0.401 4.3 
e 0.721 0.727 0.8 
‡ Cartesian coordinates of the computed structure are available on the CD accompanying this thesis. 
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Interestingly, Liddell et al. made use of a similar method of calculation in order to choose an 
algorithm for use in the semi-empirical study of hemicarcerands.[19]  The cavitand used has also 
been reported,[31] accompanied by a crystal structure, and differs from the cavitand in Figure 
4.4 only by the presence of a bromine atom at the extra-annular position, as shown in Figure 
4.5. 
 
The minimisation performed by Liddell et al. was repeated using Hyperchem [34] and the AM1 
algorithm.  The results obtained for each parameter, as shown in Figure 4.5, were in exact 
agreement with the data obtained by Liddell et al.  In order to gauge the precision and accuracy 
of the chosen MM3* force field, the same cavitand was minimised according to the above 
minimisation and MD methods outlined above, and the results compared to both the crystal data 





















Figure 4.5: Structure and criteria used for comparison between computation and crystal structure in 
investigation by Liddell et al. 
 
The results in Table 4.2 indicate that the semi-empirical calculation give values which are closer 
to the reported X-ray data, than does the MM3* calculation.  Semi-empirical methods of 
computation therefore seem to give superior results over the molecular mechanics methods (for 
this system, at least).  Interestingly, the study by Liddell et al. made use of two other semi-
empirical algorithms (MNDO, PM3) in addition to the chosen AM1.  While these algorithms 
were not as accurate as AM1, they were all more accurate than MM3* in modeling the cavitand 





Table 4.2: Comparison of selected (MM3*) calculated interatomic distances‡, with those reported in 








a 0.958 0.960 1.022 6.7 (6.5) 
b 0.792 0.787 0.820 3.5 (4.2) 
c 0.524 0.524 0.520 0.7 (0.8) 
d 0.428 0.421 0.397 7.2 (5.7) 
e 0.718 0.716 0.720 0.3 (0.4) 
‡ Cartesian coordinates of the computed structure are available on the CD accompanying this thesis. 
† Deviation of MM3* calculation relative to X-ray data.  Values in brackets represent deviation from AM1 results 
≠ AM1 results calculated by Liddell et al.; values obtained in this study agreed exactly with those presented. 
 
4.6.1 Additional Investigations of Resorcin[4]arene-based Molecules 
 
The synthetic work described in Chapter 3 of this work resulted in a number of novel crystal 
structures of synthetic intermediates, all of which are resorcin[4]arene-based molecules.  
Discussion of these X-ray structures appears in Chapters 3 and 6, and the complete data sets are 
in Appendix 3.  These intermediates were investigated computationally in an identical manner 
to those cavitands appearing in Figures 4.4 and 4.5, making use of both MM and semi-empirical 
methods.  While the synthetic intermediates bear different feet, methyl feet were used in the 
computations in keeping with the two cavitand structures already investigated.  The results of 
the MM3* and AM1 optimisations of three of these intermediates are presented below.  
 
Computational studies of the intermediates commenced with an investigation of a cavitand 























Figure 4.6: Structure and criteria used for comparison between computation and crystal structure of a 
methyl cavitand, as synthesised in this study (see Appendix 3 for the complete data). 
 
Table 4.3 shows the results of the two minimisation calculations, compared with the 
corresponding measurement taken from the crystal structure of the cavitand.  In general, good 
agreement exists between the X-ray measurements in comparison with both computationally 
derived measurements.  With regards to accuracy, the computationally derived parameters are 
very similar to the corresponding X-ray measurements, with neither computational method 
showing superior accuracy over the other.   
 
Precision of the MM3* calculation relative to the AM1 calculation also shows close agreement 
between the two methods of computation.  This is evident particularly in the RMS error 
reported between the two computationally optimized structures, which is an error resulting from 
the superimposition of the MM3* minimised structure versus the corresponding AM1 
minimised structure.  In this particular case, the error is 0.022 nm, which reflects a small 
difference between the two minimised structures.  
 
In addition, the deviations from the X-ray data as well as the disagreement between the two 
methods of calculation, in this case, are comparable with those seen in the study of the cavitand 
bearing a bromine atom at the extra-annular position.  The largest deviation also occurs for 






Table 4.3: Comparison of selected calculated interatomic distances‡, with those obtained from the X-ray 







a 0.947 0.933 0.966 2.0 (3.4) 
b 0.799 0.788 0.799 0.0 (1.4) 
c 0.528 0.526 0.513 2.8 (2.5) 
d 0.433 0.423 0.393 9.5 (7.6) 
e 0.719 0.724 0.728 1.3 (0.5) 
‡ Cartesian coordinates of the computed structure are available on the CD accompanying this thesis. 
† Deviation of MM3* calculation relative to X-ray data.  Values in brackets represent deviation from AM1 results. 
≠ Both the AM1 and MM3* sets of data were generated from calculations performed in this study. 
 
The second intermediate investigated had slightly more elaborate functionalisation at the extra-
annular position of the cavitand, in the form of a bromomethyl group.  The structure of this 






















Figure 4.7: Structure and criteria used for comparison between computation and crystal structure of a 
bromomethyl cavitand, as synthesised in this study (see Appendix 3 for complete data). 
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Table 4.4: Comparison of selected calculated interatomic distances‡, with those obtained from the X-ray 







a 0.795 0.794 0.826 3.9 (4.0) 
b 0.524 0.524 0.520 0.8 (0.8) 
c 0.430 0.420 0.395 8.1 (5.9) 
d 0.730 0.718 0.724 0.8 (0.8) 
‡ Cartesian coordinates of the computed structure are available on the CD accompanying this thesis. 
† Deviation of MM3* calculation relative to X-ray data.  Values in brackets represent deviation from AM1 results. 
≠ Both the AM1 and MM3* sets of data were generated from calculations performed in this study. 
 
The four parameters compared indicate that the computationally minimised structures are 
divergent from that of the X-ray structure.  Indeed, the accuracy of the computationally derived 
parameters relative to the X-ray measurement is poorer here than in the case of the methyl 
cavitand.  However, the AM1 results are more accurate than those from the MM3* calculation.  
The difference between the two methods of calculation shows far poorer precision than for the 
methyl cavitand above, with an RMS error of 0.423 nm between the two computationally 
derived structures.   
 
The largest deviations observed, however, highlights the fundamental difference between the 
structure forming part of a crystal structure, and that calculated using theoretical models.  It 
should be remembered for all such comparisons in this study, the data obtained from the crystal 
structure relates to a structure that is static, while that obtained from the minimization process is 
derived from only one structural conformation.  Thus, for more complex structures bearing 
flexible side chains such as that in Figure 4.7, poorer precision should be anticipated.   
 
The final intermediate investigated was a resorcin[4]arene, the structure of which is shown in 
Figure 4.8.  The structure differs significantly from the four previous cavitand structures, in that 
the aromatic moieties are no longer bound by -OCH2O- bridges.  Therefore, the rigidity of the 





















Figure 4.8: Structure and criteria used for comparison between computation and crystal structure of a 
resorcin[4]arene, as synthesised in this study (see Appendix 3 for complete data). 
 
The comparative data appears in Table 4.5.  Results indicate significant differences between 
parameters obtained from the X-ray data, and those obtained by calculation.  Accuracy of both 
models seems to be significantly affected by the lack of rigidity of the structure under 
consideration. 
 
Table 4.5: Comparison of selected calculated interatomic distances‡, with those obtained from the X-ray 







a 1.015 1.275 1.131 11.4 (12.7) 
b 0.941 1.010 0.908 3.5 (11.2) 
c 0.518 0.512 0.511 1.4 (0.2) 
d 0.404 0.315 0.354 12.4 (11.0) 
e 0.682 0.716 0.712 4.4 (0.6) 
‡ Cartesian coordinates of the computed structure are available on the CD accompanying this thesis. 
† Deviation of MM3* calculation relative to X-ray data.  Values in brackets represent deviation from AM1 results. 
≠ Both the AM1 and MM3* sets of data were generated from calculations performed in this study. 
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Interestingly, the AM1 results in this case are less accurate than the MM3* results.   
 
This is as a result of the resorcin[4]arene cavity narrowing and pinching closed during the 
minimisation process.  This phenomenon is consistent with the experimental observations, 
where the absence of a guest from the cavity of molecules such as resorcin[4]arenes results in 
the puckering of the cavity.[35]  Such puckering was not observed in the case of the MM3* 
minimisation, potentially due to the force field used, which makes use of laws of classical 
physics, as opposed to the quantum nature of the physics used in the AM1 minimisation. 
 
Indeed, in terms of precision between the two minimisation processes, the deviations reported in 
Table 4.5 indicates relatively poor precision.  This is further illustrated by an RMS error of 
0.471 nm.  Again, the largest deviations are seen for parameters a and d, which is expected 
since these two parameters would be most affected by any puckering of the molecular cavity.  In 
addition, the data again suggests that structure complexity influences the accuracy of the 
computational model.   
 
4.6.2 Summary and Aims 
 
The above comparisons indicate that both MM3* and AM1 models of molecules that have been 
observed and investigated experimentally via X-ray crystallography, deviate from reality; in 
some cases quite considerably.  However, the deviation of the MM3* models from the cavitand 
and resorcin[4]arene crystal structures as seen above is within an acceptable margin in order to 
obtain useful insight into the behaviour of the proposed ligands in this study.  In addition, 
although the semi-empirical methods above give more accurate results in general, their quantum 
mechanical nature, as discussed in section 4.2, means that the demand on computer time and 
resources during calculation is greater.  This is particularly true relative to MM methods, and is 
a situation further compounded by the large molecules dealt with in this study. 
 
Therefore, although the above comparisons are based only on (relatively) simple 
resorcin[4]arene-based molecules, it should be remembered that cavitands, porphyrins and 
indeed, hemicarcerands have all been investigated effectively using MM2 and MM3 force 
fields.  Thus, the treatment of a cavitand-capped porphyrin system using MM3* and the same 
parameters as for the simple cavitand stands to give reliable results.   
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It should be noted (from Chapter 2) that in terms of the proposed ligand, aperture size must be 
such that guests must enter into the host ligand exclusively via the apertures highlighted, based 
on size.  Therefore, the apertures must have a degree of size selectivity.  With this in mind, the 
aims of the computational investigation were as follows: 
 
1. Since the ligands are novel, examine the ligand structures obtained by 
simulation in order to gauge model precision. 
2. Minimise the structures of a series of cavitand-capped porphyrin ligands, 
investigating the size of the apertures obtained. 
3. Based on minimisation and MD, examine which bridge length will afford the 
most appropriate aperture size so as to ensure the desired size selectivity. 
 
4.7 Computational Minimisation of Target Ligand Variations [36] 
 
Computational investigations commenced by calculating the minimised structures of the series 
of ligands shown in Figure 4.9 using the minimisation parameters as set out in section 4.5.2 
above.  Once the minimised structures were obtained, the aperture width for the respective 
































Figure 4.9: Target ligand structures used as basis for computational modeling. 
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Aperture size was measured between the points of the cavitand and porphyrin that were closest 
to each other.  This is represented by the outer protons of the -OCH2O- bridges of the cavitand 
structure, and the β-pyrrole protons of the porphyrin structure.  This distance can be seen in 
Figure 4.10, the minimised structure of the target ligand bearing -(CH2)2O- bridges.   
 
Results of the minimisation procedure and approximate aperture sizes can be seen in Table 4.6.  
It should be noted that the distance as measured by MACROMODEL is taken from nucleus to 
nucleus.  Therefore, in order to obtain an effective aperture size, twice the van der Waal’s radius 
of a proton, that is, 0.240 nm,[37] was subtracted from the measured value.  In addition, since 
this measurement is not along a straight line between the cavitand and the porphyrin, the 

















Figure 4.10: Ball and stick representation of a minimised ligand structure showing aperture measurement. 
 
It should be remembered that aperture size must be such that it is able to selectively allow the 
terminus of a paraffin into the ligand cavity.  In essence therefore, to afford the terminus-
selective oxidation, the aperture needs to be large enough to allow a methyl group entry into the 
cavity but small enough to simultaneously prevent the paraffin passing through the cavity in its 
entirety.   
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Table 4.6: Potential energies and approximate aperture sizes of varied target ligand structures using 
MM3*.‡ 
Bridge length (n) Potential energy/kJ.mol-1 Approximate aperture width/nm† 
1 799.16 0.098 
2 909.43 0.127 
3 788.52 0.221 
4 893.88 0.341 
‡ Cartesian coordinates of the computed structure are available on the CD accompanying this thesis. 
† Values based on van der Waal’s radii.  
 
The van der Waal’s radius of a methyl group is 0.20 nm, to give a diameter of 0.40 nm;[38] 
therefore, an aperture size of this order is required to accommodate the terminal methyl group of 
a paraffin into the cavity.  From Table 4.6, it can be seen that the minimised aperture size for all 
the ligands investigated fall short of the desired 0.40 nm.   
 
The same minimization study was carried out on the same set of ligands, with Hyperchem 
software, using the semi-empirical AM1 algorithm.  Aperture size was measured and treated as 
above for the MM3* study and results are shown in Table 4.7.  Again, it is evident that all of the 
ligands investigated possess a minimum aperture size smaller than the desired 0.40 nm.  In 
comparison to the MM3* study however, aperture sizes in the AM1 study are, in general, 
smaller.  In the case of the shortest bridge (n = 1), the difference from the MM3* study is 
particularly significant, reflected by the large percentage deviation (33%). 
 
The difference between corresponding structures minimised by the two methods, as indicated by 
the RMS error, suggests that the difference between the two is not significant when considering 
the minimisation of the proposed ligands.  This indicates a high degree of precision between the 
two models.  Importantly, since the semi-empirical calculation is arguably a more accurate 
means of calculating the minimised structures, the high degree of precision indicates that the 
chosen MM3* method is capable of giving accurate results in this study.  There is the additional 
suggestion from trends within the data that as bridge length increases, the relative error 
decreases and the agreement between the two means of modeling improves.   
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Table 4.7: Approximate aperture sizes of varied target ligand structures using AM1.‡ 
Bridge length (n) Approximate aperture width/nm† % deviation* RMS error≠/nm 
1 0.066 32.7 0.025 
2 0.135 6.3 0.023 
3 0.201 9.1 0.015 
4 0.327 4.1 0.018 
‡ Cartesian coordinates of the computed structure are available on the CD accompanying this thesis. 
† Values based on van der Waal’s radii. 
* Deviation of AM1 results relative to MM3* results. 
≠ Error in fit between ligand structure minimised using MM3*, versus the corresponding AM1 minimisation. 
 
The results of the optimisation in the MM3* study (Table 4.6) agree with the observations seen 
for the CPK model study.  The structures that fitted particularly well in the CPK study (where n 
= 1 or 3, for bridge length in Figure 4.3) correspond to the structures with the lowest potential 
energy in the computational optimisation.  Similarly, those which exhibited particular strain in 
the bridge (where n = 2 or 4, for bridge length in Figure 4.3) in the CPK study show the highest 
potential energy in the optimisation process.   
 
In summary, therefore, the minimisation of the series of ligands using MM3* and AM1 
produced the following results: 
 
1. Both MM3* and AM1 minimisations indicate that the target ligand in Chapter 
3 possesses apertures too small to accommodate the terminus of a paraffin.   
2. The MM minimisation in conjunction with the CPK results support the 
observations and conclusions regarding the synthetic results in Chapter 3: the 
bridge length chosen proved to be too short to afford the target ligand.  
3. In comparing the MM3* minimisation to the AM1 minimisation, 
superimposition of corresponding ligand structures indicates (via RMS error) 
that modelling using MM3* does not deviate significantly from AM1.  The 
MM3* model thus has a high degree of precision.  In addition, both show that 
the target ligand bears apertures which are too small. 
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It should be remembered that, as discussed in section 4.5.1, aperture sizes can be altered by 
changing the temperature and the thermodynamic environment in which the ligand is found.  As 
such, MD calculations are especially attractive as a means by which to vary aperture size, and 
thereby identify a suitable bridge length able to afford apertures capable of accommodating the 
terminus of a paraffin. 
 
4.8 Molecular Dynamics Investigation of Ligand Apertures 
 
4.8.1 MD Study of a Reported System: Reinhoudt’s Ligand  
 
MD investigations of the ligands considered in the minimisation process commenced by first 
considering a similar ligand system which has been reported and observed experimentally to 
bind to a number of guests.  As mentioned in Chapter 2, the first examples of cavitand-capped 
porphyrins were reported by Reinhoudt et al.,[39] which were subsequently used to encapsulate 
N-methylimidazole and a number of pyridine guests.  Among the ligands synthesised was a 













































Figure 4.11: Ligand reported by Reinhoudt et al., bearing four bridges five atoms in length. 
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The similar bridge length incorporated in this ligand in comparison to the ligands investigated in 
the minimisation study made Reinhoudt’s ligand an attractive subject for dynamics simulations.  
In addition, the reported ligand (as a zinc metalloporphyrin) was observed, by UV-binding 
experiments, to form 1:1 complexes with the guests seen in Figure 4.12, with the guests binding 
to the zinc in an axial manner within the ligand cavity.  In contrast, larger guests such as those 
seen in Figure 4.13 were observed not to enter into the ligand cavity and thus could not form a 
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Figure 4.13: Guests unable to enter Reinhoudt’s ligand. The approximate size of these guests is shown. 
 
By considering the apertures of Reinhoudt’s ligand computationally bearing in mind the nature 
and size of the guests which were complexed, the reliability and validity of the MD procedure 
and results can be assessed.  Investigation commenced with the minimisation of Reinhoudt’s 
ligand, according to the procedure as set out in section 4.6.  The aperture size for the ligand in 
minimised configuration was measured at 0.463 nm, clearly too small to accommodate the 
guests shown in Figure 4.12.   
 
Subsequently, MD simulations were performed on the molecule.  A calibration was completed 
using cyclohexane, and the MM3* force field and parameters as set out in section 4.5.2 above.  
It was found that at approximately 730 K, cyclohexane was observed to undergo conformer 
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interconversion.  Therefore, room temperature (25 °C) can be approximated as being 730 K in 
the simulation, with this specific force field.  With this in mind, dynamics were completed on 
Reinhoudt’s ligand at this temperature, since the reported binding experiments were performed 
at ambient temperature.   
 
The simulations were done over 100 ps while monitoring the same interatomic distance used to 
calculate the width of ligand aperture size in the minimisation process above (Figure 4.9).  In 
addition, snapshots of ligand aperture size were taken every 0.50 ps to give 200 sample 
structures over 100 ps; in effect illustrating the variation of aperture size during the course of 
simulation.  The respective van der Waal’s radii were again subtracted from all measurements, 
and aperture size plotted as a function of time for each ligand at each temperature.  As seen in 
Figure 4.14, the graph indicates that at this particular temperature (approximated as room 
temperature), aperture size is of sufficient size to comfortably accommodate the guests as seen 
in Figure 4.12.  Maximum aperture size approaches 0.80 nm which matches the approximate 
size of the guests accommodated within the ligand cavity.  Additionally, the guests excluded 
from the cavity can be seen to have an approximate size greater than that of the aperture, 
explaining why exclusion occurred.   
 
It is, however, important to note the behaviour of the cavitand in affording the observed aperture 
size.  In minimised form, the -OCH2O- ether bridges between the aromatic scaffolding of the 
cavitand arrange such that one methylene hydrogen is found within the ligand cavity, with the 
other outside of the cavity, as shown in Figure 4.15 (left).  During MD, the additional energy 
from the simulation allows the methylene group to rotate such that both protons face outwards 






































































Figure 4.15: The rotation of the cavitand ether bridges during MD simulation.  Protons not of interest 
have been omitted for purposes of clarity. 
 
It should be remembered, from Figure 4.10, that the aperture size is measured between these 
hydrogen atoms and the β-pyrrole hydrogen atoms of the porphyrin.  This measurement changes 
significantly upon rotation of the methylene hydrogen atoms due to the enlarged aperture.  
Interestingly, this phenomenon was also observed by Sheu and Houk in the MD study of 
hemicarcerands via MM3*[18f] and used to explain why guests seemingly larger in dimension 
than aperture size were found to enter the hemicarcerand cavity.  Additionally, the conversion, 
essentially a conformational change from a chair to a boat conformation, was calculated (using 
MM3* methods) as having an activation barrier of 12 kcal.mol-1 by Sheu and Houk.  Bearing in 
mind that processes in the order of 15 to 20 kcal.mol-1[40] occur at room temperature, such a 
conformational change is possible at room temperature.   
 
Therefore, given the results of the MD simulation performed on cyclohexane and the associated 
chair-boat conformational interconversion, as well as the conformational change noted above in 
Figure 4.15, the use of 730 K as a room temperature approximation is justifiable.  The 
phenomenon in Figure 4.15 and the kinetic and thermodynamic data presented by Sheu and 
Houk further offers an explanation as to why the guests in Figure 4.12 were able to enter into 
the ligand cavity.  As a retrospective investigation, MD simulations were performed on the 
ligand at 300, 500 and 700 K in order to confirm 730 K as a valid approximation of room 
temperature.  It was found that rotation of the cavitand methylene hydrogen atoms was not 
observed at any of these temperatures, even when performing duplicate simulations over 200 ps.  
As shown in Figure 4.16, aperture size does not approach 0.80 nm as above, peaking at 























































Figure 4.16: Graph of variation of aperture size at temperatures lower than approximated room temperature for Reinhoudt’s ligand. 
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Indeed, this aperture size arose as the system possessed sufficient energy at 700 K to rotate the 
cavitand methylene groups to the point of conformation change; however, insufficient energy 
was present to overcome the activation barrier.   
 
It can hence be seen that the computational model and methods applied are able to replicate the 
experimental observations seen by Reinhoudt et al.  In particular, the investigation illustrated 
why the smaller guests exhibited enhanced binding, while the larger guests could not be 
accommodated within the ligand cavity.  The study also shows that the MD simulation can be 
reliably used to predict whether or not bridge length can afford ligand apertures able to 
selectively allow guests into the molecular cavity.   
 
It should however be noted that there are inherent differences between the above modeled 
system and Reinhoudt’s experimental system; most notably the absence of the Zn(II) metal 
centre used to complex any guests, and the use of amide-based bridges.  The inclusion of a 
metal in the ligand stands to rigidify the ligand framework to a degree, but modeling of a system 
incorporating metals is not suited to MM calculations using MM3*.  Nonetheless, although the 
ligands optimised thus far are ether-based, MD simulations can be used to investigate which of 
these affords an aperture size capable of selectively accommodate the terminus of a paraffin. 
 
4.8.2 MD Simulations of Ligands Forming Part of this Study 
 
It is evident from the minimisation process and Table 4.6, that all of the proposed molecules 
give aperture sizes that fall short of the desired size of approximately 0.40 nm.  As such, MD 
studies were carried out on the ligands bearing bridges as shown in Figure 4.17 in order to see 
how aperture size varies as a function of temperature.   
 
The MD simulations were performed in the same manner as per Reinhoudt’s molecule in 
section 4.8.2.  In addition to monitoring the same aperture dimension as in the above MD study, 
the distance perpendicular to this measurement (horizontally, between two neighbouring bridges 
linking the porphyrin to the cavitand) was also monitored to see if this distance would also 
become a factor in limiting access to the ligand cavity at elevated temperatures.  Additionally, 
the distance between the single aromatic protons of opposite aromatic residues in the cavitand 
structure (parameter d, Figure 4.4 - 4.8) was also monitored for each molecule for the same 

































Figure 4.17: Ligand structure variations used in MD studies. 
 
ligand, are summarised as graphs in the figures below.  In each graph, 0.40 nm is included as a 
reference aperture size. 
 
The MD simulation for the synthetic target (n = 1, Figure 4.17) in Chapter 3, as illustrated by 
Figure 4.18, indicated that despite the elevated temperatures, aperture size does not approach the 
desired 0.40 nm.  A maximum of approximately 0.30 nm is reached.  Interestingly, the graph 
shows that the temperature variation has no significant effect on how the aperture varies, and 
essentially shows a trace of results over the four simulations.  This indicates that there is a 
significant degree of rigidity associated with this particular ligand, brought about by the short 
bridges used to link the cavitand and porphyrin moieties.  It was also found that the maximum 
horizontal distance between two neighbouring bridges ranged between 0.44 and 0.47 nm over 
the temperature range.  The distance between opposite cavitand aromatic protons (parameter d) 
remained in the order of 0.16 nm, and did not vary appreciable as a function of temperature.  
Both of these results indicate that these distances would not influence access to the ligand cavity 
at elevated temperatures.   
 
The ligand bearing -(CH2)2O- (n = 2, Figure 4.17), having an extra methylene group present in 
the bridge, also has an average aperture size that falls short of 0.40 nm.  Figure 4.19, however, 
does indicate a lot more variation of aperture size as a function of temperature in comparison to 
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the ligand seen in Figure 4.18.  This is indicative of the increased flexibility in the ligand system 
as a result of the introduction of the additional methylene group into the bridges.   
 
Interestingly, the ligand does reach an aperture size which exceeds 0.40 nm on one isolated 
occasion.  This can be explained by the rotation of the -OCH2O- ether bridges forming part of 
the cavitand scaffold as discussed above (illustrated by Figure 4.14).  This rotation only occurs 
at elevated temperatures, in contrast to Reinhoudt’s ligand, which exhibits the rotation at room 
temperature.  This is indicative of the increased rigidity of this particular ligand relative to that 
of Reinhoudt’s, brought on by the shorter bridge length, in this case.  Analysis of the horizontal 
distance between two bridges as well as the distance between opposite cavitand aromatic 
protons (parameter d) again showed these parameters would not influence access to the ligand 
cavity at elevated temperatures. 
 
The use of a ligand having bridges four atoms in length proved to give more promising results.  
As seen in Figure 4.20, the use of -(CH2)3O- bridges (n = 3, Figure 4.17), the calculation results 
in an aperture size which exceeds 0.40 nm on a number of occasions during simulation, even at 
lower temperatures.  In addition, the general aperture size does not become excessively large.  
The ligand does exhibit rotation of the cavitand -OCH2O- ether bridges, at 900 and 1000 K, to 
give enlarged apertures.  However, this may (in theory) be prevented by avoiding the use of 
such temperatures during laboratory experimentation.  This becomes particularly important 
considering that, while the terminus of a paraffin is 0.40 nm in diameter, the remainder of the 
paraffin ranges from 0.46 to 0.49 nm.[38]  Thus, to achieve selective entry of only the paraffin 
terminus into the ligand cavity, the aperture should ideally not exceed 0.49 nm.   
 
Additionally, the horizontal distance between adjacent bridges and the distance between 
opposite cavitand aromatic protons again proved not to be a factor able to influence access to 


































































































































































Figure 4.20: Graph of variation of aperture size as a function of temperature for ligand bearing -CH2CH2CH2O- bridges.
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The final ligand considered in the MD studies possessed a five atom bridge (n = 4, Figure 4.17).  
As evident in Figure 4.21, the relatively long -(CH2)4O- bridges meant that the ligand apertures 
easily exceeded 0.40 nm, even at room temperature.  This was expected given the results 
presented for Reinhoudt’s ligand, which had a similar bridge length.  However, the apertures in 
this case approach and exceed 0.50 nm on a regular basis.  This potentially indicates that in 
terms of size selectivity for the terminus of a paraffin, this ligand may prove to have apertures 
which are too large.  In addition, the cavitand ether bridges can again be seen to undergo 
rotation, also at room temperature, to give excessively large aperture sizes.  Moreover, as with 
the previous three ligand variations, the horizontal distance between adjacent bridges and that 
between opposite cavitand aromatic protons proved not to be a factor influencing access to the 
ligand cavity at elevated temperatures. 
 
In summary, therefore, a number of noteworthy conclusions may be drawn from the above MD 
study: 
 
1. Access to the ligand cavity is feasible only through the molecular apertures 
investigated, and not through any other aperture forming part of the ligand 
structure (such as the base of the cavitand).  Therefore, size selectivity can be 
achieved via the apertures formed by a suitable length of cavitand-porphyrin 
bridge. 
2. The use of -CH2O- moieties as part of the target ligand in Chapter 3 results in 
bridges that are insufficiently long to accommodate an alkane terminus.  The 
MD studies further show that the ligand is especially rigid in nature, and 
unable to accommodate the terminus of a paraffin through its small apertures, 
even at elevated temperatures.  Thus even if ligand synthesis were a success, 
the ligand would be unable to function selectively as intended. 
3. In order to achieve a suitable aperture size for the desired selectivity, a bridge 
length of four or five atoms seems most viable, giving significant direction to 
any subsequent synthesis.  In addition, control over rotation of the cavitand -
OCH2O- ether bridges is possible by avoiding high temperatures, thereby 

























































Figure 4.21: Graph of variation of aperture size as a function of temperature for ligand bearing -CH2CH2CH2CH2O- bridges.
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4.8.3 Subsequent MD Studies: Ligands Bearing Bridges of Four or Five Atoms  
 
Two ligands were identified as offering a way forward to achieving both synthesis and 
selectivity: one bearing -O(CH2)2O- bridges and another the -O(CH2)3O- bridges, to give 
bridges four and five atoms in length, respectively.  The introduction of the additional oxygen 
atom compared with the equivalent length of bridge as seen in the ligands studied in section 
4.8.2 will be discussed in Chapter 5, along with the subsequent synthesis.  However, in order to 
confirm whether the chosen ligands are capable of affording a desirable aperture size of 
approximately 0.40 nm, an identical set of MD studies were undertaken as per the method set 
out.  
 
Computation again commenced with minimisation of the ligands under investigation according 
to the method set out in section 4.5.2.  The aperture sizes were measured, and compared with 
those seen for the four- and five-atom bridged ligands considered in section 4.8.2.  The 
minimisation and comparative results can be seen in Table 4.8.  It is evident that there is a 
minimal difference in minimised aperture size between corresponding ligands.  
 
Table 4.8: Approximate aperture sizes of four- and five-atom bridged ligand structures using MM3*.‡ 
Bridge  Effective bridge length/atoms Approximate aperture width/nm† 
-(CH2)3O- 4 0.221 
-O(CH2)2O- 4 0.219 
-(CH2)4O- 5 0.341 
-O(CH2)3O- 5 0.360 
‡ Cartesian coordinates of the computed structure are available on the CD accompanying this thesis. 
† Values based on van der Waal’s radii. 
 
As expected, the minimised aperture sizes for the identified ligands fall short of the desired 0.40 
nm thereby justifying performing MD on the two ligands in question.  
 
MD results for the ligand bearing -O(CH2)2O- bridges can be seen in Figure 4.22.  It is evident 
that aperture size exceeds 0.40 nm on a number of occasions.  Indeed, the frequency is very 
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much comparable to that of the ligand bearing an equivalent bridge length as seen in Figure 
4.20.  Once again the rotation of the cavitand -OCH2O- ether bridges (Figure 4.15) is observed, 
occurring during the course of dynamics performed at 900 and 1000 K.  This is also observed in 
Figure 4.20.  However, dynamics performed at lower temperatures, and indeed, at room 
temperature (730 K), show an aperture size able to accommodate the terminus of a paraffin. 
 
Regarding the ligand bearing -O(CH2)3O-, a similar result (Figure 4.23) was again obtained 
when compared to the equivalent molecule (Figure 4.21): the apertures easily exceed 0.40 nm 
and, on a regular basis, 0.50 nm.  Noticeably, Figure 4.23 does not exhibit the rotation of the 
cavitand ether bridges; however, on extending the MD simulation to 200 ps, rotation is 
observed.  It is also evident that at room temperature (approximated at 730 K in this study), the 
aperture size does not become excessively large despite the increased flexibility in this ligand in 
comparison to the ligand bearing -O(CH2)2O- bridges.  Indeed, an aperture size between 0.40 to 
0.46 nm is maintained during the MD simulation at room temperature.   
 
In essence, therefore, there is not a significant difference between the two newly proposed 
ligands and the two equivalent ligands examined in section 4.8.2.  Indeed, both are capable, by 
the computational results, of the selective accommodation of a paraffin terminus.  The two new 











































































































As evident in Chapter 3, the chosen bridge length for the target ligand makes it difficult to 
synthesise, by an in situ protocol or by a direct capping protocol.  Indeed, the synthetic 
observations suggested a minimum requirement of bridge length exists for a successful 
synthesis (regardless of protocol used), and that the -CH2O- bridge used is below this minimum.  
The results of the computational investigation further substantiate this conclusion; the 
minimisation results in particular supporting the conclusion that the short bridge length was a 
primary reason for the inability to synthesise the target ligand in Chapter 3.  Additionally, the 
MD study indicates that the -CH2O- bridges afford apertures that are too small to accommodate 
the terminus of a paraffin, both in a minimised configuration, and at elevated temperatures.  
Thus, even if a successful synthesis was achieved, the ligand appears to be unable to selectively 
allow only the terminus of a paraffin access to the ligand cavity. 
 
With this minimum requirement in mind, it is also important to note the observations by Cram 
et al.,[22a] and Sheu and Houk[18f] regarding the formation of complexes.  Both reported that 
longer bridge lengths and larger aperture sizes in the case of hemicarcerands did not necessarily 
afford size selectivity towards larger guests.  Therefore, while this study suggests a minimum 
requirement, the reported observations additionally suggests that a maximum bridge length 
requirement exists in order to maintain selectivity.  Beyond this maximum, hosts are no longer 
able to effectively be selective in terms of discriminating between guests based on size.   
 
Therefore, there is experimental evidence to support the notion that there exists both a minimum 
and a maximum requirement of bridge length with regards to cavitand-capped porphyrins.  
Since this study shows that -CH2O- bridges are of insufficient length to fulfill either requirement 
regarding synthesis and selectivity, longer bridges are an obvious way forward.  Subsequent 
computational investigation demonstrated that ligands having four- or five-atomed bridges are 
capable of affording an aperture size suitable for the desired selectivity towards a paraffin 
terminus.  The ligand bearing bridges consisting of five, however, may give apertures too large 
to yield the desired size selectivity.  Nonetheless, these two ligands represent viable synthetic 
targets, and will be the focus of subsequent synthetic work to follow in Chapter 5.  
 
In terms of viable computational and theoretical models, due to the novelty of the ligands under 
consideration, no absolute conclusions may be drawn regarding model accuracy and precision in 
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this study.  However, semi-empirical methods appear to be more promising, given the accuracy 
of the results obtained above in section 4.6, relative to the corresponding MM results.  Indeed, it 
has been shown that MM has problems describing the unusual environment inside hosts such as 
hemicarcerands (thus, cavitand-capped porphyrins),[18f, 19] since, as mentioned in section 4.3, 
MM models do not explicitly consider electronic interactions.  The description of the interior of 
such host molecules as a new phase of matter [41] thus warrants quantum mechanical 
approaches, such as semi-empirical or ab initio methods.  In this regard, the work reported by 
Naruta et al. illustrates the ability of ab initio methods to replicate experimentally observed 
results with analogous host molecules.[23]  Such methods, however, require greater computing 






1. a) T. Clark, A Handbook of Computational Chemistry, Wiley, 1985; b) D.M. Hirst, A 
Computational Approach to Chemistry, Blackwell, 1990; c) A. Hinchcliffe, Modeling 
Molecular Structure, Wiley, 1996; d) T. Schlick, Molecular Modeling and Simulation, 
Springer, 2002; e) P. Comba, T.W. Hambley, Molecular Modeling of Inorganic 
Compounds, Wiley, Verlag, 2001. 
2. Hyperchem Inc., Hyperchem, Computational Chemistry, 1996. 
3. J.B. Foresman, A.E Frisch, Exploring Chemistry with Electronic Structure Methods, 
Gaussian Inc., 1996. 
4. I.N. Levine, Quantum Chemistry, Prentice Hall, 2000. 
5. P. Atkins, J. de Paula, Atkin’s Physical Chemistry, Oxford University Press, 2002. 
6. C.J. Cramer, Essentials of Computational Chemistry, Wiley, Chichester, 2004. 
7. W.J. Hehre, J.Yu, P.E. Klunzinger, L. Lou, A Brief Guide to Molecular Mechanics and 
Quantum Chemical Calculation, Wavefunction, Inc., 1998. 
8. a) A.R. Leach, Molecular Modeling, Principles and Applications, Addison Wesley 
Longman, England, 1996; b) F. Jensen, Introduction to Computational Chemistry, 
Wiley, Chichester, 2007. 
9. K. Bissety, PhD Thesis, and references therein, University of Natal Durban, 2002. 
10. a) A. Hinchliffe, Chemical Modeling From Atoms to Liquids, Wiley, Chichester, 1999; 
b) A. Hinchcliffe, Molecular Modeling for Beginners, Wiley, Chichester, 2003. 
11. a) J.L. Banks, H.S. Beard, Y.X. Cao, A.E. Cho, W. Damm, R. Farid, A.K. Felts, T.A 
Halgren, D.T. Mainz, J.R. Maple, R. Murphy, D.M. Philipp, M.P. Repasky, L.Y. 
Zhang, B.J. Berne, R.A. Friesner, E. Gallicchio, R.M. Levy, J. Comput. Chem., 2005, 
26, 1752-1780; b) W. Klopper, K.L. Bak, P. Jorgensen, J. Olsen, T. Helgaker, J. Phys. 
B.: At., Mol. Opt Phys., 1999, 32, 103-130; c) P.R. Rablen, J.W. Lockman, W.L. 
Jorgensen, J. Phys. Chem. A, 1998, 102, 3782-3797; d) J. Simons, J. Phys. Chem., 
1991, 95, 1017-1029. 
12. T. Raasch, M.Sc Thesis, and references therein, University of Natal Durban, 2002. 
13. a) P. Hohenberg, W. Kohn, Phys. Rev. B, 1964, 136, 864; b) W. Kohn, L.J. Sham, Phys. 
Rev. A, 1965, 140, 1133.   
14. P. Comba, Coord. Chem. Rev., 1993, 123, 1-48. 
15. J.M. Haile, Molecular Dynamics Simulation: Elemental Methods, Wiley, New York, 
1992. 
 135
16. a) H.D. Holtje, G. Folkers, Methods and Principles in Medicinal Chemistry, VCH, New 
York, 1996; b) K. Bisetty, F.J. Corcho, J. Canto, H.G. Kruger, J.J. Perez, THEOCHEM, 
2006, 770, 221-228.  
17. a) J.C. Sherman, Tetrahedron, 1995, 51, 3395-3422; b) E. Maverick, D.J. Cram, 
Comprehensive Supramolecular Chemistry 1996, 2, 367-418; c) J. Rebek, Chem. Soc. 
Rev., 1996, 4, 255-264; (d) R. Warmuth, J. Yoon, Acc. Chem. Res., 2001, 34, 95-105. 
18. a) D.J. Cram, M.E. Tanner, C.B. Knobler, J. Am. Chem. Soc., 1991, 113, 7717-7727; b) 
D.J. Cram, M.T. Blanda, K. Paek, C.B. Knobler, J. Am. Chem. Soc., 1992, 114, 7765-
7773; c) D.J. Cram, R. Jaeger, K. Deshayes, J. Am. Chem. Soc., 1993, 115, 10111-
10116; d) T.A. Robbins, C.B. Knobler, D.R. Bellew, D.J. Cram, M.E. Tanner, J. Am. 
Chem. Soc., 1994, 116, 111-122; e) J. Yoong, C. Sheu, K.N. Houk, C.B. Knobler, D.J. 
Cram, J. Org. Chem., 1996, 61, 9323-9339; f) C. Sheu, K.N. Houk, J. Am. Chem. Soc., 
1996, 118, 8056-8070. 
19. M.J. Liddell, D. Margetic, A.S. Mitchell, R.N. Warrener, J. Comput. Chem., 2003, 25, 
542-557. 
20. a) C. von dem Bussche-Hunnefeld, D. Buhring, C.B. Knobler, D.J. Cram, J. Chem. Soc. 
Chem. Comm., 1995, 1085-1087; b) K. Nakamura, K.N. Houk, J. Am. Chem. Soc., 
1995, 117, 1853-1854. 
21. a) D.J. Cram, M.T. Blanda, K. Paek, C.B. Knobler, J. Am. Chem. Soc., 1992, 114, 
7765-7773. 
22. T.A. Robbins, D.J. Cram, J. Am. Chem. Soc., 1993, 115, 12199. 
23. J. Nakazawa, Y. Sakae, M. Aida, Y. Naruta, J. Org. Chem., 2007, 72, 9448-9455. 
24. a) S. Fischer, P.D.J. Grootenhuis, L.C. Groenen, W.P. van Hoorn, F.C.J.M. van Veggel, 
D.N. Reinhoudt, M. Karplus, J. Am. Chem. Soc., 1995, 117, 1611-1620; b) I. Thondrof, 
J. Brenn, W. Brandt, V. Bohmer, Tetrahedron Lett., 1995, 36, 6665-6668; c) B.P. Hay, 
L. Yang, J-H Lii, N.L. Allinger, THEOCHEM, 1998, 428, 203-219; d) H. Otsuka, K. 
Araki, H. Matsumoto, T. Harada, S. Shinkai, J. Org. Chem., 1995, 60, 4862-4867; e) I. 
Thandorf, J. Brenn, J. Chem. Soc. Perkin Trans. 2, 1997, 2293-2297. 
25. a) F. Weinelt, H-J Schneider, J. Org. Chem., 1991, 56, 5527-5535; b) I. Thondrof, J. 
Brenn, V. Bohmer, Tetrahedron, 1998, 54, 12823-12828; c) A. Tafi, B. Botta, M. Botta, 
G. Delle Monach, A. Filippi, M. Speranza, Chem. Eur. J., 2004, 10, 4126-4135. 
26. a) P.D. Beer, E.L. Tite, M.G.B. Drew, A. Ibbotson, J. Chem. Soc. Dalton Trans., 1990, 
2543-2550; b) G.J. Chen, R. Cruz, G.M. Martinez, F. Lara-Ochoa, THEOCHEM, 2000, 
496, 73-81; c) K.N. Houk, K. Nakamura, C. Sheu, A.E. Keating, Science, 1996, 273, 
627-629. 
 136
27. O.Q. Munro, J.C. Bradley, R.D. Hancock, H.M. Marques, F.W. Marsicano, J. Am. 
Chem. Soc., 1992, 114, 7218-7230. 
28. a) M.A. Lopez, P.A. Kollman, J. Am. Chem. Soc., 1989, 111, 6212-6222; b) R.D. 
Hancock, J.S. Weaving, H.M. Marques, J. Chem. Soc. Chem. Comm., 1989, 1176-1178. 
29. a) F. Maseras, New J. Chem., 1998, 327-332; b) J-D Marechal, G. Barea, F. Maseras, A. 
Lledos, L. Mouawad, D. Perahia, J. Comput. Chem., 2000, 21, 282-294. 
30. a) B. Botta, P. Ricciardi, C. Galeffi, M. Botta, A. Tafi, R. Pogni, R. Iacovino, I. Garella, 
B. Di Blasio, G. Delle Monache, Org. Biomol. Chem., 2003, 1, 3131-3137. 
31. a) M. Jalaie, K.B. Lipkowitz, Rev. Comput. Chem., 2000, 14, 441-486; b) T. Liljefors, 
K. Gundertofte, P-O. Norrby, I. Pettersson, Computational Medicinal Chemistry for 
Drug Discovery, Marcel Dekker, New York, 2004. 
32. D.J. Cram, S. Karbach, H-E Kim, C.B. Knobler, E.F. Maverick, J.L. Ericson, R.C. 
Helgeson, J. Am. Chem. Soc., 1988, 110, 2229-2237. 
33. a) K. Gundertofte, J. Palm, I. Pettersson, A. Stamvick, J. Comput. Chem., 1991, 12, 
200-208; b) K. Gundertofte, T. Liljefors, P-O. Norrby, I. Pettersson, J. Comput. Chem., 
1996, 17, 429-449. 
34. Hyperchem, Release 7.51 for Windows, Hypercube Inc., 2002. 
35. J.W. Steed, J.L. Atwood, Supramolecular Chemistry, Wiley, Chichester 2000. 
36. All data from the complete computational investigation is included on the CD 
accompanying this thesis, as Appendix 2. 
37. R.S. Rowland, R. Taylor, J. Phys. Chem., 1996, 100, 7384 - 7391. 
38. M.S. Whittingham, A.J. Jacobson, Intercalation Chemistry, Academic Press, 1982. 
39. O. Middel, W. Verboom, D.N. Reinhoudt, J. Org. Chem., 2001, 66, 3998-4005. 
40. J.B. Hendrickson, D.J. Cram, G.S. Hammond, Organic Chemistry, McGraw-Hill, New 
York, 1970. 
41. a) D.J. Cram, M.E. Tanner, R. Thomas, Angew. Chem. Int. Ed. Engl., 1991, 30, 1024-




SYNTHESIS OF CAVITAND-CAPPED PORPHYRIN TARGET LIGANDS 
BEARING LONGER BRIDGES 
 
The results from MD simulations in Chapter 4 indicated that in order to obtain apertures of a 
size selective towards the terminus of a paraffin, bridges consisting of four or five atoms need to 
be incorporated into the target ligand.  This requirement therefore needed to be taken into 
consideration when synthesising the ligands.   
 
Computational investigation in Chapter 4 showed that -(CH2)3O- and -(CH2)4O- bridges gave a 
suitable aperture size to accommodate a paraffin terminus.  However, attaching such alkyl 
bridges directly to the cavitand structure via functionalisation of the extra-annular position is 
synthetically more challenging than for the original synthetic target (Chapter 3).  Therefore, to 
allow for a more facile synthesis, an additional oxygen atom, directly attached to the extra-
annular carbon atom, is incorporated into the bridges.  This gives apertures formed via -
O(CH2)2O- or -O(CH2)3O- bridges, as shown in Figure 5.1.  As discussed in Chapter 4, such 
apertures are analogous in size and behaviour to those formed using -(CH2)3O- and -(CH2)4O- 







































Figure 5.1: General structure of the proposed cavitand-capped porphyrin ligands bearing longer bridges. 
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The novel nature of these ligands again required that both the in situ and direct capping 
synthetic protocols be attempted to determine if either yield a successful synthesis, as in Chapter 
3.  Both protocols and their respective origins have thus been discussed in detail and will not be 
dealt with further.   
 
5.1 In situ Approach 
 
Bearing in mind the new requirements in terms of bridge length, Scheme 5.1 illustrates a 
retrosynthetic pathway towards the synthesis of the target ligands.  Scheme 5.2 subsequently 
shows the complete synthetic scheme yielding the desired cavitand-capped porphyrins.  Both 
schemes show that the chosen synthesis uses procedures and functionalisation which are largely 
established and provide adequate yields. 
 
Synthesis commences with the preparation of resorcin[4]arene 29.[1]  The choice of 14 as 
aldehyde starting material stems from the solubility issues which were encountered in Chapter 
3.  The use of 14 results in the synthesised resorcin[4]arene having 2-phenylethyl feet that 
renders 29, and any subsequent cavitands, soluble in most organic solvents.  Noticeably, 29 
merely has a proton at the extra-annular position.  This position is readily brominated to give 30 
in good yield using N-bromosuccinimide at 0 °C, conditions which allow for control of the 
exothermic nature of reaction.[2]  Thereafter, synthesis of cavitand 31 can be completed by 
using either the procedure as set out by Bryant et al.[2] or the pressurised-vessel method of 
Kaifer et al.[3]  The two methods of cavitand formation have been discussed in detail in Chapter 
3.  Interestingly, however, synthesis of 31 is accomplished only after the bromination of 29, and 
is not attempted using 29 as the reaction precursor.   
 
Conversion of 31 to tetrol 32 proceeds via a two step, one pot synthesis.[4]  Vacuum dried 
precursor 31 is dissolved in THF, itself dry and freshly distilled from sodium benzophenone 
ketal prior to use, before being cooled to -78 °C  The extra-annular positions are metallated by 
the addition of n-butyllitium.  The bromine atoms are thus displaced by lithium to yield an 
organometallic complex, which subsequently undergoes quenching by the addition of trimethyl 
borate, B(OCH3)3.  The resultant arylboronic esters are then treated with a solution of 1:1 15 % 







































































ii) 15 % H2O2 : 1.5 M NaOH = 1:1



















































33: n = 2
34: n = 3
35: n = 2
36: n = 3
37: n = 2
38: n = 3
N -bromosuccinimide,
2-butanone
























The nature of this reaction and indeed, the reagents involved, require that all glassware be 
thoroughly dried and that synthesis be done under an inert atmosphere.  The exclusion of water 
in particular is important, since both n-butyllitium and trimethyl borate are especially moisture 
sensitive.  The presence of moisture during the lithiation step is likely to result in incomplete 
lithiation of all four extra-annular positions of 31.  Additionally, the lithiation of 31 does not 
result in the exclusive formation of 32, where all four bromine functionalities are converted to 
alcohols.  Instead, byproducts result, in the form of a mixture of the tri-, di- and 
monosubstituted alcohols.  The product profile seen is likely as a result of the oxidation step, 
which has been studied in depth elsewhere.[5]  Nonetheless, 32 forms as the majority product (in 
a yield of approximately 50 %) and can be isolated from the various byproducts using column 
chromatography.  Despite the stringent and involved nature of the reaction, and the relatively 
poor yield, 32 represents a particularly versatile cavitand, used not only as a vital precursor to 
both the in situ and direct synthetic protocols in this study, but also in carcerand and 
hemicarcerand synthesis.[3, 6] 
 
Reaction of 33 and 34 with 32, in the presence of a base, results in the synthesis of novel 
aldehydes 35 and 36, respectively.  The aldehyde reagents 33 and 34 have been synthesised in 
very good yields and characterised previously, by coupling salicylaldehyde with 1,2-
dibromoethane, or 1,3-dibromopropane, respectively, in the presence of K2CO3 and DMF.
[7]   
 
Once 35 and 36 have been synthesised, the final in situ porphyrin formation is attempted by 
following the Adler (i, Scheme 5.2) or Lindsey (ii, Scheme 5.2) conditions, so as to afford 37 
and 38, respectively.  In this regard, it should be remembered that the capped porphyrin ligand 
bearing bridges consisting of five atoms as reported by Reinhoudt et al. was synthesised 
exclusively via the use of the Adler conditions.  Therefore, these conditions may be most 
suitable in affording 37 and 38, given the analogous bridge length. 
 
5.1.1 Results: In situ Protocol 
 
Resorin[4]arene 29 was synthesised in yields comparable to that reported in the literature.[1]  
The bromination of 29 using the cited method of addition of N-bromosuccinimide (NBS) to a 
solution of 29 in 2-butanone at 0 °C, in contrast, gave 30 in poor yields (23 %) relative to that 
reported.[2]  Reaction protocol was changed slightly, resorting to the addition of the NBS over 
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approximately an hour, whilst maintaining the reaction solution at -5 °C.  While both these 
factors allowed for an improved control over the reaction isotherm, yields remained in the order 
of 25 %.  An alternative means of bromination was subsequently attempted, whereby 29 was 
suspended in glacial acetic acid, and the suspension treated with elemental bromine at room 
temperature.[8]  The method yielded a suspension of 30, which was filtered and washed with 
water to give an 87 % yield.  Proton (1H) NMR continued to be used as means of 
characterisation, as it was in Chapter 3.   
 
The NMR spectra of 29 and 30 will be discussed with reference to Figure 5.2, which shows the 



















































Figure 5.2: Expanded structures of 29 and 30, showing distinctive protons. 
 
The hydroxyl groups of 29 allow for easy identification using 1H NMR, with the eight 
associated protons (H1) appearing collectively as a singlet at 8.53 ppm in d6-acetone integrating 
to eight protons, as evident in Spectrum 1.70.  The protons associated with the 2-phenylethyl 
feet (R) give rise to multiplets at 2.52-2.61 (integrating to 16 protons) and 7.14-7.25 ppm 
(integrating to 20 protons), due to the presence of the -CH2CH2- and aromatic moieties, 
respectively.  Due to coupling with the CH2CH2- moieties of the feet, H2 appears as a multiplet 
at 4.38 ppm, integrating to four protons.  Finally, the two aromatic protons belonging to the 
resorcin[4]arene scaffold appear as singlets at 6.25 and 7.74 ppm; H3 appears further upfield.  
Since 30 differs from 29 only by the substitution H3 with bromine atoms at the extra-annular 
position, the 1H NMR spectrum of 30 (Spectrum 1.73) appears very similar to that of 29, except 
for the disappearance of the singlet at 6.25 ppm.  The loss of this signal thus serves to confirm 
the successful bromination of 29.  H2 appears, again as a multiplet, at 4.52 ppm, integrating to 
four protons, while the signal arising from the remaining aromatic proton appears at 7.76 ppm.  
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Those signals belonging to the feet are unchanged both in terms of chemical shift and 
multiplicity. 
 
The alkylation of the eight hydroxyl groups of 30 to form cavitand 31 was first attempted using 
the method of Kaifer et al.[3] in the interests of improved yields.  However, this method was 
unable to afford 31.  Given this results in addition to the mixed results seen in using this 
synthetic method in Chapter 3, the method does appear to have some limitations.  Nonetheless, 
31 was successfully synthesised via the protocol of Bryant et al.[2] in yields approaching 70 %.  
Conversion of 31 to 32 proceeded readily using the conditions cited, in a 45 % yield.[4]  
Separation of the mono-, di- and tri-substituted alcohols from the desired tetrol, however, 
proved difficult using the reported silica gel chromatographic conditions.  The use of 3:1 ethyl 
acetate:hexane as the eluant did not afford the exclusive isolation of tetrol 32, and traces of triol 
were found to be present by TLC after completion of the column.  In order to improve the 
separation of tetrol from triol, column conditions were altered, whereby a chloroform-methanol 
eluant was employed.  Gradient elution (by the slow introduction of methanol into chloroform) 
was used towards a final chloroform:methanol ratio of 85:15, which was found to be successful 
in isolating tetrol 32. 
 
With reference to Figure 5.3, the 1H NMR signals of 31 and 32 (Spectrum 1.76 and 1.79, 
































































Figure 5.3: Expanded structures of 31 and 32, showing distinctive protons. 
 
As discussed in Chapter 3, the introduction of the methylene groups as part of 31 gives rise to 
distinct signals characteristic of cavitands.  The anisotropic nature of the associated protons (H4 
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and H5) results in the appearance of two doublets, both integrating to four protons: one at 4.41 
ppm (for the ‘inner’ proton, H4) and another at 5.94 ppm (for the ‘outer’ proton, H5).  The signal 
for H2 has resolved into a triplet, which has shifted slightly downfield to 4.94 ppm, integrating 
to four protons.  The signals due to the ethyl protons associated with the 2-phenylethyl feet have 
also resolved into two multiplets at 2.47 - 2.49 ppm and 2.62 - 2.64 ppm, both integrating to 
eight protons.  The remaining aromatic protons associated with the feet, as well as those 
associated with the cavitand scaffold appear as a multiplet at 7.08 - 7.24 ppm.  Conversion of 31 
to 32, as seen in Spectrum 1.77, results most notably in the appearance of a singlet at 7.96 ppm 
due to H6, integrating to four protons.  The successful synthesis and isolation of 32 can be 
determined by the nature of this signal, as well as from those related to protons H4 and H5.  The 
presence of triol gives rise to multiple singlets at approximately 8.0 ppm as well as an additional 
pair of doublets at approximately 4.5 and 6.0 ppm.  The absence of these signals from Spectrum 
1.77 further serves to confirm the synthesis of tetrol 32. Indeed, the remainder of the signals 
associated with the feet, H2, H4 and H5 are largely unchanged from 31, and maintain the 
associated multiplicity and chemical shift.  Additionally, crystals of 31 were grown by the slow 
solvent evaporation of a solution of 31 in chloroform/acetone, and samples analysed using 
single crystal X-ray crystallography.  Discussion of the data follows in Chapter 6.   
 
Before in situ formation of porphyrin could take place, the required aldehyde residues needed to 
be incorporated into the cavitand scaffold.  In order to facilitate this, salicylaldehyde derivatives 
33 and 34 were synthesised from salicylaldehyde and the appropriate dibromoalkane.  Synthesis 
took place in DMF in the presence of K2CO3, using an excess (8 equivalents) of dibromoalkane 
reagent.  Yield in the case of 33 was 70 %, while that in the case of 34 was 97 %.  Interestingly, 
reaction was unsuccessful in yielding either 33 or 34 when using NaH in THF.  Additionally, 
while the reaction towards 34 proceeded readily to completion, the reaction towards 33 was 
unable to go to completion and unreacted salicylaldehyde remained, despite gentle heating 
during the course of reaction.  It was thus particularly important to thoroughly wash the reaction 
mixture during workup with 10 % NaOH in order to remove excess salicylaldehyde.  Excess 
dibromoalkane was removed in vacuo to yield 33 as a yellow, crystalline solid, and 34 as a 
yellow oil.  Crystals of 33 were sampled and analysed via X-ray crystallography.  The data is 
discussed in Chapter 6 to follow.  Synthesis of novel aldehydes 35 and 36 took place under 
conditions very similar to those applied to the synthesis of 33 and 34.  Tetrol 32 was dissolved 
in a small amount of dry DMF and reacted, in the presence of K2CO3, with 33 and 34 at 55 °C.  
This afforded 35 (93 % yield) and 36 (81 % yield), respectively.  Interestingly, pure 35 and 36 
were obtained without further chromatography via working up the reaction by filtering off the 
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excess K2CO3, removing the DMF under reduced pressure, and stirring the resultant oily residue 
in methanol overnight.  In addition, scaling up of the reaction beyond 0.5 g of tetrol starting 
material resulted in diminished yields and mixtures of products.  With reference to Figure 5.4, 



























































































Figure 5.4: Expanded structures of 33, 34 and 35, showing distinctive protons. 
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In the case of 33 and 34, most prominent in the spectra (Spectrum 1.82 and 1.85, respectively) is 
the presence of the aldehyde proton, appearing as a singlet at approximately 10.40 ppm 
integrating to one proton.  The downfield nature of this signal is characteristic of aldehyde 
protons.  In the case of 33, the presence of an ortho-substituted aromatic ring can be confirmed 
by the multiplicity of the aromatic signals, all of which integrate to one proton.  Spectrum 1.80 
exhibits two doublets (at approximately 7.80 ppm and 6.90 ppm) and two triplets (at 
approximately 7.50 ppm and 7.10 ppm), indicative of the respective protons coupling with 
neighbouring protons, as discussed in Chapter 3.  The signals at 7.80 and 7.50 ppm additionally 
show secondary coupling, and appear as a doublet of doublets, and a triplet of doublets, 
respectively.  In the case of 34, the analogous signals at these chemical shifts maintain this 
multiplicity and secondary splitting.  However, the signals at approximately 7.0 ppm appear 
unresolved, as a multiplet integrating to two protons.   
 
Compound 33 differs from 34 with respect to the number of methylene groups present in the 
alkyl chain attached to the salicylaldehyde residue.  Thus, the spectrum of 33 exhibits two 
triplets at 4.40 ppm and 3.69 ppm due to the coupling of the protons of one methylene group 
with the remaining protons associated with the other methylene group, and vice versa.  The 
spectrum of 34 has an added signal associated with it, as a result of the additional methylene 
group.  Appearing along with two triplets at 4.21 ppm and 3.60 ppm, is a multiplet appearing at 
2.36 ppm arising from the presence of the centre methylene group in the propyl chain.  All of 
the methylene signals in 33 and 34 integrate to two protons each, as expected.  The downfield 
position of the two triplets in 33 and 34 arise due to the deshielding nature of the neighbouring 
atoms, with the triplets appearing at 4.40 and 4.21 ppm (for 33 and 34, respectively), shifted 
downfield as a result of the close proximity to the ether oxygen atom, while the triplets at 
approximately 3.60 ppm are due to proton proximity to the bromine atom.   
 
Conversion of 32 to 35 yields a number of additional aromatic signals in the 1H NMR spectrum 
(Spectrum 1.88), as well as a distinct singlet for aldehyde protons, as shown in Figure 5.4 (H7 - 
H10, and HAld respectively).  The aromatic region shows new signals at 6.99, 7.16, 7.52 and 7.78 
ppm (all integrating to four protons), corresponding to the four protons present on the 
salicylaldehyde residues.  Signal multiplicity at 7.78 and 7.52 ppm appear as exhibited in both 
33 and 34; a doublet of doublets, and a triplet of doublets, respectively.  The COSY spectrum 
(Spectrum 1.90) of 35 confirms the secondary coupling present as discussed in Chapter 3.  The 
remaining two aromatic signals associated with the salicylaldehydes (at 7.16 and 6.99 ppm), 
however, appear as multiplets as opposed to a triplet and a doublet (respectively).  The presence 
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of the four signals supports the presence of an ortho-substituted aromatic ring, as discussed 
above for 33 and 34.  The aldehyde proton, HAld, is seen to be present by the signal at 10.31 
ppm, integrating to four protons.  The signals due to methylene protons H11 and H12 appear 
downfield (4.32 ppm) due to the deshielding nature of the two neighbouring oxygen atoms.  The 
isotropic nature of the two methylene groups results in the respective signals for protons H11 and 
H12 coinciding at the same chemical shift.  This signal also coincides with that of H4 (Figure 
5.3); thus, this signal integrates to 20 protons.  The signals relating to the feet and the cavitand 
remain unchanged in terms of multiplicity and integration.  However, all these protons have 
experienced very small changes in terms of chemical shift.  The 1H NMR signals for 35 are 
summarised in Table 5.1, with reference to Figure 5.5, which shows the 1H NMR spectrum of 
35 from 2.0 to 11.0 ppm.   
 
Table 5.1: 1H NMR data for compound 35 in CDCl3. 
Chemical shift/ppm (multiplicity, coupling constant, integration/protons) 
Proton 35 
H4, H11, H12 4.33 (m, 20) 
H2 4.72 (t, J = 7.8 Hz, 4) 
H5 5.64 (d, J = 7.1 Hz, 4) 
H7 6.99 (m, 4) 
H8 7.16 (m, 4) 
H9 7.52 (td, J = 7.8, J = 1.8 Hz, 4) 
H10 7.80 (dd, J = 7.9 Hz, J = 1.7 Hz, 4) 
HAld 10.31 (s, 4) 











































































As seen in Figure 5.6, 36 differs from 35 only by the introduction of an additional methylene 
















































































Figure 5.6: Expanded structures of 36, showing distinctive protons. 
 
As is evident in Spectrum 1.92 and 1.94, 36 exhibits very similar signals in terms of chemical 
shift and multiplicity in the aromatic region, arising from the presence of protons H7-H10.  Also 
evident is the signal due to HAld at 10.48 ppm.  All of these signals integrate to four protons.  
Signals relating to protons present in the feet and the cavitand moiety again remain largely 
unchanged in terms of multiplicity and integration, while experiencing slight changes in 
chemical shifts.  However, the presence of the extra methylene group, as noted, has led to some 
resolution of the signals at approximately 4.30 ppm, as well as an additional multiplet at 2.14 
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ppm.  The signal due to H4 (Figure 5.3) has resolved into a doublet integrating to four protons 
appearing at 4.33 ppm, and the signals due to H13 and H15 appear as two triplets at 4.13 and 4.25 
ppm integrating to eight protons each.  The signal multiplicity, in this case, is a result of the 
respective coupling of H13 and H15 with H14.  The multiplet at 2.14 ppm arises due to the 
coupling of H14 with H13 and H15, and integrates to eight protons.  Table 5.2 summarises the 1H 
NMR signals of 36, while Figure 5.7 shows the spectrum of 36 from 2.0 to 11.0 ppm.  
 
Table 5.2: 1H NMR data for compound 36 in CDCl3. 
Chemical shift/ppm (multiplicity, coupling constant, integration/protons) 
Proton 36 
H14 2.15 (m, J = 6.0 Hz, 8) 
H13, H15 4.14, 4.25 (each t, J = 5.9 Hz, 8) 
H4 4.33 (d, J = 7.1 Hz, 4) 
H2 4.74 (t, J = 7.9 Hz, 4) 
H5 5.63 (d, J = 7.1 Hz, 4) 
H10 6.98 (m, 4) 
H9 7.13 (m, 4) 
H8 7.50 (td, J = 7.8 Hz, J = 1.8 Hz, 4) 
H7 7.81 (dd, J = 7.9 Hz, J = 1.9 Hz, 4) 
HAld 10.48 (s, 4) 











































5.1.2 In situ Cyclisation and Ligand Synthesis 
 
The in situ cyclisation towards the synthesis of 37 and 38 commenced with the use of the Adler 
conditions.  The decision to use these conditions was based primarily on the observations by 
Reinhoudt et al. as discussed in Chapter 3.  
 
Synthesis initially adopted the conditions set out by Reinhoudt et al. (as per Chapter 3) towards 
the synthesis of 37, whereby aldehyde precursor 36 was added to refluxing propionic acid in 
high dilution (approximately 0.1 mM, based on 36).  Once dissolved, freshly distilled pyrrole 
was added and the reflux continued overnight.  At this time, a small aliquot was removed and 
subjected to TLC using a benzene mobile phase.  However, no porphyrin material was 
observed.   
 
A review of the literature regarding mechanistic aspects of the Adler conditions [9] revealed 
that, in general, porphyrin formation reached a maximum after 8 - 10 hours of reflux.  
Moreover, the general procedure of porphyrin synthesis following the Adler conditions [9b, 10] 
involved a reflux ranging from 25 - 30 minutes to 5 hours, at which time the solution was 
allowed to stir at room temperature overnight.  As such, the reaction was repeated using 36 and 
freshly distilled pyrrole.  After a 30 minute reflux, the mixture was left to cool at room 
temperature, and after 5 hours of reaction time, an aliquot was sampled and subjected to TLC 
using benzene as the eluant.  A purple porphyrinic material was observed at an Rf of 
approximately 0.5, in addition to a bright blue compound at an Rf of approximately 0.4.  The 
latter compound was identified as the chlorin product; a compound analogous in structure to a 
porphyrin, but without complete structural conjugation via the absence of a double bond 
between a pair of β-pyrrole carbon atoms.  Since the chlorin oxidises to the porphyrin in air, the 
reaction was left to stir at room temperature overnight, at which time the TLC was repeated.  
Only a porphyrin product was observed as a purple compound at an Rf of approximately 0.6; the 
chlorin was now absent from the reaction mixture.  The presence of the porphyrin product was 
further confirmed by preliminary analysis using UV-Vis spectroscopy, which exhibited the 
distinctive Soret band at 419 nm indicative of porphyrinic compounds. 
 
Isolation of 37 was achieved with relative ease using silica gel chromatography, where elution 
with benzene was able to free the target ligand readily from the polymeric matrix arising from 
the cyclisation reaction.  However, in order to obtain 37 as analytically pure, residual polymeric 
 153
material was removed by further column chromatography.  Thereafter, the purple material was 
recrystallised by liquid diffusion of methanol into a solution of 37 in chloroform, to yield the 
ligand as a dark purple, microcrystalline material.  This material was characterised by NMR 
spectroscopy, with reference to Figure 5.8, which shows the repeat unit of 37 indicating the 
associated distinctive protons.  Figure 5.9 shows the 1H NMR spectrum of 37 from 2.0 to 9.0 



































Figure 5.8: Repeat unit of 37, showing distinctive protons. 
 
As evident in Figure 5.9, the 1H NMR spectrum of 37 exhibits signals characteristic of both a 
porphyrin and a cavitand.  With regards to the porphyrin, the most distinctive signal appears 
upfield at -2.90 ppm (not shown in Figure 5.9), integrating to two protons due to the presence of 
the two amine protons of the porphyrin free base.  The position of these signals is due to the 
large ring current of the porphyrin, which was discussed in Chapter 3.  The presence of the β-
pyrrole protons (Hβ, Figure 5.8) can be seen by the appearance of the two singlets at 8.80 and 
8.70 ppm, collectively integrating to eight protons.  The signals appear in a ratio of 1:2, 










































Signals related to the meso-phenyl rings (H7 - H10) appear as a series of multiplets at 7.84, 7.75, 
7.40 and 7.31 ppm, all integrating to four protons.  The multiplicity observed is similar to that 
seen in the 35 and 36; the multiplets at 7.84 and 7.75 appearing as a doublet of doublets, and a 
triplet of doublets, respectively.  The presence of the ring current has seen these signals 
experience a slight downfield shift, relative to the analogous signals in precursor 35.   
 
The signals from H11 and H12 appear as a pair of triplets integrating to eight protons each.  The 
chemical shifts and multiplicity of these protons, however, have changed markedly in 
comparison to aldehyde precursor 35, as a result of the presence of the porphyrin ring current.  
While the signals from these protons appear concurrently at 4.33 ppm in the case of 35, the ring 
current in the case of 37 results in the protons becoming anisotropic in nature.  As such, the 
signal from H11 appears as a triplet at 3.48 ppm, while the signal from H12 appears as a triplet at 
4.35 ppm.  Since H11 is located alongside an ether oxygen atom, which electronically couples to 
the porphyrin macrocycle by virtue of its electron lone pairs, the related proton signal appears 
further upfield than for H12.  Indeed, H12 resonates at essentially an identical chemical shift 
compared with the analogous signal present in 35. 
 
The signals related to H4 and H5 have also undergone changes in terms of chemical shift.  While 
both still appear as doublets integrating to four protons, H5 has shifted to 5.10 ppm, while H4 
now appears at 3.13 ppm. This represents an upfield shift of approximately 0.5 ppm and 1 ppm, 
respectively, relative to cavitand precursor 35.  The marked shift is due to the capsule-like 
nature of the ligand, which, particularly in the case of H4 which lies within the ligand cavity, has 
a shielding effect on both protons.  The signal due to H2 appears as a triplet, integrating to four 
protons, at 4.40 ppm, which represents a small upfield movement in chemical shift compared 
with the cavitand precursor discussed above.  Additionally, the remaining protons related to the 
2-phenylethyl feet, as well as the single cavitand aromatic proton, maintain the respective signal 
multiplicity and chemical shift seen in 35.  Table 5.3 summarises the 1H NMR signals of 37, 
which includes the signals of analogous protons for precursor 35 for comparative purposes. 
 
Subsequent COSY and HSQC NMR (Spectra 1.98 and 1.99, Appendix 1) analysis of 37 
confirmed the presence of the target ligand, showing the expected contact of H4 with H5, H11 
with H12, and the various contacts seen between the meso-aromatic protons H7 - H10.  With 
regards to these latter protons, the COSY spectrum again illustrates the long range coupling 
present between the various protons.  There were additionally no contacts observed for the two 
amine protons, and the β-pyrrole protons.   
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Table 5.3: 1H NMR data for compound 37, compared with precursor 35, in CDCl3. 
Chemical shift/ppm (multiplicity, integration/protons) 
Proton 35 37 
H2 4.72 (t, 4) 4.40 (t, 4) 
H4 4.33 (m, 20)‡ 3.13 (d, 4) 
H5 5.64 (d, 4) 5.10 4(d, 4) 
H7 7.80 (dd, 4) 7.84 (dd, 4) 
H8 7.52 (td, 4) 7.75 (td, 4) 
H9 7.16 (m, 4) 7.40 (m, 4) 
H10 6.99 (m, 4) 7.31 (m, 4) 
Hβ - 8.80, 8.70 (s, 8) 
H11 4.33 (m, 20)‡ 3.48 (t, 8) 
H12 4.33 (m, 20)‡ 4.35 (t, 8) 
Feet 
2.39 - 2.46, 2.59 - 2.63 (each m, 
8); 7.18 - 7.24 (m, 20) 
2.10 - 2.16, 2.36 - 2.41 (each m, 8); 
6.93 - 7.11 (m, 20) 
‡ The signal for these protons in the case of 35 appears concurrently as a multiplet with other protons, collectively 
integrating to twenty protons. 
 
Importantly, the 1H NMR spectrum of 37 exhibits sharp signals, indicating that 37 does not exist 
as a mixture of rotamers,[11] but assumes only one conformation.  The COSY spectrum serves 
further to confirm this.  Indeed, the spectra suggest that 37 is symmetrical in nature (presumably 
C4), which is in keeping with the structural characteristics of the minimised structure of this 
ligand investigated in Chapter 4.[12]  Mass spectrometry (MS) (using ESI-TOF methods) 
additionally gave a molecular ion M/z signal of 1800.5112, which matches the expected mass 
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for 37 of 1800.6771.  This served as confirmation of the successful synthesis and isolation of 
the target ligand. 
 
In order to further confirm the Adler conditions as the exclusive synthetic conditions by which 
to obtain 37 (as observed by Reinhoudt et al.), the Lindsey conditions were implemented as a 
means of performing the in situ cyclisation.  Preliminary UV-Vis analysis of the reaction 
indicated the absence of the Soret band at approximately 420 nm, and as such the conditions 
were deemed unable to afford 37. 
 
5.1.3 In situ Synthesis of 37 Using Microwave Techniques 
 
The use of classical Adler reflux conditions for the in situ cyclisation gave 37 in a yield of 11 
%.  In order to improve on this yield, a microwave heating source for the cyclisation reaction 
was investigated; a method which has become increasingly popular as a means by which to 
synthesise meso-tetraphenylporphyrin derivatives and corresponding metalloporphyrins.[13]  
Since the production of a porphyrin from pyrrole and an aromatic aldehyde is determined 
largely by kinetic factors,[9, 10] the use of microwave irradiation as a heating source was 
proposed as a means by which to increase the kinetic energy of the reactants.  Microwave 
energy has been shown to increase reaction rates of organic reactions by rapidly heating at a 
molecular level, which is unlike conventional heating methods.[14]  Thus, the yield of porphyrin 
stood to be improved by increasing the rate of condensation of pyrrole molecules with aldehyde 
molecules.  Certainly, microwave synthesis is hitherto unreported as a means by which to 
synthesise cavitand-capped porphyrin ligands. 
 
Microwave synthesis commenced by dissolving up 75 mg of 35 in 2 mL of acid, and 
microwaving in a closed tube at 160 °C.  This temperature was chosen primarily since it is in 
excess of the boiling point of propionic acid (141 °C), which ensured that the reaction conditions 
were (at least) similar to those in the classical reflux conditions.  After maintaining the reaction 
vessel at 160 °C for 20 minutes, it was allowed to cool to room temperature, at which time the 
tube was opened and the reaction mixture stirred overnight in air.  Investigation of the mixture 
by TLC the next day, using benzene as mobile phase, confirmed the presence of porphyrin.  
After chromatographic isolation and purification of the reaction material using identical 
conditions as discussed above for the classical Adler reaction, the microwave reaction yielded 
37 in a 23 % yield.   
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The reported microwave synthesis of porphyrins showed that yields were maximised when 
reaction times were in the order of three to five minutes.[13a, f]  As such, the reaction was 
repeated on the same scale using the same volume of propionic acid and temperature as per the 
first reaction, changing reaction time to five minutes.  After purification, the yield of 37 
increased to 27 %, which is approaching the yield of simple (uncapped) porphyrins synthesised 
by the Adler, and indeed, the Lindsey conditions.  
 
In order to optimise synthetic conditions for the microwave synthesis of cavitand-capped 
porphyrins, a number of further reactions were attempted on an identical scale (75 mg), varying 
reaction temperature, volume of propionic acid used, and reaction time.  Table 5.4 summarises 
the varied conditions and the resultant yield of 37 after purification. 
 
Table 5.4: Summary of variable conditions and yields of 37, synthesised via microwave techniques. 
Volume acid/mL Temperature/°C Time/minutes Yield/% 
2 160 20 23 
2 160 5 27 
2 160 3 21 
4 160 5 24 
2 145 5 12 
4 145 5 10 
2 120 5 - 
4 120 5 - 
 
As is evident in Table 5.4, the reactions performed at 160 °C all produced 37 in yields above 20 
%.  Additionally, the reactions that proceeded for five minutes gave the best yields, while those 
at slightly shorter, or longer reaction times giving somewhat diminished yields.  The volume of 
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propionic acid, and therefore the concentration of reagents in cyclisation appears not to 
significantly influence yields.  The yields regarding reactions performed at temperatures 
approximately at the boiling point of propionic acid (145 °C) are essentially half of those 
performed at 160 °C.  These reactions gave yields comparable to those seen for the refluxed 
reactions which initially afforded 37.  Again, the concentration of reagents has not seen any 
significant differences in terms of yield.  Finally, the reactions performed at temperatures below 
boiling point (120 °C) gave no product. 
It can therefore be concluded that microwave reactions performed at 160 °C for five minutes 
give the best conditions for the formation of cavitand-capped porphyrin 37.  These conditions 
compare favourably with the synthetic optimisation reported elsewhere in the literature for the 
microwave synthesis of porphyrins.  Indeed, Cavaleiro et al.[13f] found yields to be optimal in 
the synthesis of tetraphenylporphyrin using similar reaction times and temperatures.   
 
5.2 In situ Synthesis of 38 
 
In light of the results obtained for synthesis of 37 from 35, an identical reaction protocol was 
adopted for the synthesis of 38 from precursor 36. 
 
As such, synthesis of 38 commenced via the use of the classical Adler conditions, whereby 36 
was dissolved in refluxing propionic acid, freshly distilled pyrrole added to the reaction and 
reflux continued for 30 minutes.  Once the solution was cooled to room temperature and 
allowed to stir overnight in air, TLC was used to track the reaction as in the case of 37.  
Reaction again yielded a porphyrinic material, which was further confirmed by the presence of 
the Soret band in preliminary UV-Vis analysis.   
 
However, attempts to isolate and purify 38 from the reaction matrix using silica gel 
chromatography was more difficult than in the case of 37.  It was found that benzene was able 
to free the purple product from the polymeric matrix of reaction, but thereafter the material 
became immobile on the column.  The product was found to be immobile on the silica gel and 
could not be eluted with benzene.  Further elution with chloroform was unable to displace the 
purple material from the silica gel.  However, upon changing the mobile phase to 50 % ethyl 
acetate in chloroform, the product eluted from the silica gel.  Despite co-elution of some 
polymeric material with the product, the majority of the polymeric material from reaction was 
removed.  A secondary column was attempted, using a benzene mobile phase, but the product 
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again struggled to elute from the column.  Although various changes to the mobile phase were 
made, including the use of ethyl acetate and dichloromethane, 38 could not be obtained in a 
purified form free of polymeric material, via chromatography.  Additionally, recrystallisation 
was also ineffective in affording pure 38. 
 
5.2.1 In situ Synthesis of 38 Using Microwave Techniques 
 
Results from the computational study offered a possible explanation as to why the 
chromatographic behaviour of 38 was so different to that of 37.  As mentioned, the four-atom 
bridge of 37 results in a highly symmetrical molecule.  However, the additional atom in the 
bridges of 38 breaks this symmetry, and results in more conformational flexibility.[12, 15]  The 
differences in symmetry is illustrated in Figure 5.10, showing the minimised structures of 37 
(left) and 38 (right), and offers a possible explanation as to why the interaction of 37 with silica 












Figure 5.10: The minimised structures of the target ligands; 37 (left), and 38 (right). Hydrogen atoms are 
omitted for clarity. 
 
With this in mind, microwave synthesis offered a potential means by which to obtain 38.  
Microwave techniques have been shown to help overcome inter- and intramolecular aggregation 
as well as steric hindrance.[16]  Thus, the issues posed by the additional conformational 
flexibility of 38 in synthesis may be overcome.  As such, the microwave protocol used in the 
synthesis of 37 was adopted for the synthesis of 38. 
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The presence of 38 as product from microwave reaction was confirmed by UV-Vis analysis.  
Column chromatography was again employed as a means by which to purify the reaction 
material.  A preliminary column using a mobile phase 95:5 chloroform:ethyl acetate was able to 
free the reaction product from the majority of the polymeric material which arose from reaction.  
Subsequently, a column using a benzene eluant was effective in isolating 38 from the residual 
polymeric material, this time without the purple product becoming immobilized on the silica 
gel.  Analytically pure material was obtained by successive liquid diffusion recrystallisations (as 
per 37) to yield 38 as a purple, microcrystalline material.  This material was again characterised 
by NMR spectroscopy. Figure 5.11 shows the repeat unit of 38 indicating distinctive protons, 
whilst Figure 5.12 shows the 1H NMR spectrum of 38 from 2.0 to 9.0 ppm, for discussion 




































Figure 5.11: Repeat unit of 38, showing distinctive protons. 
 
Figure 5.12 exhibits a 1H NMR spectrum which is a combination spectrum of cavitand and 
porphyrin, as in the case of 37.  Although not shown in Figure 5.12, the distinctive signals from 
the two amine protons associated with the porphyrin structure are again present upfield, at -2.82 
ppm, integrating to two protons.  This is indicative of the successful in situ formation of 38.  







































eight protons) associated with the β-pyrrole protons, Hβ (Figure 5.11).  The signal resonates as a 
singlet, which is in contrast to the equivalent signal in the case of 37.   
 
Signals arising from protons H7 - H10 again appear as a series of multiplets, at 7.85, 7.72, 7.38 
and 7.30 ppm, all of which integrate to four protons.  These signals exhibit the same multiplicity 
as observed and discussed in the case of 35, 36, and indeed, 37 previously.  Relative to 
precursor 36, the signals due to protons H7 - H10 have again experienced a shift downfield.  
 
As the distinctive difference between 37 and 38, the additional methylene group present in the 
bridges of 38 accounts for an additional signal in the 1H NMR spectrum in comparison to the 
spectrum of 37.  As such, a multiplet due to the presence of H14 is observed in the alkyl region 
at 1.87 ppm, integrating to eight protons.  In terms of precursor 36, this represents a slight 
upfield shift relative to the analogous protons.  The signals from H13 and H15 appear as a pair of 
triplets integrating to eight protons each.  The signal arising from H13 again appears further 
upfield (relative to H15) due to proximity of this methylene group to the ether oxygen atom, 
which is electronically coupled to the porphyrin macrocycle.  The associated chemical shift for 
H13 of 3.44 ppm is very similar to the chemical shift of H11, the analogous protons in ligand 37.  
The signal due to H15 yields a similar situation, giving a chemical shift (4.19 ppm) very similar 
to that of H12 present in 37.   
 
The signals due to H4 and H5 have undergone dramatic upfield shifts as observed in the case of 
37.  In the case of 38, the signal due to H5 appears at 5.16 ppm, while H4 appears at 3.29 ppm.  
Both signals maintain their multiplicity, appearing in each case as doublets integrating to four 
protons.  Interestingly, the noted upfield shift is less dramatic in 38 than in 37.  This is likely 
due to the presence of the extra methylene group built into the ligand bridges, which yields a 
larger capsule-like ligand in comparison to 37.  As such, the degree of shielding that the capsule 
affords to these protons is diminished, thus resulting in a less dramatic upfield shift.   
 
The signal due to H2 appears at 4.44 ppm as a triplet, integrating to four protons.  The remaining 
signals relating to the 2-phenylethyl feet, as well as the single cavitand aromatic proton, 
maintain the respective signal multiplicity and chemical shift seen in 36.  Table 5.4 summarises 
the 1H NMR signals of 38, which includes the signals of analogous protons for precursor 36 and 




Table 5.3: 1H NMR data for compound 38, compared with precursor 36 and ligand 37, in CDCl3. 
Chemical shift/ppm (multiplicity, integration/protons) 
Proton 36 37 38 
H2 4.74 (t, 4) 4.40 (t, 4) 4.44 (t, 4) 
H4 4.33 (d, 4) 3.13 (d, 4) 3.29 (d, 4) 
H5 5.63 (d, 4) 5.10 (d, 4) 5.16 (d, 4) 
H7 7.81 (dd, 4) 7.84 (dd, 4) 7.85 (dd, 4) 
H8 7.50 (td, 4) 7.75 (td, 4) 7.72 (td, 4) 
H9 7.13 (m, 4) 7.40 (m, 4) 7.39 (d, 4) 
H10 6.98 (m, 4) 7.31 (m, 4) 7.30 (t, 4) 
Hβ - 8.80, 8.70 (s, 8) 8.73 (s, 8) 
H11 (H13)‡ (4.14 (t, 8))‡ 3.48 (t, 8) (3.44 (t, 8))‡ 
H12 (H15)‡ (4.25 (t, 8))‡ 4.35 (t, 8) (4.19 (t, 8))‡ 
H14 - - 1.87 (m, 8) 
Feet 
2.41 - 2.45, 2.60 - 
2.64 (each m, 8); 7.18 
- 7.24 (m, 20) 
2.10 - 2.16, 2.36 - 
2.41 (each m, 8); 6.93 
- 7.11 (m, 20) 
2.14 - 2.19, 2.40 - 
2.43 (each m, 8); 6.95 
- 7.09 (m, 20) 
‡ The protons appearing in parenthesis are only present in 36 and 38, while the protons appearing outside are related 
to 37 exclusively.  Comparison is made due to the analogous nature of the related chemical shifts. 
 
COSY and HSQC NMR (Spectra 1.105 and 1.106) analysis of 38 served to further confirm the 
successful synthesis and isolation of the target ligand, showing the expected contacts as 
discussed above regarding 37.  MS analysis further served to confirm the synthesis of 38, 
yielding a M/z signal of 1856.5912, in close agreement with the calculated mass of 1856.7397. 
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The use of microwave heating thus not only provided improved yields (as in the case of 37), but 
additionally aided in simplifying the isolation of 38.  The results also highlight the significance 
of the bridge length and its effect on ligand symmetry.  As shown in Chapter 4, bridges 
comprising an even number of atoms resulted in ligands of lower potential energy and increased 
symmetry; those comprising an odd number of atoms conversely gave ligands having higher 
potential energy and decreased symmetry.  The above synthetic observations indicate that this 
‘odd-even’ effect extends to the synthesis and physical behaviour of these ligands.[17]    
 
Again to confirm the Adler conditions as the exclusive synthetic conditions by which to obtain 
38, the Lindsey conditions were investigated as the synthetic protocol for the in situ cyclisation.  
As in the case of 37, preliminary UV-Vis analysis of the reaction product showed that the Soret 
band at approximately 420 nm was absent, indicating that the protocol was unable to afford 37. 
 
5.3 Identification of Minimum Bridge Length for Successful Capped-porphyrin Synthesis 
 
The results from Chapter 3 indicated that a minimum bridge length exists which affords a 
successful synthesis of cavitand-capped porphyrins.  Given the successful synthesis of ligands 
bearing four- and five-atom bridges, as well as the results from Chapter 3, it is of interest to 
identify the minimum bridge length required for a successful capping.  Since a two-atom bridge 
was shown to be too short for a successful synthesis using the in situ synthetic protocol, while 
bridges four atoms in length were capable of affording a cavitand-capped porphyrin, a bridge 
consisting of three atoms was investigated in order to see if capping could be completed. 
 
Cavitand 32 was used as the precursor towards the synthesis of the corresponding aldehyde as 
shown in Scheme 5.3.  Aldehyde reagent 39 was synthesised as per the method used in the 
formation of 33 and 34; by coupling salicylaldehyde to bromochloromethane in the presence of 
K2CO3.  Coupling of 39 to 32 thus ensured that the required three-atom (OCH2O) bridges would 














































































Scheme 5.3: Synthesis towards a cavitand-capped porphyrin bearing bridges three atoms in length. 
 
The synthesis of 39 was achieved in a 67 % yield.  Coupling of 39 with 32 proved to proceed 
differently than in the case of analogues 35 and 36.  Attempts to follow the related synthetic 
conditions, whereby 32 (in DMF) was coupled to the aldehyde reagent in the presence of 
K2CO3, were unsuccessful in yielding aldehyde 40, whether reaction was performed at room 
temperature or at 55 °C.  As such, reaction conditions were altered in favour of those conditions 
which successfully yielded aldehydes 6 and 27 (Chapter 3); 32 was dissolved in dry THF and 
treated with NaH before addition of 39 and reflux.  Under these conditions, 40 was successfully 
obtained, albeit in diminished yields (34 %) relative to analogues 35 and 36.  The 1H NMR 
spectra of 39 and 40 are very similar to the analogues bearing longer alkyl bridges discussed 
above; the full spectra can be seen in Appendix 1.    
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The conversion of 40 to cavitand-capped porphyrin 41 was attempted following the microwave 
conditions which yielded 37 and 38.  However, on work up of the reaction material and 
subsequent preliminary analysis using UV-Vis spectroscopy, the Soret band at approximately 
420 nm was absent (Spectrum 1.116).  It was thus concluded that the reaction was unsuccessful.  
The negative result therefore implies that, with respect to this system, the minimum requirement 
of bridge length to successfully obtain a cavitand-capped porphyrin is four atoms; with regards 
to the in situ protocol at least. 
 
5.4 Direct Capping Approach Revisited 
 
Results from Chapter 3 indicated that, in terms of the direct capping protocol, ligands bearing 
two atom bridges could not be synthesised.  The reason for this was based on crystallographic 
evidence which suggested that the porphyrin and the cavitand were mismatched in terms of size; 
the porphyrin being too large to comfortably interact with the cavitand and complete capping.  
However, given the results of the attempted in situ synthesis of 41, it is of interest to investigate 
the synthesis of 41 by adopting the direct capping procedure.  The use of three atoms as bridge 
length (as opposed to two) may be sufficient to allow for an interaction between cavitand and 
porphyrin conducive to porphyrin capping.   
 
In order to find conditions which would afford the desired capping, synthesis began with an 
investigation into the formation of 38 via the direct capping protocol.  Since 38 has been 
successfully synthesised and fully characterised, identification of reaction product, and hence 
evaluation of the direct capping procedure used, stood to be significantly simplified.  
Additionally, the longer bridges (five atoms) and their increased flexibility negates any possible 
problems regarding mismatching of cavitand size relative to the porphyrin.  The synthetic 
approach can be seen in Scheme 5.4. 
 
Synthesis again commenced with the use of 32 as precursor, which was coupled to 1,3-
dibromopropane (under conditions identical to those which afforded 35 and 36) to give 42 in a 













































































Scheme 5.4: Synthesis towards 38 following a direct capping protocol. 
 
The subsequent coupling of 42 with porphyrin 12 was attempted by adopting the conditions of 
Naruta et al.[18] whereby 42, 12 and K2CO3 in THF and NMP (all reagents dried) were heated in 
a sealed pressure tube for four days at 120 °C.  Thereafter, the reaction was stopped and worked 
up via evaporation of the THF, neutralisation of excess K2CO3 with dilute HCl, and extraction 
of the NMP.  However, TLC of the organic phase using a benzene mobile phase did not show 
any product when spotted against 38.  Further TLC of the crude product in 1:1 ethyl 
acetate:hexane indicated that 42 had completely reacted; presumably consumed in 
polymerisation side reactions.  As such, the reaction was attempted again, this time making use 
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of high dilution conditions and refluxing the reaction solution for five days at 100 °C under a 
nitrogen atmosphere.  Again, TLC of the crude product did not indicate the presence of 38, 
despite the complete reaction of 42. 
 
Since the conditions of Naruta et al. were unable to afford 38, synthetic conditions were 
changed once again towards gentler reaction conditions.  THF was replaced by DMF, and the 
reaction mixture stirred at room temperature under a nitrogen atmosphere.  After five days, a 
small aliquot was removed and added to water saturated with NaHCO3, which was subsequently 
extracted with chloroform.  TLC of the dried organic layer using a benzene mobile phase again 
failed to show the presence of 38.  However, unreacted starting materials 42 and 12 could be 
seen by TLC, and consequently, the reaction was heated to 55 °C.  After a further four days of 
reaction, TLC nevertheless indicated that 38 had not formed, despite the complete reaction of 
42. 
 
It was therefore concluded that the direct capping procedure was incapable of affording 38, 
despite numerous changes to reaction conditions.  Importantly, it is evident given the results 
above as well as those in Chapter 3 that the direct capping protocol is inadequate in affording 
cavitand capping of a porphyrin involving four bridges.  Indeed, given that 41 possesses bridges 
that are two atoms shorter in length than 38, and hence, more rigid than 38, the use of the direct 




A successful synthetic pathway towards the preparation of two cavitand-capped porphyrins has 
been identified.  Ligands bearing four and five atom bridges have been fully characterised by 
UV-Vis and NMR spectroscopy, as well as mass spectrometry.  All three methods indicated that 
37 and 38 have indeed been synthesised, isolated and purified.   
 
Additionally, the in situ protocol was shown to be the exclusive method by which to prepare the 
synthetic targets.  This was, however, the case only on implementing the Adler conditions 
during the final cyclisation step.  The use of the Lindsey conditions failed to yield the intended 
ligands, an observation which is consistent with those made by Reinhoudt et al. when reporting 
similar ligands with analogous bridge lengths.  The use of microwave heating in the final in situ 
cyclisation step presented a novel means by which to prepare cavitand-capped porphyrins.  It 
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was, moreover, observed to increase yields relative to reactions performed using conventional 
heating, as well as aid in simplifying the isolation of 38. 
 
Further synthetic investigation has also revealed that in terms of the in situ method of synthesis, 
a bridge length of four atoms is the minimum requirement to afford a successful cyclisation and 
porphyrin formation.  As such, 37 bears the shortest bridges hitherto reported for cavitand-
capped porphyrins bearing four interconnecting bridges.  It therefore also possesses the smallest 
molecular cavity hitherto reported for such capped porphyrins host molecules. 
 
Additionally, the direct capping synthetic protocol failed to afford a cavitand-capped porphyrin 
bearing four bridges, despite the success of the in situ approach in the synthesis of an identical 
molecule.  Bearing in mind this result, together with results from Chapter 3 regarding the same 
synthetic methodology, it is clear that this protocol is ineffective in preparing cavitand-capped 
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CRYSTALLOGRAPHIC INVESTIGATION OF SYNTHETIC 
INTERMEDIATES 
 
6.1 Synthetic Intermediates From Initial -CH2O- Bridged Ligand  
 
The resorcin[4]arene-based hosts which were recrystallised as described in Chapter 3, represent 
both the synthetic intermediates towards the target ligand, as well as examples of clathrate 
complexes as mentioned in Chapter 1.  Resorcin[4]arene 17 is the starting compound in the 
synthesis of cavitand 20, via a synthetic pathway identical to that used in the synthesis of the 
methyl-footed resorcin[4]arene-based hosts seen in the in situ approach.  In this regard, 5, 22 
and 6 represent more complex resorcin[4]arene-based hosts that result from the successive 
functionalisation of simpler hosts very similar to compounds 17 and 20.  Although previously 
known compounds, the crystal structures of 5 and 22 have not been reported, while 6, 17 and 20 
represent entirely new compounds.  As such, all the crystallography performed on these 
compounds is novel, and therefore an overview of the respective crystal structures will be 
presented.[1] 
 
Samples were sent for analysis to the University of Kwazulu-Natal (UKZN), Pietermaritzburg 
(in the case of 17), as well as to the University of the Witwatersrand (WITS) (5, 6, 20 and 22).  
Intensity data for 17 was collected on an Oxford Xcalibur 2 area detector diffractometer with 
Mo Kα radiation (50 kV, 40 mA).  The collection method involved ω-2θ scans.  Data reduction 
was carried out using the program CrysAlis RED 1.171.29.9,[2a] absorption corrections were 
performed using the multi-scan method.[2b] 
 
For the samples analysed at WITS, intensity data were collected on a Bruker APEX II CCD area 
detector diffractometer with graphite monochromated Mo Kα radiation (50 kV, 30 mA) using 
the APEX 2 [3a] data collection software. The collection method involved ω-scans of width 0.5° 
and 512 x 512 bit data frames. Data reduction was carried out using the program SAINT-NT.[3b]   
All of the crystal structures were solved by direct methods using SHELXTL.[2c] Non-hydrogen 
atoms were first refined isotropically, followed by anisotropic refinement by full matrix least-
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squares calculations based on F2 using SHELXTL. Hydrogen atoms were first located in the 
difference map then positioned geometrically and allowed to ride on their respective parent 
atoms.  Diagrams were generated using Mercury.[4] 
 
Table 6.1 shows selected crystal data for compounds 5, 6, 17, 20 and 22.[5]   
 
6.1.1 2-phenylethyl resorcin[4]arene, 17 
 
As a representative starting point to cavitand formation and subsequent functionalisation, novel 
resorcin[4]arene 17 is a particularly illustrative structure through which to commence this 
crystallographic analysis.  As set out in Chapter 3, 17 is the result of the acid catalysed 
condensation of 2-methyl resorcinol and 3-phenylpropionaldehyde.  Although bearing eight 
hydroxyl groups, the hydrophobicity of the 2-phenylethyl feet renders 17 only partially soluble 
in methanol.  As a means of purification therefore, 17 was recrystallised from hot methanol to 
yield a microcrystalline solid which was pure enough to use in subsequent reactions.  In order to 
obtain crystals suitable for single crystal X-ray crystallography, 17 was slowly recrystallised at 
room temperature to yield orange needle-like crystals.  Interestingly, the crystals obtained 
disintegrated upon their removal from the supernatant liquid.  Nonetheless, samples were 
obtained and sent for analysis.  The molecular structure of 17 can be seen in Figure 6.1 below, 














Figure 6.1: Molecular structure of 17 from side on (left), and from above (right). 
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Table 6.1: Selected refinement data for compounds 5, 6, 17, 20 and 22. 
 5 6 17 20 22 
Acquisition temperature (K) 173 173 105 173 173 
Crystal system orthorhombic monoclinic monoclinic orthorhombic triclinic 
Space group Pnma P21/m P21/n Pna2 P-1 
a (Å) 16.684 11.923 12.311 24.329 11.515 
b (Å) 19.006 23.281 30.615 20.628 11.932 
c (Å) 13.470 12.232 16.502 11.783 22.799 
α (º) 90.000 90.000 90.000 90.000 93.655 
β (º) 90.000 117.005 92.8385 90.000 92.921 
γ (º) 90.000 90.000 90.000 90.000 118.676 
V (Å3) 4271.4 3025.0 6212.7 5913.2 2730.8 
Z 4 1 4 8 2 
Dc (g cm-3) 1.624 1.257 1.199 1.233 1.455 
Rint 0.1045 0.0822 0.0284 0.0619 0.0653 




Figure 6.1 illustrates several interesting features regarding 17.  The orientation of the 2-
phenylethyl feet is particularly noteworthy.  These are arranged perpendicular to one another, in 
an edge-to-face manner to form a 'box'.  Such C-H…π interactions are well known, and have 
been seen in a number of systems.[6]  Indeed, such interactions have been seen in related X-ray 
structures.[7]  The presence of a residual methanol molecule in the cavity illustrates the ability 
of these compounds to act as host systems.  Figure 6.2 (in a space-filled representation) clearly 
illustrates both the orientation of the feet to form a box, and the guest methanol molecule, which 
can also be seen occupying the cavity from the bottom, through the box.  Peripheral methanol 














Figure 6.2: Space filled representation of 17 showing the orientation of the feet (left), and the presence of 
residual methanol in the cavity (right). 
 
Although hydrophilic in nature, the cavity is able to accommodate methanol, orientated with the 
hydroxyl group of the methanol away from the cavity.  This is conceivably due to the 
hydrophilic nature of the methanolic hydroxyl group conflicting with the hydrophobic nature of 
the cavity. 
 
A number of intra- and intermolecular hydrogen bonding interactions are observed in the 
structure of 17, as alluded to in Chapter 1.  Both inter- and intramolecular interactions are 
formed between the numerous hydroxyl groups which constitute the rim of the resorcin[4]arene 
cavity.  The intramolecular hydrogen bonds between the hydroxyl groups constituting the cavity 
rim of 17 range between 1.86 and 2.06 Å.  As shown in Figure 6.3, the hydrogen bonding 
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appears to occur in pairs with two opposite interactions approximately equal in length: a pair of 
the order 1.866 and 1.873 Å, and another pair 2.003 and 2.060 Å.  In addition to these 
intramolecular interactions, there are four intermolecular interactions between individual 
resorcin[4]arene molecules, and the residual methanol.  The van der Waals O…O range from 
2.04 to 2.63 Å.  In the case of the methanol inside the cavity, the intermolecular hydrogen 


















Figure 6.3: Hydrogen bonding interactions of 17. 
 
In addition, there are a number of interactions between the residual methanol solvent 
(particularly within the resorcin[4]arene cavities) and the resorcin[4]arene hydroxyl groups.  As 
mentioned, the crystals of 17 disintegrated on removal from the methanol from which they were 
crystallised.  This is an indication that these intermolecular hydrogen bonds are significant in 
the crystal structure.  Figure 6.4 shows more clearly the influence of the methanol within the 
molecule cavities, and the associated hydrogen bonding.  The methanol is coloured in yellow, 



















Figure 6.4: Hydrogen bonding interactions of 17. 
 
In order to illustrate more clearly the role of the residual methanol in maintaining the packing 
and integrity of the crystals themselves, Figure 6.5 shows one layer of resorcin[4]arene 
molecules (viewed down the a axis).  Clearly evident is the presence of a vein of methanol 
(again in yellow, in ball and stick representation) in between each column of interdigitated 














Figure 6.5: The packing of one layer of 17, illustrating the cohesive role of the residual methanol. 
 179
6.1.2 2-phenylethyl cavitand, 20 
 
Novel cavitand 20 results from the alkylation of the hydroxyl groups of 17, to give a more rigid 
cavitand, as discussed in Chapter 1.  Therefore, 20 is representative of the second synthetic 
intermediate of the target ligand.  The 2-phenylethyl feet again give the cavitand a high degree 
of hydrophobicity; as such crystals of 20 were grown by slow diffusion of methanol into a 
solution of 20 in 1:1 ethyl acetate: hexane.  The crystals obtained were white, needle-like 
species which were sampled and sent for single X-ray crystallography at WITS.  The molecular 













Figure 6.6: Molecular structure of 20 from side on (left), and from above (right). 
 
The newly-introduced methyl bridges, replacing the eight hydroxyl groups in 17, and linking the 
four aromatic moieties, are clearly apparent.  In this regard, the origin of the anisotropy related 
to the 'inner' and 'outer' protons is particularly evident, as discussed in Chapter 3.  The inner 
protons are visibly pointing into the cavity, with the outer protons facing the opposite direction.  
The feet of 20, although identical to those in 17, differ in orientation from what was seen in 17.  
Although the π-CH interaction mentioned previously is still present, it only occurs between two 
of the four phenyl rings constituting the feet, and consequently the 'box' seen in 17 does not 
form.   
 
In terms of the cavity, 20, like 17, also has residual solvent from recrystallisation.  In this case, 
the ethyl acetate molecule occupying the cavity is clearly evident.  Interestingly, it is the 
presence of this residual solvent in the cavity which is responsible for the disruption in the 
 180
organization of the feet noted above.  This kind of disruption by solvent has been reported in 
similar structures bearing identical feet, where the presence of solvent has given a very similar 
orientation of the aromatic rings.[8]  The orientation of the feet, as well as the guest ethyl acetate 


















Figure 6.7: The presence of ethyl acetate in the cavity of 20. 
 
The disruption in feet organization by the ethyl acetate can be seen more clearly in Figures 6.8.  
The angled representation on the right clearly shows the occurrence of the ethyl acetate in 
between the phenyl rings of the feet. Solvent appears in a spacefilled representation and is 
coloured yellow. 
 
The relative orientation of the molecules of 20 also differs to that seen in 17.  The individual 
cavitand molecules are orientated such that their cavities face in the same direction relative to 
their neighbours, tilted at an angle (approximately 20°) with respect to the b axis.  The row 
above or below has molecular cavities facing in the same direction, however, this now appears 
slanted (again with respect to the b axis) in the opposite direction to the first row.  The degree of 
















Figure 6.8: The orientation of the ethyl acetate in 20, disrupting the phenyl rings of the feet. 
 
The next layer possesses the same arrangement of individual molecules, but is rotated by 180°.  
There is thus no interdigitation, which is in contrast to the packing seen in 17.  In addition, the 
absence of any significant hydrogen bond donors and acceptors in 20, as a result of the 
alkylation of the hydroxyl groups of 17, results in a lack of any hydrogen bonding interactions 
in the packing of 20.   
 
A representative layer of cavitand molecules showing the 'zigzag' columns present in the 
packing is shown in Figure 6.9.  The orientation of the next layer, relative to the first (Figure 
6.9) can be seen in Figure 6.10, where the cavitand molecules have been coloured accordingly 
to clarify illustration.  Red illustrates the layer in front, as it appears in Figure 6.9, with the 















































6.1.3 Bromomethyl cavitand, 5 (methyl feet) 
 
Representing the brominated cavitands which served as the basis for the coupling reaction 
between cavitand and porphyrin, cavitand 5 is the result of the first functionalisation of the 
benzylic methyl groups of a simple cavitand precursor.  In this particular case, 5 bears simple 
methyl feet as opposed to the more complex feet which were seen in 17 and 20.  However, the 
feet still allowed for slow recrystallisation from a solution of 5 in 1:1 ethyl acetate: hexane to 
yield white block-like crystals.  Crystals were selected and data collected at WITS, which was 










Figure 6.11: Molecular structure of 5 from side on (left), and from above (right). 
 
As can be seen, the newly introduced bromine atoms are orientated such that two (opposite) 
bromines face into the cavity and two out.  One outward-facing bromine atom appears to be 
disordered.  The 'inner' and 'outer' protons are again evident as they were in 20.  However, the 
short length of the feet is particularly noteworthy, in comparison to the 2-phenylethyl feet seen 
in 17 and 20.  As discussed in Chapter 3, the target ligand synthesised using this particular 
precursor gave especially insoluble material.  The origin of this insolubility is clearly evident in 
Figure 6.11, as the feet, which essentially render the bottom of the cavitand a rounded surface, 
are unable to interact significantly with any solvent. 
 
The host capabilities of cavitands are again illustrated in Figure 6.12 by the presence of residual 
ethyl acetate within the cavity.  The solvent molecule is also disordered across the mirror plane.  
The individual molecules of 5 are packed and layered in very much the same way as in the case 
of 20, appearing in the same tilted configuration as discussed previously with layers rotated 
180° with respect to each other.  The angle of the tilt is again approximately 20°.  Again, no 
















Figure 6.12: The presence of ethyl acetate in the cavity of 5. 
 
The packing and the layering within the crystal structure can be seen in Figure 6.13 and 6.14 
respectively.  Again, the different layers in Figure 6.14 have been coloured in order to 
differentiate and illustrate the arrangement of layers relative to each other.  The layer as seen in 






























Figure 6.14: Orientation of the layering present in the crystal structure of 5. 
 
6.1.4 Bromomethyl cavitand, 22 (pentyl feet) 
 
The pentyl-footed bromomethyl cavitand 22, although bearing the same functionalisation as 5 
and differing merely in the length of the feet, is remarkably different in terms of both molecular 
and crystal structure.  As seen in Figure 6.15, the C5H11 feet of 22 are arranged such that two 
adjacent feet appear structured and linear, whereas the remaining two are kinked and appear less 
regular.  In addition, the arrangement of bromine atoms exhibited by 22 is in contrast to that 
seen in 5: all four bromine atoms face inwards towards each other and the molecular cavity, as 
opposed to two inwards, two outwards as seen in the case of 5.  This is indicated more clearly in 
Figure 6.16, a space filled representation of 22.   
 
Figure 6.15 also shows the distinct lack of any solvent molecule present within the cavity of 22.  
This is in contrast not only to 5, but also the other resorcin[4]arene-based hosts discussed.  The 
reason for this potentially lies in the orientation of the bromine atoms, as seen in Figure 6.16.  
The large bromine atoms are arranged such that they prevent any residual solvent from 




































Figure 6.16: Space filled representation of 22 showing the orientation of the bromine atoms. 
 
The bromine atoms are also involved in a particularly interesting intermolecular arrangement of 
the individual cavitand molecules.  The individual molecules are arranged in opposite 
orientations such that the bromine atoms face each other in close contact, as seen in Figure 6.17, 















Figure 6.17: Interaction of the bromine atoms present due to the orientation of individual molecules of 22. 
 
What therefore results is a packing arrangement with alternate layers of bromine atoms, in 
















Figure 6.18: Packing present in 22, with the alternating layers of bromine atoms. 
 
The packing observed can also be seen to be responsible for the way in which two of the pentyl 
feet of 22 appear linear and structured, while the other two appear bent and kinked.  Figure 6.19 
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shows that the pair of linear feet from one cavitand molecule interdigitates with the 
















Figure 6.19: Representative layer showing the orientation of the feet in the packing of 22. 
 
for the remaining pair of feet in each case to extend in a linear fashion.  As a result, these appear 
bent and kinked.   
 
Figure 6.19 also shows layering in the crystal structure of 22 which is similar to that seen in the 
case of 17, and in contrast to 19 and 5.  In the case of 22, the individual molecules are orientated 
such that cavities face in opposite directions relative to each other, as opposed to in the same 
direction in the case of 19 and 5.  In addition, as seen in Figure 6.20, the next layer (in yellow) 
























Figure 6.20: Orientation of the layering present in the crystal structure of 22. 
 
6.1.5 Tetrasalicylaldehyde, 6 
 
Novel tetrasalicylaldehyde 6 serves as the precursor to the attempted formation of the target 
ligand following the in situ synthetic protocol outlined in Chapter 3.  As with 5, recrystallisation 
of 6 took place from a solution in 1:1 ethyl acetate:hexane.  The molecular structure of 6, and its 
implication for synthesis, has been discussed in Chapter 3 and will not be dealt with here.  
However, the packing of 6 proves to be remarkably different to the other three structures 
discussed. 
 
As shown in Figure 6.21, the unit cell of 6 consists of two molecules as opposed to four in all 
the other structures.  The individual molecules are orientated such that one is inverted relative to 
the other, with the two splayed salicylaldehyde residues of each molecule facing in opposite 
directions.   
 
In terms of packing, the 'one up, one down' orientation as seen in Figure 6.22 results in layers of 
molecules which can be broken down into columns of molecules, running in opposite directions 
to each other.  This orientation allows for the π electrons of the salicylaldehyde phenyl rings to 
interact resulting in stacking of the salicylaldehyde residues.  This is illustrated in Figure 6.22, 





































Figure 6.22: Representative layer showing nature of the packing in the crystal structure of 6. 
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Interestingly, the layers pack such that they face the same direction.  This is in contrast to the 
layering seen in both 19 and 5, and similar to 22.  The layering can be seen in Figure 6.23, 
where the respective layers are coloured differently as done previously.  For purposes of clarity, 



















Figure 6.23: Layering orientation present in the crystal structure of 6. 
 
6.2 Synthetic Intermediates From Ligands Bearing Longer Bridges 
 
The synthesis undertaken in Chapter 5 yielded fewer crystal structures than in Chapter 3; only 
two structures were obtained from the synthetic work, both of which were previously reported.  
However, a short discussion of the data obtained will be presented, with comparison to the 
reported structures.  Both sets of data were collected at WITS as per the instrument details and 
refinement methods set out at the beginning of this chapter.  Graphics were again rendered using 
Mercury.  Table 6.2 shows selected crystal data for compounds 31 and 33 appearing with the 
corresponding data from the respective previously reported structural data.[1, 9, 10] 
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Table 6.2: Selected refinement data for compounds 31 and 33, together with the respective corresponding data for the equivalent, previously reported structures. 
 31 Reported equivalent of 31 33 Reported equivalent of 33 
Acquisition temperature (K) 173 295 173 296 
Crystal system orthorhombic orthorhombic monoclinic monoclinic 
Space group Pnma Pnma P21/c P21/c 
a (Å) 20.436 20.200 7.671 7.745 
b (Å) 11.935 12.011 16.120 16.233 
c (Å) 24.712 24.675 7.252 7.367 
α (º) 90.000 90.000 90.000 90.000 
β (º) 90.000 90.000 99.374 98.908 
γ (º) 90.000 90.000 90.000 90.000 
V (Å3) 6027.2 5986.70 884.88 915.01 
Z 4 4 4 4 
Dc (g cm-3) 0.695 1.418 1.719 1.663 
Rint 0.084 - 0.049 0.028 
R1 [F2 > 2σ(F2)] 0.067 0.074 0.027 0.038 
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6.2.1 Bromocavitand, 31 
 
Cavitand 31, as discussed in Chapter 5, serves as the synthetic precursor for the lithiation 
reaction which produces the versatile tetrol cavitand 32.  As in the case of 20, 31 is the product 
of the alkylation of the hydroxyl groups of the preceding resorcin[4]arene.  The crystal structure 
of 31 has been reported previously by Sherman et al. [9] over 17 years ago.  Table 6.2 indicates 
that 31 and the reported data are similar in many aspects, in particular with regards to the 
parameters of the unit cell, which is expected due to both structures belonging to identical space 
groups and crystal systems.  The agreement value (R1) of 6.7 % in the case of 31, however, is 
better relative to that reported by Sherman et al. (7.4 %), conceivably due to the lower data 
acquisition temperature.   
 
The molecular structure of 31 again shows the presence of residual solvent molecules from the 
recrystalisation process, as seen in a number of molecular structures above.  As shown in Figure 
6.24, acetone is present between the 2-phenylethyl feet of 31, while a disordered chloroform 














Figure 6.24: Molecular structure of 31 from side on (left), and above (right). 
 
The presence of the residual acetone disrupts any aromatic interactions as seen above in the case 
of 17, and as such the orientation of the aromatic moieties present in the feet of 31 largely 
















Figure 6.25 The orientation of the acetone in 31, disrupting the phenyl rings of the feet. 
 
With regards to the packing of the individual cavitand molecules, the orientation of these is such 
that the molecular cavities face in the same direction relative to their neighbours, tilted at an 
angle of approximately 20° to form rows of equivalently orientated cavitand molecules.  The 
row above or below has molecular cavities facing in the same direction, however, this now 
appears slanted in the opposite direction to the first row.  The degree of tilt appears to be the 
same, and yields a 'zigzag' appearance to a layer of molecules which is very similar to that seen 
in the case of 20 and 5, as discussed above.  Figure 6.26 shows the packing present in a 
representative layer of 31. 
 
The next layer possesses the same arrangement of individual molecules, but is rotated by 180°.  
The orientation of this next layer, relative to the first can be seen in Figure 6.27, where the 
cavitand molecules have been coloured differently to clarify packing orientation.  Red illustrates 
the layer in front, as it appears in Figure 6.26, with the second layer appearing behind in yellow.  
In addition, the lack of any significant hydrogen bond donors and acceptors in 31 results in the 










































6.2.2 o-(2-Bromoethoxy)benzaldehyde, 33 
 
Compound 33 is a fundamental building block towards the formation of the synthetic precursor 
to the in situ cyclisation and preparation of target ligand 37 in this study.  The crystals for single 
crystal X-ray analysis were obtained by heating 33 to beyond its melting point (51-52 °C) and 
thereafter letting it cool to room temperature.  The molecular structure of 33 can be seen in 
Figure 6.28.  It is evident from the side view (right) that both the aldehyde group and the ether 
oxygen atom are found almost in the same plane as the benzene ring, with the bromine atom 
appearing perpendicular to this plane.  This is in keeping with observations made by Wang et al. 













Figure 6.28: Molecular structure of 33 from above (left), and side on (right). 
 
The functional groups present in 33 give rise to both intra- and intermolecular hydrogen 
bonding.  An intramolecular hydrogen bond is present between the proton associated with the 
aldehyde functional group, and the ether oxygen atom; while an intermolecular hydrogen bond 
appears between a proton belonging to the -CH2Br functionality and the aldehyde oxygen atom 
from a neighbouring residue.  These interactions are illustrated in Figure 6.29, which shows the 
intramolecular interaction on the left, and the intermolecular interaction on the right.  The 
distance over which the hydrogen bonds act in the crystal structure of 33 correspond closely too 
the equivalent interactions reported by Wang et al.  Thus for the intramolecular hydrogen bond, 
the interaction is in the order of 2.43 Å (exactly matching the reported distance), while that for 














Figure 6.29: Illustration of the intramolecular (left) and intermolecular (right) hydrogen bonding 
interactions present  in 33. 
 
In terms of packing within the crystal structure, extensive π-π interactions result in the 
individual molecules of 33 stacking.  The packing is such that columns of molecules are 
observed where the individual moieties (within a single column) are arranged parallel relative to 
the neighbouring units above and below.  The molecules are further found to lie slightly offset 
from the horizontal.  The neighbouring column is arranged in a similar fashion, but the slight 
offset from the horizontal occurs in the opposite direction.  The packing arrangement is 















Figure 6.30: Layering orientation present in the crystal structure of 33. 
 
 198
In terms of further comparison to the reported structure, the data presented in Table 6.2 
indicates that the two data sets share very similar unit cell parameters.  However, as in the case 
of 31, the lower data acquisition temperature in the case of 33 conceivably results in a better 




The crystal structures of the synthetic intermediates above clearly illustrate the ability of 
resorcin[4]arene-based molecules to act as hosts, as discussed in Chapter 1.  In addition, the 
inherent rigidity of cavitands can be seen in the structures of 20, 5, 22, 6 and 31.  The structure 
of 17 is an excellent illustration of the host capabilities of resorcin[4]arenes, and demonstrates 
the hydrogen bonding which is characteristic of resorcin[4]arenes.  Although the structures of 
the cavitands discussed are slightly different in terms of functional groups at the extra-annular 
position, and feet in particular, there are close similarities regarding the nature of the packing 
and layering seen.  This is especially true of the simpler cavitands, 5, 20 and 31.  Additionally, 
33 represents a much simpler organic molecule but still exhibits notable properties in the solid 
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The initial synthetic procedures used in this study towards the synthesis of the proposed 
cavitand-capped porphyrin target ligands were unable to afford the product.  Both the in situ 
synthetic approach and the direct capping approach indicated that the short -CH2O- ether 
bridges used to link the cavitand to the porphyrin were the primary reason for the failed 
synthesis; the bridges proving to be too short to allow capping of the porphyrin.  The synthetic 
observations, together with the literature on cavitand-capped porphyrin synthesis, support the 
notion that the success of both synthetic approaches is subject to bridge length, and shows that 
there exists a minimum requirement of bridge length which allows for a successful synthesis; the 
-CH2O- ether bridges falling short of this minimum.  
 
Subsequent computational studies on the target ligand indicated that access to the ligand cavity 
could only be achieved via the ligand apertures.  Therefore, the viability of using the 
investigated apertures to obtain selectivity based on size was confirmed.  In terms of the initial 
synthetic target, the investigation indicated (via minimisation and molecular dynamics) that the 
chosen -CH2O- bridges were too short in length to afford an aperture size which was able to 
allow the size selective entry of a paraffin terminus into the ligand cavity.  Thus, even if 
synthesis was achieved, the ligand could not provide adequate apertures to perform 
regioselective oxidation. 
 
However, the use of longer bridges in simulations, in particular those comprising four or five 
atoms, did afford more accommodating apertures.  Given these results, therefore, the synthetic 
target was adjusted towards ligands bearing -O(CH2)2O- (four atom) and -O(CH2)3O- (five 
atom) bridges.  The subsequent synthesis employed the in situ approach, which was found to be 
successful in affording these new target molecules, with complete characterisation using UV-
Vis and NMR spectroscopic methods, as well as mass spectrometry.  The ligands were only 
obtained on the implementation of the Adler conditions for the final in situ cyclisation step in 
synthesis; this confirmed previously reported observations for analogous ligands.  Additionally, 
this step made use of microwave heating.  The new and hitherto unreported means of heating 
was found to increase yields appreciably, as well as aid in simplifying the isolation of the five-
atom bridged ligand.   
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Bearing in mind the suggestion of the existence of a minimum bridge length requirement for a 
successful synthesis of such ligands, further investigation revealed that synthesis involving 
bridges consisting of three atoms failed to afford a capped porphyrin.  The minimum 
requirement was thus identified as four atoms. 
 
A viable and effective synthetic protocol for the preparation of two new cavitand-capped 
porphyrins for use in regioselective oxidative catalysis has thus been identified.  Indeed, the 
protocol has yielded a ligand bearing the shortest bridges hitherto reported for cavitand-capped 
porphyrins bearing four interconnecting bridges.  It therefore also possesses the smallest 
molecular cavity hitherto reported for such capped porphyrin host molecules. 
 
In order to evaluate the efficacy of these ligands in the proposed catalysis, metallation of the 
porphyrin moiety is required.  Additionally, computational methods can be used in preliminary 
investigations of the complexation and decomplexation behaviour of host-guest systems based 
on the synthesised host molecules.  These threads therefore represent scope for further 






All solvents and reagents were obtained from Acros, Aldrich, Fluka, Merck or Alfa-Aesar.  
Unless otherwise stated, these were used without further purification.  Microwave synthesis was 
completed using a CEM Liberty microwave peptide synthesiser, using sealed borosilicate tubes.  
Thin-layer chromatography (TLC) was conducted on aluminium-backed, precoated silica gel 
plates (Merck, silica gel 60, 20 cm X 20 cm).  Column chromatography was performed with 
silica gel 60 (Merck, particle size 0.040-0.063 mm).  Proton NMR spectra were recorded at 298 
K at 300 MHz on a Varian Unity Inova spectrometer; carbon NMR spectra were recorded at 75 
MHz with the same instrument under the same conditions.  Instances where proton and carbon 
NMR spectra were recorded at 400 MHz (100 MHz for 13C experiments) a Varian Oxford 
spectrometer or a Bruker Avance spectrometer were used, at an operating temperature of 298 K.  
Proton and carbon NMR spectra recorded at 600 MHz (150 MHz for 13C experiments) were 
done using a Bruker Ultrashield spectrometer.  Chemical shifts are reported in parts per million 
(ppm).  Ultraviolet-Visible (UV-Vis) spectra were recorded at 298 K on a Varian Cary 50 
CONC single beam UV-Vis spectrophotometer, using a quartz cell of 1 cm path length. A scan 
speed of 150 nm per minute was used.  Infrared (IR) spectra were recorded on a Nicolet Impact 
400 spectrophotometer at 293 K, as KBr discs.  Wavenumbers are reported in units of cm-1, 
where sh refers to a shoulder, br refers to a broad signal, and w to a weak signal.  Elemental 
microanalyses were obtained using a Leco CHNS-932 micro-elemental analyzer, and are 
reported for novel compounds.  All melting points are uncorrected.  Mass spectrometric data 
was obtained using a Bruker micrOTOF-Q II instrument operating at ambient temperatures, 




Stereoisomer (3) [1] 
 
To a stirring solution of water (150 mL), ethanol (150 mL) and 32% aqueous HCl (75 mL), 2-
methylresorcinol, 1, (15.04 g, 0.121 mol) was added.  The reaction solution was cooled to 0 °C 
in an ice-salt bath, before acetaldehyde, 2, (5.32 g, 0.121 mol) was added slowly over 30 
minutes.  Once addition was complete, the solution was allowed to slowly attain room 
temperature, after which time it was refluxed at 80 °C for 24 hours.  The solution was cooled to 
room temperature, and the orange needles that separated were filtered from the solution.  The 
material was washed with cold 1:1 ethanol:water until the washings were light yellow, before 
being collected and stirred in hexane overnight.  The solid was filtered from hexane and dried, 
to yield the title compound as an orange powder.  The material was suitable for use in 
subsequent reactions without further purification. (16.29 g, 90 %), mp 226-228 °C. 1H NMR [d6-
DMSO, 300 MHz]: δ = 1.69 (d, 12 H, CH3), 1.94 (s, 12 H, Ar CH3), 4.44 (q, 4 H, CHCH3), 7.40 
(s, 4 H, Ar H), 8.68 (s, 8 H, OH). 13C NMR [CDCl3, 75 MHz]: δ = 149.23, 126.27, 121.74, 
120.48, 111.89, 28.84, 20.67, 10.51. IR (KBr): 3440br, 3245sh, 2950, 2910, 2860w, 1605, 1475, 
1445sh, 1360w, 1330w, 1315w, 1255w, 1210, 1170w, 1110, 1060, 915, 880, 820, 760w, 715w, 




bis[1,3]dioxocino[5,4-i:5',4'-i']benzo[1,2-d:5,4-d']-bis[1,3]benzodioxocin Stereoisomer (4) [2] 
 
Dry 3 (1.00 g, 1.66 mmol) and Cs2CO3 (3.00 g, 9.21 mmol) was added to stirring, dry DMSO 
(10 mL) in a pressure tube (ACE pressure tube, Aldrich).  To the resulting pink solution, 
CH2BrCl (3.00 mL, 46.0 mmol) was added before further DMSO (10 mL).  The tube was sealed 
and heated at 88 °C for 16 hours.  After cooling to room temperature, the tube contents were 
poured into 2% HCl (200 mL) and the voluminous solid formed was filtered and washed with 
water.  The cream coloured solid was chromatographed on silica gel using a mobile phase of 7:3 
hexane-ethyl acetate.  The fractions collected were concentrated on a rotary evaporator to yield 
a cream coloured solid.  The solid was stirred in methanol overnight, and filtered off to yield the 
product as a white powder. (0.95 g, 88 %), mp >300 °C. 1H NMR [CDCl3, 300 MHz]: δ = 1.73 
(d, 12 H, CH3), 2.00 (s, 12 H, Ar CH3), 4.26 (d, 4 H, inner of OCH2O), 4.97 (q, 4 H, CHCH3), 
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5.91 (d, 4 H, outer of OCH2O), 7.10 (s, 4 H, Ar H). 13C NMR [CDCl3, 75 MHz]: δ = 152.86, 
138.86, 123.57, 117.00, 98.47, 31.24, 16.11, 10.32. IR (KBr): 2960, 2930w, 2880sh, 1725, 
1665sh, 1580w, 1460, 1425w, 1400w, 1375w, 1335, 1295, 1230, 1205sh, 1150, 1100, 1020sh, 





Stereoisomer (5) [3] 
 
Vacuum dried methyl cavitand 4 (1.00 g, 1.54 mmol) and N-bromosuccinimide (1.10 g, 6.31 
mmol) were added to CCl4 (100 mL).  A catalytic amount of benzoyl peroxide was added to the 
solution, and the solution allowed to reflux overnight.  The light orange solution was then 
allowed to cool to room temperature, during which time a succinimide precipitate formed.  The 
precipitate was filtered off, and the yellow filtrate concentrated on a rotary evaporator.  The 
resulting solid was chromatographed on silica gel using a mobile phase of 3:1 hexane-ethyl 
acetate.  The fractions that were collected were concentrated on a rotary evaporator, and the 
yellow solid product that resulted stirred in methanol overnight.  The solution was then filtered 
to yield the title compound as an off-white powder. (0.96 g, 69 %), mp >300 °C. 1H NMR 
[CDCl3, 300 MHz]: δ = 1.74 (d, 12 H, CH3), 4.43 (s, 8 H, CH2Br), 4.56 (d, 4 H, inner of 
OCH2O), 5.01 (q, 4 H, CHCH3), 6.02 (d, 4 H, outer of OCH2O), 7.26 (s, 4 H, Ar H). 13C NMR 
[CDCl3, 75 MHz]: δ = 153.12, 138.99, 124.44, 120.48, 99.04, 31.18, 22.95, 16.05. IR (KBr): 
2980w, 2940w, 2875w, 1595, 1415, 1440w, 1400, 1345, 1305, 1250, 1205, 1145, 1100, 1095, 
1050w, 1010w, 980, 935w, 895sh, 805, 750, 695, 600, 560, 490w, 480. 
 
 
Tetrasalicylaldehyde 6  
 
To a stirring solution of salicylaldehyde (1.01 g, 8.30 mmol) in dry THF (70 mL) under a 
nitrogen atmosphere, NaH (60% suspension in mineral oil, 0.33 g, 8.30 mmol) was added.  To 
the resulting bright yellow solution, bromomethyl cavitand 5 (1.00 g, 1.04 mmol) was added as 
a solution in dry THF (10 mL), dropwise over 30 minutes.  The solution was refluxed for 4 
days; TLC using a mobile phase of 3:2 hexane-ethyl acetate showed mono-, di-, tri- and tetra-
substituted products.  Over this time, the solution became grey in colour.  Once cooled to room 
temperature, the solution was concentrated on a rotary evaporator.  The products were 
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chromatographed on silica gel using a mobile phase of 3:2 hexane-ethyl acetate.  Fractions of 12 
mL were collected, and TLC performed on them in the same mobile phase, such that all 
fractions containing the desired tetra-substituted product (Rf = 0.37) were combined, and the 
undesired products discarded.  Once all the fractions containing the desired product were 
collected, they were concentrated on a rotary evaporator to yield an off-white solid.  The 
material was then stirred in methanol, followed by hexane, before being filtered and collected to 
yield the title compound as a white solid. (0.35 g, 28 %), mp 127-130 °C. 1H NMR [CDCl3, 300 
MHz]: δ = 1.88 (d, J = 7.6 Hz, 12 H, CH3), 4.57 (d, J = 6.9 Hz, 4 H, inner of OCH2O), 4.96 (s, 8 
H, ArOCH2Ar), 5.05 (q, J = 7.1 Hz, 4 H, CHCH3), 5.82 (d, J = 6.8 Hz, 4 H, outer of OCH2O), 
7.04 (t, J = 7.1 Hz, 4 H, Ar H), 7.14 (d, J = 8.5 Hz, 4 H, Ar H), 7.40 (s, 4 H, cavitand Ar H), 
7.53 (t, J = 7.0 Hz, 4 H, Ar H), 7.73 (d, J = 7.6 Hz, 4 H, Ar H), 10.18 (s, 4 H, Ar CHO). 13C 
NMR [CDCl3, 75 MHz]: δ = 189.83, 160.93, 154.04, 139.09, 135.88, 129.70, 125.56, 121.77, 
121.43, 114.18, 100.00, 62.07, 31.22, 16.14. IR (KBr): 2985w, 2940w, 2870w, 1735, 1690, 
1600, 1585w, 1480w, 1465, 1400w, 1385w, 1340sh, 1300w, 1290, 1240w, 1220w, 1195w, 1165, 
1100, 1075w, 1020w, 975, 940w, 850, 835w, 755, 670w, 645w, 585w, 500w, 445w. Anal Calcd 
for C68H56O16 (1129.17): C 72.33, H 4.99. Found: C 72.58, H 5.08. 
 
 
5,10,15,20-Tetrakis(2-methoxyphenyl)-21H,23H-porphyrin (11) (Lindsey conditions) [4] 
 
To dry, freshly distilled CHCl3 (1.5 L), 2-methoxybenzaldehyde 8 (2.04 g, 0.015 mol) and 
freshly distilled pyrrole 9 (1.00 g, 0.015 mol) was added under a nitrogen atmosphere with 
vigorous stirring.  The reaction vessel was shielded from light, and BF3 (as the diethyl ethearate 
complex, 0.16 mL) was added via syringe.  The solution was allowed to stir for 1.5 hours, at 
which time 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ, 2.55 g, 0.011 mol) was added as a 
powder and the solution heated to 60 °C.  After 1.5 hours of heating, the solution was allowed to 
attain room temperature, and triethylamine (10 mL) was added to neutralize excess acid.  After 
20 minutes of stirring, 40 g of silica was added directly to the reaction vessel for preadsorption 
of the crude material.  Chromatography was performed (in some instances, up to three times) on 
silica gel using a mobile phase of 95:5 CHCl3-methanol to give the title compound as a dark 
purple microcrystalline solid, consisting of a mixture of four isomers.  (0.96 g, 35 %), mp >300 
°C. 1H NMR [CDCl3, 300 MHz]: δ = 3.56, 3.58, 3.60 (3 s, rel. int. 1:2:1, 12 H, 4 OCH3), 7.28-
7.36 (m, 8 H, 4 HC(3'), 4 HC(5')), 7.76 (t, 4 H, HC(4')), 7.93, 7.99, 8.03 (3 d, rel. int. 1:2:1, 4 H, 
HC(6')), 8.69, 8.80 (2 s, rel. int. 2:1, 8 H, HC(β) of pyrrole). 13C NMR [CDCl3, 75 MHz]: 
δ = 159.48, 159.45, 135.73, 135.66, 135.58, 131.41, 131.24, 129.67, 119.35, 115.48, 110.91, 
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55.86. IR (KBr): 3445w, 3320w, 3000w, 2935w, 2720w, 1700w, 1595w, 1585, 1560w, 1490, 
1465, 1434, 1405w, 1375w, 1350, 1295w, 1250, 1215w, 1185, 1160w, 1110, 1050, 1030, 995w, 
985w, 965, 860w, 800, 795w, 755, 725, 670w, 650, 570, 490. UV-Vis (CHCl3): 644.05, 589.72, 
550.57, 513.93, 443.32, 419.47 (Soret), 400.32sh, 365sh, 350sh. 
 
 
5,10,15,20-Tetrakis(2-hydroxyphenyl)-21H,23H-porphyrin (12) [4, 5]  
 
To dry, freshly distilled CH2Cl2 (50 mL), tetramethoxyporphyrin 11 (2.00 g, 2.72 mmol) was 
added as a solid under a nitrogen atmosphere to give a purple solution.  To this, BBr3 (8.7 mL, 
0.093 mol) was added to the solution via syringe, and the reaction vessel shielded from light.  
After stirring for 5 hours, water (30 mL) was carefully added to the bright green solution to 
neutralise excess acid, and the product precipitated from solution.  The contents of the reaction 
vessel were transferred to a 500 mL beaker, and the solution treated carefully with a saturated 
solution of NaHCO3, so turning the solution purple.  Once effervescence subsided, the solution 
was subjected to extraction using ethyl acetate.  The organic layers were collected and dried 
over anhydrous Na2SO4 before gravity filtration.  The solution was concentrated on a rotary 
evaporator, suspended in a small amount of hexane and filtered.  The retained dark purple 
material was washed further with hexane to give the title compound as a purple solid. (1.68 g, 
91 %), mp >300 °C.  TLC (SiO2, 9:1 CHCl3-Et2O): Rf 0.19 (αααα isomer), 0.33 (αααβ), 0.46 
(ααββ), 0.59 (αβαβ). 1H NMR [CDCl3, 300 MHz]: δ = 4.93 (br. s, 4 H, OH), 7.32-7.39 (m, 8 
H, 4 HC(3'), 4 HC(5')), 7.68-7.76 (t, 4 H, HC(4')), 7.95 (m, 4 H, HC(6')), 8.91 (s, 8 H, HC(β) of 
pyrrole). 13C NMR [CDCl3, 75 MHz]: δ = 155.54, 135.02, 130.67, 127.37, 119.64, 115.63. IR 
(KBr): 3630-3220v. br, 3120w, 3100w, 2925w, 2850w, 1690w, 1650w, 1640w, 1625w, 1610w, 
1585w, 1560, 1470w, 1455, 1380w, 1350, 1290, 1250w, 1220, 1185w, 1160, 1100, 965, 885w, 
815, 800w, 755, 730w, 650, 475w, 460w. UV-Vis (CHCl3): 642.55, 586.99, 547.05, 512.95, 











Stereoisomer (16) [6] 
 
To a stirring solution of water (100 mL), ethanol (100 mL) and 32% aqueous HCl (50 mL), 2-
methylresorcinol, 1, (10.28 g, 0.08 mol) was added.  The reaction vessel was immersed in an 
ice-salt bath and the solution cooled to temperatures within a range of 0-5 °C, before hexanal, 
13, (8.30 g, 0.08 mol) was added slowly over 60 minutes.  Once addition was complete, the 
solution was allowed to slowly attain room temperature, after which time it was refluxed at 80 
°C for 24 hours.  The solution was cooled to room temperature, and water added in order to 
precipitate out the crude product.  The orange-brown material that separated was filtered from 
the solution.  The material was washed with cold 1:1 ethanol:water until the washings were light 
yellow, before being collected, redissolved in warm methanol and recrystallized overnight. The 
resulting off white material was then filtered from the methanol solution and thereafter stirred in 
hexane to remove residual aldehyde.  The solid was filtered from hexane and dried, to yield the 
title compound as an off-white powder. (10.93 g, 64 %), mp >300 °C. 1H NMR [d6-DMSO, 300 
MHz]: δ = 0.86 (t, 12 H, CH3), 1.33 (m, 24 H, (CH2)3), 1.94 (s, 12 H, Ar CH3), 2.20 (m, 8 H, 
CH2), 4.18 (t, 4 H, CH(CH2)4CH3), 7.25 (s, 4 H, Ar H), 8.67 (s, 8 H, OH). 13C NMR [CDCl3, 75 
MHz]: δ = 149.16, 125.00, 121.30, 111.76, 34.50, 33.20, 31.67, 27.884, 22.51, 14.20, 10.24. IR 
(KBr): 3425br, 2940sh, 2930, 2845, 1600, 1470, 1445sh, 1360sh, 1325, 1300w, 1260, 1185w, 





4,6,10,12,16,18,22,24-octol Stereoisomer (17) 
 
To a stirring solution of water (100 mL), ethanol (200 mL) and 32% aqueous HCl (50 mL), 2-
methylresorcinol, 1, (12.41 g, 0.10 mol) was added.  The reaction vessel was immersed in an 
ice-salt bath and the solution cooled to temperatures within a range of 0-5 °C, before 3-
phenylpropionaldehyde, 14, (13.42 g, 0.10 mol) was added slowly over 30 minutes.  Once 
addition was complete, the solution was allowed to slowly attain room temperature, after which 
time it was refluxed at 80 °C for 48 hours.  The solution was cooled to room temperature, and 
water added in order to precipitate the crude product.  The brown material that separated was 
filtered off.  The material was washed with cold 1:1 ethanol:water until the washings were light 
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yellow, before being collected, redissolved in warm methanol and recrystallized overnight. The 
resulting peach-coloured material was then filtered from the methanol solution and thereafter 
stirred in hexane to remove residual aldehyde.  The solid was filtered off and dried, to yield the 
title compound as a peach-coloured microcrystalline solid. (13.93 g, 58 %), mp 282-284 °C. 1H 
NMR [d6-DMSO, 300 MHz]: δ = 1.97 (s, 12 H, Ar CH3), 2.49-2.50 (m, 28 H, CH2CH2Ar, and 
DMSO as solvent signal), 4.26-4.30 (t, J = 7.0 Hz, 4 H, CHCH2CH2Ar), 7.13-7.29 (m, 20 H, 
C6H5), 7.39 (s, 4 H, Ar H), 8.73 (s, 8 H, OH). 13C NMR [CDCl3, 75 MHz]: δ = 149.34, 142.40, 
128.70, 128.38, 125.81, 125.00, 111.88, 40.53, 40.25, 39.13, 38.86, 10.26. IR (KBr): 3395br, 
3005w, 2925, 2845w, 1600, 1470, 1450sh, 1380w, 1340w, 1300, 1255sh, 1190, 1098, 1035w, 
925w, 895, 845sh, 795sh, 750, 705, 560w, 500. Anal Calcd for C64H64O8 (961.195): C 79.97, H 





Stereoisomer (18) [6, 7] 
 
To a cooled (0 °C), stirring solution of 2-methylresorcinol, 1, (5.01 g, 0.04 mol) in ethanol (75 
mL) and 32% aqueous HCl (25 mL), dodecanal, 15, (7.44 g, 0.04 mol) was added as a solution 
in ethanol (50 mL) over half an hour.  Once addition was complete, the solution was allowed to 
slowly attain room temperature, after which time it was refluxed at 75 °C for 24 hours.  The 
solution was cooled to room temperature and the crude product precipitated out as an orange 
solid.  The orange material was filtered from the solution and repeatedly washed with methanol.  
Thereafter, the solid was collected and stirred in methanol for 4 hours, before being filtered and 
dried under vacuum, to yield a peach coloured powder. (8.56 g, 73 %), mp 286-287 °C. 1H NMR 
[d6-acetone, 300 MHz]: δ = 0.91 (t, 12 H, C10H20CH3), 1.32 (m, 72 H, C9H18), 2.08 (s, 15 H, Ar 
CH3 and acetone as solvent signal), 2.30 (m, 8 H, CH2CH2C9H19), 4.34 (t, 4 H, CHCH2C10H21), 
7.43 (s, 4 H, Ar H), 7.98 (s, 8 H, OH). 13C NMR [CDCl3, 75 MHz]: δ = 149.34, 126.82, 124.48, 
121.02, 110.90, 34.28, 33.65, 31.57, 29.47, 29.41, 29.35, 29.22, 28.192, 27.94, 22.24, 13.27, 
8.69. IR (KBr): 3370br, 2925, 2850, 1612, 1467, 1441, 1377w, 1335w, 1269, 1198, 1163, 







bis[1,3]dioxocino[5,4-i:5',4'-i']benzo[1,2-d:5,4-d']-bis[1,3]benzodioxocin Stereoisomer (19) [8, 9] 
 
To a solution of CH2BrCl (7.1 mL, 0.113 mol) and K2CO3 (43.5 g, 0.335 mol) in dry, degassed 
DMF (700 mL), octol 16 (20.0 g, 0.024 mol) in DMF (100 mL) was added over 1.5 hours.  
After stirring for 24 hours at room temperature under a nitrogen atmosphere, CH2BrCl (7.1 mL, 
0.113 mol) was added and the solution heated to 45 °C.  After a further 24 hours, a further 
aliquot of CH2BrCl (7.1 mL, 0.113 mol) was added, and the solution heated to 65 °C.  After 48 
hours at 65 °C, the pink solution was cooled to room temperature, before being neutralized by a 
2M HCl solution.  After filtering off the resulting solid, the solvent was removed via rotary 
evaporation before any remaining carbonate salts were neutralized with 2M HCl. The resulting 
solid was filtered off, and all solid materials combined before being washed with methanol.  The 
crude product was obtained as a light brown solid.  Chromatography on silica gel using a mobile 
phase of 75:25 hexane-ethyl acetate, followed by stirring in methanol, gave the title compound 
as an off-white solid. (2.53 g, 12 %), mp 136-137 °C. 1H NMR [CDCl3, 300 MHz]: δ = 0.89 (t, 
12 H, CH3), 1.15-1.35 (m, 24 H, (CH2)3), 1.95 (s, 12 H, Ar CH3), 2.10-2.20 (m, 8 H, CH2), 4.25 
(d, 4 H, inner of OCH2O), 4.73 (t, 4 H, CH(CH2)4CH3), 5.85 (d, 4 H, outer of OCH2O), 6.95 (s, 
4 H, Ar H). 13C NMR [CDCl3, 75 MHz]: δ = 153.22, 137.96, 123.62, 117.56, 98.51, 37.01, 
32.09, 31.72, 29.94, 27.68, 22.72, 14.14, 10.36. IR (KBr): 2927, 2859, 1594w, 1465, 1398w , 







Dry 17 (1.00 g, 1.66 mmol) and Cs2CO3 (3.00 g, 9.21 mmol) were added to stirring, dry DMSO 
(10 mL) in a pressure tube (ACE pressure tube, Aldrich).  To the resulting pink solution, 
CH2BrCl (3.00 mL, 46.0 mmol) was added before further DMSO (10 mL).  The tube was sealed 
and heated at 88 °C for 16 hours.  After cooling to room temperature, the tube contents were 
poured into 2% HCl (200 mL) and the voluminous solid formed was filtered and washed with 
water.  The cream coloured solid was chromatographed on silica gel using a mobile phase of 
70:30 hexane-ethyl acetate (Rf = 0.59).  The fractions collected were concentrated on a rotary 
evaporator to yield a cream coloured solid.  The solid was stirred in methanol overnight, and 
filtered to yield the product as a white powder. (0.97 g, 92 %), mp 145-147 °C. 1H NMR 
 210
[CDCl3, 300 MHz]: δ = 2.00 (s, 12 H, Ar CH3), 2.44-2.52 (m, 8 H, CH2CH2Ar), 2.62-2.67 (m, 8 
H, CH2CH2Ar), 4.26 (d, J = 7.0 Hz, 4 H, inner of OCH2O), 4.83 (t, J = 8.0 Hz, 4 H, 
CHCH2CH2Ar), 5.88 (d, J = 7.0 Hz, 4 H, outer of OCH2O), 7.00 (s, 4 H, Ar H), 7.11-7.23 (m, 
20 H, C6H5). 13C NMR [CDCl3, 75 MHz]: δ = 153.48, 141.91, 137.79, 128.55, 125.96, 117.35, 
98.51, 37.16, 34.53, 32.64, 10.38. IR (KBr): 2920, 2850w, 1755, 1625w, 1590, 1455, 1430sh, 
1400w, 1360w, 1340w, 1295, 1230, 1145, 1080, 1005w, 975, 915sh, 800sh, 790w, 750, 695, 





bis[1,3]dioxocino[5,4-i:5',4'-i']benzo[1,2-d:5,4-d']-bis[1,3]benzodioxocin Stereoisomer (21) [2, 6] 
 
Dry 18 (1.00 g, 0.086 mmol) and Cs2CO3 (3.00 g, 9.21 mmol) were added to stirring, dry 
DMSO (10 mL) in a pressure tube (ACE pressure tube, Aldrich).  To the resulting solution, 
CH2BrCl (3.00 mL, 46.0 mmol) was added before further DMSO (10 mL).  The tube was sealed 
and heated at 88 °C for 16 hours.  After cooling to room temperature, the tube contents were 
poured into 2% HCl (200 mL) and left overnight.  The resulting sticky orange residue was 
extracted into CHCl3.  The organic layer was then dried over MgSO4, before being directly 
adsorbed onto silica.  The crude product was chromatographed on silica gel using a mobile 
phase of chloroform.  The fractions collected were concentrated on a rotary evaporator to yield a 
light orange coloured solid.  The solid was stirred in methanol overnight, filtered and dried 
under vacuum overnight to yield the purified product. (0.67 g, 64 %), mp 168-170 °C. 1H NMR 
[CDCl3, 300 MHz]: δ = 0.88 (t, 12 H, C10H20CH3), 1.24 (m, 72 H, C9H18), 1.95 (s, 12 H, Ar 
CH3), 2.16 (m, 8 H, CH2CH2C9H19), 4.25 (d, 4 H, inner of OCH2O), 4.73 (t, 4 H, CH 
CH2C10H21), 5.85 (d, 4 H, outer of OCH2O), 6.94 (s, 4 H, Ar H). 13C NMR [CDCl3, 75 MHz]: 
δ = 153.22, 137.95, 123.60, 117.58, 98.508, 36.958, 31.966, 52.86, 138.86, 123.57, 117.00, 
98.47, 36.96, 31.97, 29.90, 29.75, 29.43, 27.98, 22.72, 14.15, 10.36. IR (KBr): 2918, 2850, 










Stereoisomer (22) [3, 9] 
 
Vacuum dried methyl cavitand 19 (1.00 g, 1.15 mmol) and N-bromosuccinimide (0.90 g, 5.04 
mmol) were added to CCl4 (100 mL).  A catalytic amount of benzoyl peroxide was added to the 
solution, and the solution allowed to reflux overnight under irradiation of white light.  The 
orange solution accompanied by a succinimide precipitate was then allowed to cool to room 
temperature.  The precipitate was filtered off, and the orange filtrate concentrated on a rotary 
evaporator.  The resulting solid was chromatographed on silica gel using a chloroform mobile 
phase.  The collected fractions were concentrated on a rotary evaporator, and the orange solid 
product stirred in methanol overnight.  The solution was then filtered, and the product dried 
overnight to yield the title compound as a dark orange powder. (1.03 g, 76 %), mp 280-282 °C. 
1H NMR [CDCl3, 300 MHz]: δ = 0.89 (t, 12 H, CH3), 1.28-1.50 (m, 24 H, (CH2)3), 2.15-2.22 
(m, 8 H, CH2), 4.40 (s, 8 H, CH2Br), 4.55 (d, 4 H, inner of OCH2O), 4.76 (t, 4 H, 
CH(CH2)4CH3), 6.02 (d, 4 H, outer of OCH2O), 7.11 (s, 4 H, Ar H). 13C NMR [CDCl3, 75 
MHz]: δ = 153.55, 138.13, 124.55, 121.18, 98.17, 36.87, 32.68, 31.98, 30.08, 27.55, 22.67, 
14.10. IR (KBr): 2926, 2858, 1589w, 1470, 1453, 1398, 1241, 1147, 1056w, 1013, 970, 936, 





Stereoisomer (24) [7] 
 
Vacuum dried methyl cavitand 21 (1.00 g, 0.83 mmol) and N-bromosuccinimide (1.10 g, 6.31 
mmol) were added to C6H5Cl (100 mL).  A catalytic amount of benzoyl peroxide was added to 
the solution, and the solution allowed to reflux overnight under irradiation of white light.  The 
orange solution, accompanied by a succinimide precipitate, was then allowed to cool to room 
temperature.  The precipitate was filtered off, and the orange filtrate concentrated on a rotary 
evaporator.  The resulting solid was chromatographed on silica gel using a chloroform mobile 
phase.  The collected fractions were concentrated on a rotary evaporator, and the orange solid 
product stirred in methanol overnight.  The solution was then filtered, and the purified product 
dried overnight to yield the title compound as a dark orange powder. (0.86 g, 68 %), mp >300 
°C. 1H NMR [CDCl3, 300 MHz]: δ = 0.85 (t, 12 H, C10H20CH3), 1.13 (m, 72 H, C9H18), 2.16 (m, 
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8 H, CH2CH2C9H19), 4.38 (s, 8 H, CH2Br), 4.53 (d, 4 H, inner of OCH2O), 4.72 (t, 4 H, CH 
CH2CH2C9H19), 6.05 (d, 4 H, outer of OCH2O), 7.14 (s, 4 H, Ar H). 13C NMR [CDCl3, 75 
MHz]: δ = 153.54, 138.11, 124.53, 121.00, 98.89, 36.82, 31.96, 30.09, 29.82, 29.72, 29.43, 
27.88, 22.72, 14.16. IR (KBr): 2921, 2851, 1589w, 1470, 1454, 1432w, 1398w, 1349w, 1303w, 




General procedure for direct capping of porphyrin [10] 
 
Porphyrin 12 (0.31 g, 0.46 mmol) was added as a purple powder to a 2-necked round bottom 
flask (fitted with a double layer condenser) which had been flushed with nitrogen.  Dry THF 
(100 mL) was then added, and the porphyrin solution degassed with nitrogen for ten minutes.  
Thereafter, oven-dried (110 °C) K2CO3 (2.00 g, 0.020 mol) was added to the solution, which 
was then heated to 110 °C under a nitrogen atmosphere.  During the heating period, 
bromomethyl cavitand (5, 22 and 24) (0.59 mmol) was added as a THF solution (100 mL) 
dropwise over 30 minutes.  Once the addition was completed, the solution was kept under 
nitrogen and allowed to reflux at 110 °C for five days.  After this period, TLC was performed on 
the reaction solution using a benzene mobile phase.  Once reaction was complete, the solution 
was cooled to room temperature, and the THF removed in vacuo.  The resulting purple solid 
was dissolved in chloroform, and the solution washed with 1 M HCl, water (repeated three 
times) and brine (repeated twice).  The organic layer was subsequently dried over Na2SO4.  The 
material was adsorbed onto silica, and chromatographed using a benzene mobile phase.  The 
violet band which eluted was collected, the benzene removed and the resultant purple solid 
stirred in methanol overnight.  Filtration from the methanol yielded the reaction product. 
 
 
Tetrasalicylaldehyde 27  
 
To a stirring solution of salicylaldehyde (0.36 g, 2.69 mmol) in dry THF (50 mL) under a 
nitrogen atmosphere, NaH (60% suspension in mineral oil, 0.065 g, 2.69 mmol) was added.  To 
the resulting bright yellow solution, bromomethyl cavitand 22 (0.400 g, 0.34 mmol) was added 
as a solution in dry THF (20 mL) dropwise over 30 minutes.  The solution was refluxed for 3 
days; TLC, using a mobile phase of 1:1 hexane-ethyl acetate, showed tri- and tetra-substituted 
products.  Over this time, the solution became grey in colour.  Once cooled to room 
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temperature, the solution was concentrated on a rotary evaporator.  The products were 
chromatographed on silica gel using a mobile phase of 1:1 hexane-ethyl acetate.  Fractions of 12 
mL were collected and TLC performed on them in the same mobile phase, such that all fractions 
containing the desired tetra-substituted product (Rf = 0.56) were combined, and the undesired 
products discarded.  Once all the fractions containing the desired product were collected, they 
were concentrated on a rotary evaporator to yield a white solid.  The material was then stirred in 
methanol, before being filtered and collected to yield the title compound as a white solid. (0.33 
g, 80 %), mp 136-138 °C. 1H NMR [CDCl3, 400 MHz]: δ = 0.91 (t, J = 7.1 Hz, 12 H, CH3), 1.36 
(m, 24 H, (CH2)3), 2.26 (m, 8 H, CH2), 4.54 (d, J = 7.1 Hz, 4 H, inner of OCH2O), 4.83 (t, J = 
8.1 Hz, 4 H, CH(CH2)4CH3), 4.95 (s, 8 H, ArOCH2Ar), 5.77 (d, J = 7.0 Hz, 4 H, outer of 
OCH2O), 7.03 (t, J = 7.5 Hz, 4 H, Ar H), 7.14 (d, J = 8.4 Hz, 4 H, Ar H), 7.27 (s, 4 H, cavitand 
Ar H), 7.53 (td, J = 8.9 Hz, 4 H, Ar H), 7.73 (dd, J = 7.5 Hz, 4 H, Ar H), 10.17 (s, 4 H, Ar 
CHO). 13C NMR [CDCl3, 75 MHz]: δ = 189.93, 160.95, 154.44, 138.19, 135.87, 129.70, 
125.55, 121.93, 121.41, 114.17, 100.07, 62.11, 36.94, 32.02, 30.12, 27.58, 22.70, 14.13. IR 
(KBr): 2929, 2859, 1686, 1597, 1476, 1454, 1378, 1283, 1240, 1189w, 1151, 1088, 1019w, 964, 
853, 755, 654, 585, 487w, 441w. Anal Calcd for C84H88O16 (1353.59): C 74.54, H 6.55. Found: 





Stereoisomer (29) [6] 
 
To a stirring solution of ethanol (400 mL) and 32% aqueous HCl (100 mL), resorcinol, 28, (20.0 
g, 0.182 mol) was added.  The reaction solution was cooled to -4 °C in an ice-salt bath, before 3-
phenylpropionaldehyde, 14, (24.15 g, 0.180 mol) was added slowly over 30 minutes.  Once 
addition was complete, the solution was allowed to slowly attain room temperature over a 
period of 24 hours, after which time it was refluxed at 80 °C.  After approximately 6 hours of 
reflux, the solution went from a clear, orange solution to a cloudy solution containing a red 
suspension.  After 3 days of reflux, the reaction mixture was cooled to room temperature before 
further cooling to 0 °C in an ice bath.  The solution was filtered and the retained product washed 
with cold 1:1 ethanol:water before being collected and stirred in hexane overnight.  The solid 
was filtered from hexane and dried, to yield the title compound as an orange powder.  The 
material was suitable for use in subsequent reactions without further purification. (30.82 g, 75 
%), mp >300 °C dec. 1H NMR [d6-acetone, 400 MHz]: δ = 2.52-2.61 (m, 16 H, CH2CH2Ar), 
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4.38 (m, 4 H, CHCH2CH2Ar), 6.25 (s, 4 H, Ar H), 7.14-7.26 (m, 20 H, CH2CH2C6H5), 7.74 (s, 4 
H, Ar H), 8.53 (s, 8 H, OH). 13C NMR [d6-acetone, 100 MHz]: δ = 152.86, 143.46, 129.45, 
129.17, 126.46, 125.65, 125.24, 103.79, 37.00, 35.59, 34.64. IR (KBr): 3222br, 2936w, 2863w, 





4,6,10,12,16,18,22,24-octol Stereoisomer (30) [8, 11] 
 
Dry 29 (25.0 g, 0.027 mol) was suspended in glacial acetic acid (500 mL) in an open round-
bottomed flask with vigorous stirring in a well ventilated fume cupboard.  The resulting orange 
suspension was treated with a solution of elemental bromine (11.1 mL, 0.221 mol) in glacial 
acetic acid (50 mL), which was added over 30 seconds.  After a further 30 seconds, the solution 
turned a light brown colour, and a small amount of HBr gas was liberated.  The reaction mixture 
was subsequently heated to 30 °C which was maintained overnight.  Once cooled to room 
temperature, the solution was filtered and the retained solid collected before being stirred in 
deionised water for 8 hours.  The product was obtained as a white solid by filtration of this 
aqueous suspension to give the title compound which was pure enough for use in subsequent 
reactions. (29.33 g, 87 %), mp 259-261 °C dec. 1H NMR [d6-acetone, 400 MHz]: δ = 2.59-2.81 
(m, 16 H, CH2CH2Ar), 4.50-4.53 (m, 4 H, CHCH2CH2Ar), 7.13-7.24 (m, 20 H, CH2CH2C6H5), 
7.77 (s, 4 H, Ar H), 8.38 (s, 8 H, OH). 13C NMR [d6-acetone, 100 MHz]: δ = 149.03, 143.02, 
129.42, 129.29, 126.68, 125.02, 125.57, 100.83, 37.15, 36.68, 35.33. IR (KBr): 3388br, 
29345w, 1611, 14955w, 1468, 1454sh, 1342w, 1302, 1250w, 1204w, 1178w, 1152, 1087, 





Stereoisomer (31) [8, 12] 
 
To a solution of CH2BrCl (16.3 mL, 0.243 mol) and oven-dried (110 °C) K2CO3 (99.25 g, 0.718 
mol) in dry, degassed DMF (700 mL), octol 30 (25.0 g, 0.0205 mol) in DMF (100 mL) was 
added over 1.5 hours.  After stirring for 24 hours at room temperature under a nitrogen 
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atmosphere, CH2BrCl (16.3 mL, 0.243 mol) was added and the solution heated to 45 °C.  After a 
further 24 hours, a further aliquot of CH2BrCl (16.3 mL, 0.243 mol) was added, and the solution 
heated to 63 °C.  After 48 hours at 65 °C, the light brown solution was cooled to room 
temperature, and the K2CO3 neutralised by the addition of a 6 % HCl solution.  The crude 
product simultaneously precipitated from solution, and was collected on filtration of the 
neutralized reaction mixture.  The cream-coloured solid was suspended in methanol and stirred 
for 24 hours, before being filtered from the methanol and dried.  The material was 
chromatographed on silica gel using a chloroform mobile phase, before being stirred once again 
in methanol, filtered and dried to give the title compound as an off-white solid. (25.90 g, 70 %), 
mp 285-290 °C dec. 1H NMR [CDCl3, 400 MHz]: δ = 2.47-2.49 (m, 8 H, CH2CH2Ar), 2.62-2.64 
(m, 8 H, CH2CH2Ar), 4.41 (d, 4 H, inner of OCH2O), 4.94 (t, 4 H, CHCH2CH2Ar), 5.95 (d, 4 H, 
outer of OCH2O), 7.09-7.24 (m, 24 H, Ar H and CH2CH2C6H5). 13C NMR [CDCl3, 100 MHz]: 
δ = 152.84, 141.74, 139.69, 129.25, 128.92, 126.81, 119.52, 114.41, 99.03, 38.33, 34.79, 32.89. 
IR (KBr): 2939w, 1729w, 1602w, 1469sh, 1452, 1415, 1299, 1234, 1091, 1057w, 1017, 984sh, 





Stereoisomer (32) [13] 
 
A solution of vacuum-dried 31 (5.0 g, 3.94 mmol) in dry THF (800 mL) was set to stir in an 
oven-dried round-bottomed flask under a nitrogen atmosphere, sealed with a septum.  The 
solution was cooled to -80 °C, and treated with n-butyllithium (~ 1.6 M solution in hexane, 40.0 
mL, 64 mmol), which was rapidly added via the septum using a syringe.  After 1 minute, 
trimethyl borate (12 mL, 105 mmol) was added, so turning the solution into a dark yellow 
emulsion.  The flask and its contents were removed from the cooling bath, and allowed to attain 
room temperature slowly, during which time the emulsion disappeared to yield a yellow 
solution.  After stirring at room temperature for 1 hour, the solution was again cooled to -80 °C, 
and treated with 1:1 15 % H2O2:1.5 M NaOH (100 mL) to give a viscous, white reaction 
mixture.  The solution was allowed to warm to ambient temperature and stirred overnight, over 
which time it cleared to give a clear, slightly yellow solution.  Thereafter, Na2S2O5 (20 g, 0.105 
mol) was carefully added to the stirring solution, which resulted in the formation of two layers.  
The THF was subsequently removed in vacuo to yield a white solid in the residual water, which 
was filtered.  The mixture of alcohols was preadsorbed onto silica before being subjected to 
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chromatography on silica gel.  The gravity column (30 cm in length X 5.5 cm in diameter) was 
gradient eluted, starting with 100 % chloroform, accompanied by the slow addition of methanol 
towards a final chloroform-methanol ratio of 85:15.  The tetrol title compound was exclusively 
isolated as the most polar fraction (Rf = 0.16, by TLC in 85 :15 chloroform:methanol) and found 
to be pure. (1.80 g, 45 %), mp >300 °C dec. TLC (SiO2, 3:1 EtOAc-Hexane): Rf 0.14 (tetrol), 
0.34 (triol), 0.56 (diol), 0.70 (mono-ol). 1H NMR [d6-acetone, 400 MHz]: δ = 2.55-2.2.61 (m, 8 
H, CH2CH2Ar), 2.63-2.68 (m, 8 H, CH2CH2Ar), 4.42 (d, 4 H, inner of OCH2O), 4.79 (t, 4 H, 
CHCH2CH2Ar), 5.83 (d, 4 H, outer of OCH2O), 7.18-7.25 (m, 24 H, Ar H and CH2CH2C6H5), 
7.96 (s, 4 H, Ar OH). 13C NMR [d6-acetone, 100 MHz]: δ = 143.54, 143.48, 143.33, 139.44, 
129.34, 129.25, 126, 61, 111.30, 100.74, 38.17, 35.21, 33.04. IR (KBr): 3368br, 2938w, 1587, 




2-(2-bromoethoxy)benzaldehyde (33) [14] 
 
To a stirring solution of oven-dried (110 °C) K2CO3 (13.0 g, 0.0941 mol) in dry DMF (80 mL), 
salicylaldehyde (10.0 g, 0.0819 mol) was added so turning the solution bright yellow.  After 10 
minutes of stirring at room temperature, 1,2-dibromoethane (123.07 g, 0.655 mol) was added 
and the reaction mixture left to stir further for 3 days.  Thereafter, the mixture was poured into 
water, and the liberated oil extracted from the aqueous emulsion with diethyl ether.  The organic 
layer was treated with 10 % NaOH (3 times) followed by extraction with water (twice) before 
being dried over Na2SO4.  The diethyl ether was evaporated, and the excess 1,2-dibromoethane 
reagent removed via high vacuum distillation.  The yellow oil obtained was cooled to room 
temperature to yield the title compound as a yellow, crystalline solid. (13.11 g, 70 %), mp 50-52 
°C. 1H NMR [CDCl3, 400 MHz]: δ = 3.69 (t, 2 H, OCH2CH2Br), 4.40 (t, 2 H, OCH2CH2Br), 
6.94 (d, 1 H, Ar H), 7.04 (t, 1 H, Ar H), 7.52 (td, 1 H, Ar H), 7.81 (dd, 1 H, Ar H), 10.41 (s, 1 
H, Ar CHO). 13C NMR [CDCl3, 100 MHz]: δ = 189.60, 160.40, 135.93, 128.48, 125.22, 121.52, 
112.70, 68.23, 28.81. IR (KBr): 2863w, 1676, 1596, 1581sh, 1482, 1452, 1396, 1382, 1289, 





2-(2-bromopropoxy)benzaldehyde (34) [14] 
 
Application of the above procedure for 33, using salicylaldehyde (10.0 g, 0.0819 mol) and 1,3-
dibromopropane (132.26 g, 0.655 mol), yielded the title compound as a yellow oil. (19.29 g, 97 
%). 1H NMR [CDCl3, 400 MHz]: δ = 2.37 (m, 2 H, CH2CH2 CH2), 3.60 (t, 2 H, OCH2CH2Br), 
4.21 (t, 2 H, OCH2CH2Br), 6.97-7.03 (m, 2 H, Ar H), 7.52 (td, 1 H, Ar H), 7.81 (dd, 1 H, Ar H), 
10.45 (s, 1 H, Ar CHO). 13C NMR [CDCl3, 100 MHz]: δ = 189.57, 161.01, 136.11, 128.63, 
124.95, 121.06, 112.58, 65.92, 32.10, 29.74. IR (KBr): 2870w, 1726sh, 1683, 1597, 1583sh, 
1485, 1456, 1386, 1283, 1237, 1189, 1160, 1102, 1041sh, 1021, 928, 836, 808w, 753, 647, 599, 
563, 501, 439. 
 
 
Tetrasalicylaldehyde 35  
 
To a stirring solution of oven-dried (110 °C) K2CO3 (0.69 g, 5.00 mmol) in dry DMF (40 mL), 
dry 32 (0.50 g, 0.490 mmol) was added and stirred until completely dissolved.  To the resulting 
light yellow solution, 33 (0.90 g, 3.93 mmol) was added and the reaction mixture gently heated 
at 55 °C for three days.  During this period, the solution became yellow and cloudy, with a white 
precipitate deposited on the sides of the reaction vessel.  The mixture was cooled to room 
temperature, at which time the unreacted K2CO3 and the white precipitate gravity-filtered from 
the solution.  The filtrate was collected, and the DMF removed in vacuo, yielding a dark yellow, 
oily residue.  Methanol was added to the residue to remove excess 33 and precipitate out the 
title compound.  The resultant white suspension was stirred overnight, and the title compound 
was obtained by filtration from the methanol as a pure, white powder. (0.74 g, 93 %), mp 106-
108 °C dec. 1H NMR [CDCl3, 400 MHz]: δ = 2.39-2.46 (m, 8 H, CH2CH2Ar), 2.59-2.63 (m, 8 
H, CH2CH2Ar), 4.33 (m, 20 H, inner of OCH2O and OCH2CH2O), 4.72 (t, J = 7.8 Hz, 4 H, 
CHCH2CH2Ar), 5.64 (d, J = 7.1 Hz, 4 H, outer of OCH2O), 6.80 (s, 4 H, cavitand Ar H), 6.99 
(m, 4 H, Ar H), 7.16 (m, 4 H, Ar H), 7.18-7.24 (m, 20 H, CH2CH2C6H5), 7.52 (td, J = 7.8 Hz, J 
= 1.8 Hz, 4 H, Ar H), 7.80 (dd, J = 7.9 Hz, J = 1.7 Hz, 4 H, Ar H), 10.31 (s, 4 H, Ar CHO). 13C 
NMR [CDCl3, 100 MHz]: δ = 189.97, 161.36, 148.42, 144.38, 141.93, 138.95, 136.04, 128.26, 
128.04, 126.12, 125.19, 121.05, 114.49, 112.91, 99.43, 71.58, 68.32, 37.19, 34.52, 32.36. IR 
(KBr): 2939w, 2870w, 1683, 1599, 1480, 1455sh, 1438, 1315, 1286, 1188w, 1155, 1103, 1018, 
980, 938sh, 831, 752, 697, 654w, 587. Anal Calcd for C100H88O20 (1609.77): C 74.61, H 5.51. 
Found: C 74.73, H 5.57. 
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Tetrasalicylaldehyde 36  
 
Application of the above procedure for 35, using dry 32 (0.50 g, 0.490 mmol) and 34 (0.95 g, 
3.93 mmol), yielded the title compound as a pure, white powder. (0.66 g, 81 %), mp 96-100 °C 
dec. 1H NMR [CDCl3, 400 MHz]: δ = 2.13-2.16 (mt, J = 6.0 Hz, 8 H, CH2CH2CH2), 2.41-2.45 
(m, 8 H, CH2CH2Ar), 2.60-2.64 (m, 8 H, CH2CH2Ar), 4.14 (t, J = 5.8 Hz, 8 H, CH2CH2O), 4.25 
(t, J = 6.0 Hz, 8 H, CH2CH2O), 4.33 (d, J = 7.1 Hz, 4 H, inner of OCH2O), 4.74 (t, J = 7.9 Hz, 4 
H, CHCH2CH2Ar), 5.63 (d, J = 7.1 Hz, 4 H, outer of OCH2O), 6.79 (s, 4 H, cavitand Ar H), 
6.98 (m, 4 H, Ar H), 7.13 (m, 4 H, Ar H), 7.18-7.24 (m, 20 H, CH2CH2C6H5), 7.50 (td, J = 7.8 
Hz, J = 1.8 Hz, 4 H, Ar H), 7.81 (dd, J = 7.9 Hz, J = 1.9 Hz, 4 H, Ar H), 10.48 (s, 4 H, Ar 
CHO). 13C NMR [CDCl3, 100 MHz]: δ = 189.88, 161.48, 148.49, 144.44, 141.89, 138.90, 
136.11, 128.72, 128.56, 126.17, 125.10, 120.85, 114.23, 112.61, 99.51, 70.00, 65.29, 37.21, 
34.60, 32.52, 30.00. IR (KBr): 2944w, 1684, 1598, 1456sh, 1438sh, 1387w, 1285, 1240, 1188w, 
1152, 1103, 1047, 1018, 976, 841w, 754, 698, 588. Anal Calcd for C104H96O20 (1665.87): C 
74.98, H 5.81. Found: C 75.19, H 5.90. 
 
 
Cavitand-capped porphyrin 37 (reflux, Adler conditions) 
 
Propionic acid (200 mL) was stirred in a 250 mL round-bottomed flask, and heated to reflux in 
air.  Once gently refluxing, 35 (0.20 g, 0.12 mmol) was added to the reaction vessel and left to 
dissolve.  On dissolution, the reaction vessel was shielded from light, and freshly distilled 
pyrrole 9 (0.0330 g, 0.49 mmol) added to the solution.  Over a period of approximately 10 
minutes, the reaction mixture went black.  Reflux continued for a further 20 minutes, at which 
time the heating ceased, and the reaction was left to stir while slowly attaining room 
temperature.  Stirring continued overnight, and the vessel contents poured into a separating 
funnel.  Water, saturated with NaHCO3, and CH2Cl2 (100 mL) was added to the separating 
funnel, and the reaction mixture subsequently extracted carefully.  The extraction of the organic 
layer was repeated once more with aqueous NaHCO3, and after effervescence subsided 
completely, the organic layer was dried over Na2SO4, filtered and preadsorbed onto silica (3 g).  
Silica gel chromatography using a benzene eluant afforded a purified purple material.  Once the 
benzene was removed, the purple residue was dissolved in a small amount of CHCl3, and 
methanol allowed to slowly diffuse into the solution in order to recrystallise the title compound.  
After 2 days, 37 was isolated as a dark purple, microcrystalline solid. (0.023 g, 11 %), mp >300 
°C. 1H NMR [CDCl3, 400 MHz]: δ = -2.88 (s, 2 H, NH), 2.12-2.18 (m, 8 H, CH2CH2Ar), 2.38-
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2.43 (m, 8 H, CH2CH2Ar), 3.14 (d, J = 7.3 Hz, 4 H, inner of OCH2O), 3.48 (t, J = 5.6 Hz, 
OCH2CH2O), 4.35 (t, J = 5.5 Hz, OCH2CH2O), 4.42 (t, J = 7.9 Hz, 4 H, CHCH2CH2Ar), 5.12 
(d, J = 7.3 Hz, 4 H, outer of OCH2O), 6.36 (s, 4 H, cavitand Ar H), 6.95-6.99 (m, 8 H, 
CH2CH2C6H5), 7.09-7.12 (m, 12 H, CH2CH2C6H5), 7.31-7.36 (m, 4 H, Ar H), 7.42 (d, J = 8.4 
Hz, 4 H, Ar H), 7.77 (td, J = 7.3 Hz, J = 1.8 Hz, 4 H, Ar H), 7.85 (dd, J = 7.4 Hz, J = 1.7 Hz, 4 
H, Ar H), 8.71, 8.82 (both s, 8 H, HC(β) of pyrrole). 13C NMR [CDCl3, 100 MHz]: δ = 158.10, 
158.03, 149.99, 146.76, 143.41, 141.58, 138.15, 138.07, 136.52, 131.49, 129.76, 128.44, 
128.27, 125.89, 119.93, 115.49, 112.90, 112.13, 99.24, 71.29, 67.87, 36.58, 34.20, 32.22. IR 
(KBr): 2923w, 1598w, 1578w, 1468, 1437, 1313, 1245, 1209, 1151, 1112, 1048, 1021, 978, 
874w, 797, 748, 697, 650w, 586, 481. UV-Vis (CHCl3): 647, 588, 547, 513, 419 (Soret), 398.53, 
399sh. MS (ESI-TOF) Calcd for C116H94O16N4: 1800.6771. Found: 1800.5112. 
 
 
Cavitand-capped porphyrin 37 (microwave heating, Adler conditions) 
 
Propionic acid (4 mL) was added to a borosilicate microwave reaction tube containing 35 (0.076 
g, 0.05 mmol).  Once the material dissolved, freshly distilled pyrrole 9 (0.0138 g, 0.20 mmol) 
was added, together with a small stirrer bar, and the tube sealed with a Teflon-lined cap.  The 
tube was inserted into the microwave heating unit, and heated rapidly whilst stirring to 160 °C.  
Once the temperature had been attained, it was maintained for five minutes, after which time the 
tube was allowed to cool to room temperature.  The vessel was removed from the microwave, 
shielded from light and its cap removed, before being allowed to stir overnight in air.  The 
vessel contents were then poured into a separating funnel.  Water, saturated with NaHCO3, and 
CH2Cl2 (100 mL) were added, and the reaction mixture extracted carefully.  The extraction of 
the organic layer was repeated once more with aqueous NaHCO3, and after effervescence 
subsided completely, the organic layer was dried over Na2SO4, filtered and preadsorbed onto 
silica (2 g).  Silica gel chromatography using a benzene eluant afforded a purified purple 
material.  Once the benzene was removed, the purple residue was dissolved in a small amount of 
CHCl3, and methanol allowed to slowly diffuse into the solution in order to recrystallise the title 







Cavitand-capped porphyrin 38 (microwave heating, Adler conditions) 
 
Propionic acid (4 mL) was added to a borosilicate microwave reaction tube containing 36 (0.077 
g, 0.05 mmol).  Once the material dissolved, freshly distilled pyrrole 9 (0.0138 g, 0.20 mmol) 
was added, together with a small stirrer bar, and the tube sealed with a Teflon-lined cap.  The 
tube was inserted into the microwave heating unit, and heated rapidly whilst stirring to 160 °C.  
Once the temperature had been obtained, it was maintained for five minutes, after which time 
the tube was allowed to cool to room temperature.  The vessel was removed from the 
microwave, shielded from light and its cap removed, before being allowed to stir overnight in 
air.  The vessel contents were then poured into a separating funnel.  Water, saturated with 
NaHCO3, and CH2Cl2 (100 mL) was added, and the reaction mixture extracted carefully.  The 
extraction of the organic layer was repeated once more with aqueous NaHCO3, and after 
effervescence subsided completely, the organic layer was dried over Na2SO4, filtered and 
preadsorbed onto silica (2 g).  Silica gel chromatography using a 95:5 chloroform:ethyl acetate 
eluant afforded a purified purple material.  This material was preadsorbed once more onto silica, 
before being subjected to column chromatography using a benzene eluant.  This yielded a 
purple, oily residue upon removal of the benzene.  Methanol was added to precipitate out the 
purified capped porphyrin, which was filtered from the methanol and carefully collected.  The 
material was dissolved in a small amount of CHCl3, and methanol allowed to slowly diffuse into 
the solution in order to recrystallise the title compound.  Recrystallisation was repeated, and 
after three days, 38 was isolated as a dark purple, microcrystalline solid. (0.014 g, 15 %), mp 
>300 °C. 1H NMR [CDCl3, 400 MHz]: δ = -2.82 (s, 2 H, NH), 1.87 (m, 8, OCH2CH2CH2O), 
2.14-2.19 (m, 8 H, CH2CH2Ar), 2.40-2.43 (m, 8 H, CH2CH2Ar), 3.29 (d, J = 7.4 Hz, 4 H, inner 
of OCH2O), 3.44 (t, J = 5.6 Hz, OCH2CH2CH2O), 4.19 (t, J = 5.7 Hz, OCH2CH2CH2O), 4.44 (t, 
J = 8.2 Hz, 4 H, CHCH2CH2Ar), 5.16 (d, J = 7.4 Hz, 4 H, outer of OCH2O), 6.39 (s, 4 H, 
cavitand Ar H), 6.95-6.97 (m, 8 H, CH2CH2C6H5), 7.09-7.10 (m, 12 H, CH2CH2C6H5), 7.30 (t, J 
= 7.4 Hz, 4 H, Ar H), 7.38 (d, J = 8.5 Hz, 4 H, Ar H), 7.72 (t, J = 7.5 Hz, 4 H, Ar H), 7.85 (dd, J 
= 7.3 Hz, J = 1.0 Hz, 4 H, Ar H), 8.73 (s, 8 H, HC(β) of pyrrole). 13C NMR [CDCl3, 100 MHz]: 
δ = 158.40, 147.16, 143.79, 141.67, 138.15, 136.89, 132.03, 130.87, 129.66, 128.81, 128.44, 
128.28, 125.87, 119.88, 115.80, 113.28, 112.86, 99.15, 69.30, 68.17, 65.80, 38.75, 36.66, 34.29, 
32.15, 30.74. IR (KBr): 2922, 2852w, 1598w, 1578w, 1469, 1438, 1316, 1255, 1209w, 1153, 
1106, 1049, 1020w, 966, 800, 750, 697, 648w, 587, 484. UV-Vis (CHCl3): 647, 591, 549, 515, 




2-chloromethoxybenzaldehyde (39) [15] 
 
To a stirring solution of oven-dried (110 °C) K2CO3 (6.50 g, 0.0471 mol) in dry DMF (80 mL), 
salicylaldehyde (5.0 g, 0.0410 mol) was added so turning the solution bright yellow.  After 10 
minutes of stirring at room temperature, bromochloromethane (42.44 g, 0.328 mol) was added 
and the reaction mixture left to stir further for 3 days.  Thereafter, the mixture was poured into 
water, and the liberated oil extracted from the aqueous emulsion with diethyl ether.  The organic 
layer was treated with 10 % NaOH (3 times) followed by extraction with water (twice) before 
being dried over Na2SO4.  The diethyl ether was evaporated, and the excess 
bromochloromethane reagent removed under reduced pressure to give a white, crystalline solid. 
(4.68 g, 67 %), mp 118-120 °C. 1H NMR [CDCl3, 400 MHz]: δ = 6.02 (s, 2 H, CH2), 7.14-7.20 
(m, 1 H, Ar H), 7.34-7.43 (m, 1 H, Ar H), 7.58-7.66 (m, 1 H, Ar H), 7.85-7.94 (m, 1 H, Ar H), 
10.47 (s, 1 H, Ar CHO). 13C NMR [CDCl3, 100 MHz]: δ = 189.58, 157.36, 136.35, 128.95, 
126.47, 123.02, 115.70, 91.57. IR (KBr): 2863, 1687, 1597, 1582sh, 1479, 1459, 1414, 1388, 
1284, 1215, 1194, 1159, 1101, 1004, 829, 753, 643, 580, 41414, 1388, 1284, 1215, 1194, 1159, 
1101, 1004, 829, 753, 643, 580, 479, 438. 
 
 
Tetrasalicylaldehyde 40  
 
To a stirring solution of 32 (0.50 g, 0.490 mmol) in dry THF (50 mL) under a nitrogen 
atmosphere, NaH (60% suspension in mineral oil, 0.16 g, 6.53 mmol) was added.  To the 
resulting cream-coloured solution, 39 (0.68 g, 4.0 mmol) was added and the solution gently 
heated to reflux.  The reaction continued for 3 days, during which time the solution assumed a 
grey colour.  TLC, using a mobile phase of 1:1 hexane-ethyl acetate, showed the desired product 
(Rf = 0.40) in addition to excess 39 (Rf = 0.60).  After 3 days, the reaction mixture was cooled to 
room temperature, and concentrated on a rotary evaporator.  The products were 
chromatographed on silica gel using a mobile phase of 1:1 hexane-ethyl acetate.  The eluant was 
concentrated on a rotary evaporator to give a yellow residue.  Trituration of this residue with 
hexane yielded a white solid, which was subsequently stirred in methanol to remove residual 39.  
Filtration of this solution yielded the title compound as a white solid. (0.26 g, 34 %), mp 113-
115 °C dec. 1H NMR [CDCl3, 400 MHz]: δ = 2.43-2.49 (m, 8 H, CH2CH2Ar), 2.64-2.68 (m, 8 
H, CH2CH2Ar), 4.44 (d, J = 6.8 Hz, 4 H, inner of cavitand OCH2O), 4.79 (t, J = 7.9 Hz, 4 H, 
CHCH2CH2Ar), 5.39 (s, 4 H, OCH2O), 5.96-5.99 (m, 8 H, outer of cavitand OCH2O and extra-
annular OCH2O), 6.66 (s, 4 H, cavitand Ar H), 7.12-7.22 (m, 24 H, CH2CH2C6H5 and Ar H), 
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7.35 (d, J = 8.4 Hz, 4 H, Ar H), 7.59 (t, J = 7.8 Hz, 4 H, Ar H), 7.84 (d, J = 7.7 Hz, 4 H, Ar H), 
10.44 (s, 4 H, Ar CHO). 13C NMR [d6-acetone, 100 MHz]: δ = 189.27, 143.57, 143.50, 143.39, 
143.34, 143.28, 139.46, 136.92, 129.36, 129.26, 128.76, 126.62, 123.62, 116.45, 111.33, 
100.76, 91.60, 38.19, 35.24, 33.05. IR (KBr): 2933, 1690, 1599, 1492w, 1461, 1444, 1319w, 
1244, 1209, 1149, 1102, 1067, 977, 832w, 752, 697, 645w, 590, 512w. Anal Calcd for 





bis[1,3]benzodioxocin Stereoisomer (42)  
 
To a stirring solution of oven-dried (110 °C) K2CO3 (0.69 g, 5.00 mmol) in dry DMF (40 mL), 
dry 32 (0.50 g, 0.490 mmol) was added and stirred until completely dissolved.  To the resulting 
light yellow solution, 1,3-dibromopropane (0.79 g, 3.93 mmol) was added and the reaction 
mixture gently heated at 50 °C for three days.  During this period, the solution became yellow 
and cloudy, with a white precipitate deposited on the sides of the reaction vessel.  The mixture 
was cooled to room temperature, at which time the unreacted K2CO3 and the white precipitate 
gravity-filtered from the solution.  The filtrate was collected, and the DMF removed in vacuo, 
yielding a dark yellow, oily residue.  Methanol was added to the residue to remove excess 1,3-
dibromopropane and precipitate out the title compound.  The resultant white suspension was 
stirred overnight, and the title compound was obtained by filtration from the methanol as a pure, 
white powder. (0.46 g, 63 %), mp 110-113 °C dec. 1H NMR [CDCl3, 400 MHz]: δ = 2.11-2.19 
(m, 8 H, CH2CH2CH2), 2.42-2.48 (m, 8 H, CH2CH2Ar), 2.64-2.68 (m, 8 H, CH2CH2Ar), 3.59 (t, 
J = 6.5 Hz, 8 H, OCH2CH2CH2Br), 4.07(t, J = 5.5 Hz, 8 H, OCH2CH2CH2Br), 4.38 (d, J = 7.0 
Hz, 4 H, inner of OCH2O), 7.11-7.20 (m, 20 H, CH2CH2C6H5). 13C NMR [CDCl3, 100 MHz]: 
δ = 148.46, 144.20, 141.73, 138.75, 128.59, 128.43, 126.04, 114.12, 99.43, 70.87, 37.04, 34.48, 
33.31, 32.37, 30.25. IR (KBr): 2937w, 1470, 1438, 1316, 1150, 1104w, 1018, 979, 749w, 698, 
587, 485. Anal Calcd for C76H76O12Br4 (1501.03): C 60.81, H 5.10 Br 21.29. Found: C 61.02, H 
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Spectrum 1.63: FAB mass spectrum of 26  
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